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ABSTRACT 
An enrichment selection method was used to isolate Chinese hamster 
ovary (CHO) AK 412 variants resistant to 1 Pg/ml cytochalasin D (CD). 
P 
The cytochalasin D-resistant (Cyd ) variant phenotype was thoroughly 
characterized by physiological, cytogenetic, morphological, and bio­
chemical techniques. 
The Cyd -variemts were shown to possess a membrane lesion which con­
fers CD resistêmce by reducing the uptake of CD from the extracellular 
medium. The change in membrane structure conferring CD resistance was 
correlated with several changes in membreme function, including: a 
generalized drug cross-resistance; hypersensitivity to a membrane specific 
drug (procaine); significant changes in cell surface morphology; differ­
ences in cellular adhesion properties; and a decrease in membrane 
pliability. 
Cell surface proteins (glycoproteins) were radiolabeled by three 
125 different methods: (1) [ X]-lactoperoxidase catalyzed iodination; (2) 
labeling of surface galactose residues by []-NaBH^ -galactose oxidase; 
and (3) metabolic labeling of cell surface glycoproteins with [^ H]-fucose 
and -glucosamine. Autoradiograms from SDS-polyacrylamide gels of 
labeled membrane proteins revealed at least six differences between the 
Cyd -variants and the CHO parent. In all cases, the labeled proteins 
migrated slightly slower in the varieint, suggesting that increased 
glycosylation emd/or some other modification of membrane glycoproteins 
is associated with CD-resistemce. 
X 
Although no definitive genetic mechanism or gene product responsible 
for CD resistance was established, indirect evidence strongly suggests 
R 
that CD resistance (and other characteristics associated with the Cyd -
phenotype) is mediated by gene an^ lification. The amplified gene exists 
in the form of a novel homogeneous staining region (HSR) on the long arm 
of chromosome 1. 
CD-resistance is unstable in nonselective medium. However, three 
independent experiments demonstrated cellular inheritance of the Cyd^ -
phenotype. Loss of CD resistance during subculturing in nonselective 
medium results from two processes: (1) segregation of CD-sensitive cells 
from the CD-resistant population; and (2) a strong selective growth ad­
vantage for CD-sensitive segregants in nonselective medium. CD-resistance 
and -sensitivity correlate with the presence or absence of the HSR on 
chromosome 1, further strengthening the hypothesis that the molecular 
(genetic) basis of CD resistance in gene amplification. 
The Cyd -variants are quite useful in studying the relationship be­
tween structure and function in the plasma membrane. The characteristics 
associated with the Cyd -phenotype have been observed in many other drug-
uptake and efflux mutants. A model is proposed that attempts to explain 
reduced drug uptake or increased drug efflux in terms of gene éunplification. 
In this model, amplification of a gene(s) that controls glycosylation 
and/or phosphorylation levels of cell surface glycoproteins results in a 
pleiotropic phenotype. 
1 
I. INTRODUCTION 
The plasma menibrcme and cell cytoskeleton are essential structural 
components of normal cells. They function in cell growth, division, dev-
velopment, communication, and differentiation (Wallach, 1975; Goldman et al. 
1976; Poste and Nicholson, 1977a,b, 1981; Wolf and Murray, 1980.). These 
structures regulate drug permeability, ion and metabolite transport, 
endocytosis, exocytosis, cell fusion, adhesion, capping, cellular 
architecture, cell motility and cell division. 
Little is known about the relationship between changes in the 
chromosomal genetic material (DMA), and normal and abnormal control 
of the plasma membrane and cell cytoskeleton. It has been proposed that 
changes in one or both of these structures results in a number of disease 
states, such as ccincer (Wallach, 1975) and muscular dystrophy (Wolf and 
Murray, 1980; Lucy, 1980). Therefore, understanding the molecular con­
trols regulating normal plasma membrane and cell cytoskeleton structure 
and function is of primary importance. 
Cytochalasin is a fungal metabolite known to ellicit specific and 
significant changes in both the plasma membrane and cell cytoskeleton 
(Tanenbaum, 1978). "Hie goal of this research project was the vitro 
isolation of mammalian cell mutants resistant to cytochalasin. The 
cytochalasin D-resistant mutants I have isolated exhibit striking 
changes in membrane function. These changes include: altered drug 
permeability, cell division, cell surface morphology, cellular adhesion 
and membrane pliability. A number of differences in cell surface 
2 
glycoproteins are also associated with changes in membrane function. 
In addition, alterations in chromosome structure were correlated with 
the cytochalasin D-resistant phenotype. 
3 
II. REVIEW OF LITERATURE 
Genetic analysis of the bacterial genome and the isolation of 
bacterial mutants have proved to be important techniques in relating 
subcellular structure with function in prokaryotes (Watson, 1976; Lewin, 
1980). However, significant obstacles are encountered in attempting to 
use similar genetic cuialyses in higher eukaryotes. 
Bacteria are single celled organisms, whereas, higher eukaryotes 
are multicellular. Because the genetic background of multicellular 
organisms is known to significantly modify the phenotype of that 
organism, conclusions reached from experiments on whole animals are 
often equivocal and difficult to interpret (Winchester, 1982). Further­
more, the genetic systems of most higher eukaryotes, especially mammals, 
make it difficult if not incessible to obtain a series of genotypes 
identical except for allelic differences at defined loci (Lewin, 1980). 
Isolation of mutants in higher eukaryotes is limited by the low number 
of individuals that can be screened, difficulties in devising selective 
techniques, the often lethal nature of mutation to the whole animal, 
the small numbers of progeny per mating, emd the relatively long gene­
ration period. Also, it is often extremely difficult to correlate an 
isolated mutant phenotype with the function of a mutated gene. Genetic 
analysis using organ and/or tissue culture suffers from mcuiy of the 
same problems as for whole animal analysis. 
The observation that cells derived from animal tissue could be 
grown with relative ease in culture (Carrel, 1912; Sanford et al., 1948; 
4 
Puck, 1958, 1972; Eagle, 1955) provided a major breakthrough in the 
development of alternatives to whole animal analysis, êind to organ or 
tissue culture. It is now possible to isolate and clone cells from 
tissue expiants (primary cell cultures) and to grow such cells into 
large populations. Barring mutation and selection, progeny from a 
cloned, primary cell should be genotypically identical. Because the 
media used to culture cells can be well-defined, external modifying 
factors can be controlled. The generation time of cells in culture 
is fairly rapid, from 12 to 30 hours, allowing large numbers of identi­
cal cells to be obtained over a short period of time. 
One problem inherent in working with primary cell culture is the 
limited number of cell divisions primary cells undergo before senescing 
or dying (Hayflick and Hoorehead, 1961; Holliday, 1975; Finch and Hay-
flick, 1977). The number of cell divisions available to a particular 
primary cell culture varies depending on the orgeuiism from which the 
cells were derived, the cell type, the age of the organism from which 
the cells were isolated, and other as yet undefined factors. However, 
rarely do primary cell cultures suirvive past 50 to 60 cell doublings 
(Holliday, 1975; Hill et al., 1977). This problem has been overcome by 
working with transformed cell lines, cell lines that possess an infinite 
capacity to divide (Puck, 1972; Lewin, 1980). The origins of transformed 
cells, commonly referred to as permanent or established cells, and the 
methods by which they are obtained are beyond the scope of this review. 
The important point is that permanent cell lines from a large variety of 
5 
tissues and a wide range of species can be permanently established in 
culture (Puck, 1972) either as a spontaneous event or with the aid of 
chemical or viral agents (Puck, 1958; Girard, 1965; Freeman, 1973; 
Tasne et al., 1974). In addition,.permanent cell lines can be derived 
directly from animal tumors (Sato et al., 1957). 
Although the chromosomes of cells ^  vivo and permanent cell 
lines derived from them are not identical and can vary considerably in 
number, arrangement and stability, it is widely presumed that gene regu­
latory patterns in normal and transformed cells are similar (Puck, 
1972; Ringertz and Savage, 1976). Permanent cell lines cultivated 
in vitro maintain their characteristic structure and morphology and 
synthesize essential proteins which will maintain homeostasis ; these may 
include enzymes involved in ancUwlic and catabolic pathways, proteins 
involved in the cell cycle as well as proteins necessary for the 
structural integrity of the cell (Ephrussi, 1972). Meiny cell lines, 
under appropriate conditions, can be induced to express a battery of 
differentiation-specific functions. These include globin production 
(Clarkson et al., 1978), collagen synthesis (Adams et al., 1982), anti­
body synthesis (Early and Hood, 1981), and nyogenesis (Nadal-Ginard, 
1978; Inestrosa, 1982). Normal expression of these functions are 
essential for survival of an intact emimal but are not necessary for 
viability of permanent cell lines. 
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A. Mutant Isolation in Cultured 
Cells 
Bacteria generally contain one to four copies of a single identical 
chromosome containing a single copy of each structural gene (Hayes, 1968; 
Watson, 1976). A mutation in a structural gene located on a bacterial 
chromosome rapidly segregates out and is expressed within one or a few 
generations (Alan Atherly, Department of Genetics, Iowa State University, 
Ames, Iowa, personal communication). Thus, isolation of recessive muta­
tions in a single step can be achieved fairly readily, with mutation 
rates in the range of 10 to 10 per cell per generation (Watson, 1976). 
The assumption of the somatic cell geneticists of the 1950s cind 1960s was 
that somatic cells could be treated as unicellular organisms, and hence, 
methods for the isolation and characterization of somatic cell mutants 
would be analogous to those used for bacteria. However, somatic cells 
from higher eukaryotes are diploid, containing at least two copies of 
each type of chromosome and thus at least two copies of each structural 
gene. Theoretically, isolation of recessive mutations in somatic cells 
"8 "14 by a single step should be rare; on the order of 10 to 10 per cell 
per generation (assuming mutation rates of 10 to 10 per allele). 
Therefore, one would e^ qpect that most, if not all, somatic cell mutants 
would be dominant, codominant, or incompletely dominant; i.e., es^ ressed 
in autosomal genes when only one gene is mutated. However, the 
majority of mutants isolated from somatic cells behave recessively when 
tested in somatic cell hybrids (Siminovitch, 1976). 
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Several hypotheses have been offered to explain the surprisingly 
high mutation rate at many loci and to e^ qplain the relative ease with 
which recessive mutants are obtained from diploid cells. The most popu­
lar explanation is that many cell lines, e.g., Chinese hamster ovary 
(CHO), are not diploid over their whole genome, but are extensively and 
functionally hemizygous (Siminovitch, 1976, 1979a, 1981). An alterna­
tive explanation is that somatic cells are extensively heterozygous and 
that recessive mutants arise by either segregation or inactivation of 
the wild type allele (Farrell and Norton, 1977; Chasin and Urlaub, 1976). 
Heritable variation in phenotype could result from either gene 
mutation or from an "epigenetic" event. A mutational event is defined 
as any heritable nucleotide base chemge, deletion, or rearrangement in 
the primary structure of DNA (DeHars, 1974; Siminovitch, 1976). By 
this definition, mutation includes not only point and deletion mutations, 
but also chromosomal rearrangements and chromosome loss or gain, as long 
as heritable changes result. Some geneticists regard increases in gene 
copy number (gene amplification), chromosomal rearrangements (giving rise 
to position effects), and Lyonization of a previously active gene 
(analogous to X-chromosome inactivation), as genetic events (Adelberg, 
1979). However, not all somatic cell geneticists agree that gene 
amplification or Lyonization are mutational events (DeMars, 1974). 
The definition of an epigenetic event is ambiguous ; it is usually 
defined as phenotypic variation not considered gene mutation and not in­
volving changes in DNA structure (Adelberg, 1979). Epigenesis has often 
8 
been ascribed to cases of phenotypic variation in which a genetic basis 
for the observed variation is not readily apparent. Attributing a 
variant phenotype to epigenetic mechanisms often resulted from in­
adequate knowledge of the biochemistry and molecular biology of gene 
regulation. As advances were made in these fields, previous cases of 
supposed epigenesis were superseded by genetic explanations of the 
observed variation (see section: Gene Amplification). it has been 
suggested that there is very little evidence demonstrating epigenetic 
phenomena as a mechanism in the generation of somatic cell variants 
(Siminovitch, 1976; Adelberg, 1979). 
The molecular causes underlying epigenetic events remain undefined, 
although events such as stable inheritance of an inactive X chromosome 
in mammalian cells (i.e., the Barr body) is considered to be an epi­
genetic phenomenon by some (Adelberg, 1979). Epigenetic phenomena may be 
analogous to the molecular events leading to cellular differentiation 
(e.g., myogenesis, keratinization, globin gene switching, immunoglobulin 
switching, etc.)(Adelberg, 1979). It is implied that cell differentiation 
does not involve rearrangements of DNA sequences and is dependent upon 
changes in chromosomal proteins, DNA methylation, etc. Only recently 
have we begun to understand the molecular events underlying differentia­
tion, and the evidence indicates, at least in some cases, that major 
gene rearrangements, including gene amplification, play an integral 
role in cellular differentiation processes (Schimke, 1981). 
An example of an epigenetic event can be found in certain cases of 
9 
methotrexate resistance. This topic will be dealt with more thoroughly in 
the section on gene amplification (see pp. 40-44). Briefly, methotrexate 
(MTX) kills cells by binding very tightly to and inhibiting the enzyme 
dihydrofolate reductase (DHFR). Memy MTX-resistant lines have been iso­
lated by stepwise enrichment selection (see section: Selection of Membrane 
and Cytoskeletal Mutants of Cultured Mammalian Cells) in increasing con­
centrations of MTX. Some cells are able to overcome MTX-induced death 
by a phenomenon called "enzyme induction" (Bertino et al., 1981). The 
increase in DHFR levels may allow cells to survive MTX treatment because 
MTX is actively transported out of the cell, and a small amount of 
MTX dissociation from increased DHFR levels allows enough residual DHFR 
activity for the cell to survive. This mode of drug resistance is not 
heritable or stable. The combined effects of dilution of the enzyme 
by cell division coupled with a return to normal DHFR turnover rates 
after prolonged MTX removal, restore DHFR to control levels. Thus, MTX-
resistance is rapidly lost after removal of MTX. This is an example of 
a phenotypic change (resistance to MTX) due to an epigenetic event (no 
DMA structural changes accompany the MTX-resistant phenotype). 
Morgan Harris (Harris, 1982) has presented strong evidence for an 
epigenetic mechanism underlying stable variation in cultured cells. 
Harris investigated the induction of thymidine kinase (TK) in tk 
Chinese hamster cells. Previous work indicated that TK deficiency and 
loss of potential for plating in HAT medium may arise by a process of 
mutation coupled with site-specific repression by bromodeoxyuridine (BrdU) 
10 
at the tk locus. Tk cells were exposed to a series of chemicals known 
to induce differentiation in a number of cell systems, presumably by 
causing hypomethylation of DNA bases. Addition of 5-azacytidine (5-
aza-CR), n-butyrate or L-ethionine to tk (and thus, HAT ) cells resulted 
in a massive conversion of cells to the HAT^  state, with frequencies as 
M  ^
high as 10% of the original HAT cell population. The tk revertants 
contained levels of TK activity intermediate between those of tk and 
wild-type cells (thus, cells were tk /+). None of the three agents 
used to induce tk^  revertants demonstrated any mutagenic potential. 
Treatment of tk cells with graded concentrations of EMS resulted in 
only a slight increase in the frequency of HAT cells (10 to 10 
— 3 
per cell per generation) compared to treatment with 5-aza-CR (10 to 
10 per cell per generation). 
Harris concluded that, at least for tk Chinese hamster cells, one 
of the TK alleles can exist in a heritably stable, repressed or non-
expressed state due to nongenetic (epigenetic) mechanism(s). Re-
reversion tests for HAT^  to HAT~ revealed high rates of reversion (1.2 
-3 
to 5.3 X 10 per cell per generation) previously reported by others 
(Roufa et al., 1973; Adair et al., 1980). Interestingly, Harris was 
unable to induce HAT revertants in tk HAT mouse cells (LMTK and 
3T3-4E). Widely disparate results between mouse and hamster cell lines 
is quite common, and this has made it difficult to make generalizations 
regarding the nature of mutation in cultured cells. 
A number of laboratories have reported evidence for gene or allele 
11 
inactivation at one or more loci in CHO ëind other hcunster cell lines 
(Harris, 1975; Morrow, 1977; Bradley, 1979; Bradley and Letovanec, 1982; 
Campbell and Worton, 1981; Tischfield et al., 1982; Simon et al., 1982; 
Stallings et al., 1982). A wide variety of interpretations were 
presented in order to explain the mechanism of gene inactivation or 
"allelic silence", including: position effect variegation as observed 
in Orosophilla (Baker, 1968); involvement of an insertion element or 
transposon; mitotic recombination; chromosomal nondisjunction; the 
presence of a locus-specific mutator gene; mutational hot spots; or 
the presence of deletions. At the present time, it is not possible to 
decide which explanations are correct. Most likely, all play a role in 
the ease with which recessive mutations are obtained in diploid somatic 
cells. The mechanism(s) responsible for generating recessive mutations 
at a high rate at any one particular locus may depend on the locus, the 
cell line used, and/or culture conditions (i.e., factors such as pH, 
temperature, and serum, etc.). It is possible that other as yet 
unknown mechanisms are important as well. 
The controversy as to whether somatic cell variants obtained 
in vitro are of genetic or epigenetic origin is still unresolved. There 
exists strong evidence that many of the recessive mutations in somatic 
cells are of true genetic origin, including missenses, nonsense, frame-
shift and deletion mutants (Siminovitch, 1976, 1981). Before the de­
velopment of molecular biology, it was very difficult to understand 
epigenetic events mechanistically, and to study them exqperimentally. 
Consequently, such varicints were ignored or discarded. Sophisticated 
12 
molecular biological and biochemical techniques have now made it possible 
to deal with the question of genetic vs. epigenetic mechanisms at the 
molecular level. 
1. Criteria for the classification of phenotypic variants as mutants 
Criteria have been established to define a "true" somatic cell 
muteuit as opposed to an epigenetic variant (Thompson and Baker, 1973; 
Ringertz and Savage, 1976; Siminovitch, 1981). One of the primary 
criteria is that the altered phenotype occurs randomly, and with a 
frequency that is increased by mutagens (Chu and Mailing, 1968). How­
ever, the frequency of some mutations, such as gene amplification, is re­
fractory to mutagen treatment (Schimke etal., 1978a,b). Also, the frequen-
of mutation may depend on the type of mutagen used, the fixation time, 
the locus under study, culture conditions, and other factors (Thompson 
and Baker, 1973; Clive et al., 1972; Arlett et al., 1975; Cole and 
Arlett, 1976; Friedrich and Coffino, 1977). 
It has been reported that there is little effect of ploidy on 
mutagen-induced mutation rates (Harris, 1971), which is the opposite 
result one would ei^ pect if the criterion of increased mutation 
frequency after mutagen treatment was a valid one. However, the 
results of Harris have been challenged by others (Siminovitch, 1976) 
éuid, the ability to enhance mutation frequencies with mutagen is widely 
used as a criterion in establishing a somatic cell variant as a mutant. 
A second frequently used criterion is that the altered phenotype 
is stedDly transmitted to daughter cells long after removal of selective 
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pressure {Hsie et al., 1979). If one includes gene amplification under 
the category of mutation, the criterion of stable inheritance is not 
always applicable (see section: Gene Amplification). 
The association between em altered phenotype and a change in 
enzymatic activity or other physico-chemical properties of specific 
gene products is considered strong evidence for establishing a pheno-
typic variant as a mutant (Thompson and Baker, 1973; Siminovitch, 1976; 
Ringertz and Savage, 1976; Hsie et al., 1979; Lewin, 1980). Altered 
gene products have been demonstrated in a large number of recessive 
mutants and in some dominant ones (Siminovitch, 1976). 
The ability to assign an altered phenotype (gene product) to a 
certain chromosome or map it to a specific chromosome region provides 
virtually unequivocal evidence that the variant cell is a mutant 
(Ringertz and Savage, 1976; Lewin, 1980). This criterion was diffi­
cult to demonstrate in somatic cells due to the absence of sexual 
reproduction and meiotic exchange, which is necessary for recombinational 
analysis. This has now been accon^ lished for many cell variants due to 
improved cell hybridization techniques (Siminovitch, 1976). However, 
Adelberg (1979) has suggested that mapping is not a good criterion for 
distinguishing genetic from nongenetic events since epigenetic events 
may map in a similar fashion. 
The ability to obtain phenotypic revertants and increase re­
version frequency by the addition of mutagens is another criterion 
commonly associated with somatic cell mutants (Ringertz and Savage, 
1976). This criterion is not useful in cases of deletion mutation and 
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in some cases of gene amplification. 
The most definitive proof for a mutational origin of a specific 
cellular phenotype is to demonstrate either base pair or other sequence 
changes at the gene level (Hsie et al., 1979). 
The designation of a somatic cell variant as a mutant has, in some 
instances, been arbitrary. For example, Baskin et al. (1981) haVe iso­
lated mouse neuroblas toma cell lines resistant to a number of different 
drugs. These drug-resistant lines were designated as drug-resistant 
mutants in spite of the fact that not one of the criteria commonly used 
for this determination had been met. In fact, in some of the drug-
resistant lines, inheritance of the drug-resisteint phenotype was un­
stable. On the other hand, Hamont et al. (1978) have isolated HTC cells 
resistant to two inhibitors of ornithine decarboxylase and designated 
these drug-resistant lines as variants. 
Thus, depending on the investigator(s), the rigor with which 
these criteria are applied varies considerably. This has resulted in 
the labeling of cell lines with similar phenotypes as varicints in one 
instance and as mutants in another. In this review, the procedure will 
be to use the author's assignment of variant or mutant. The cyto-
chalasin D-resistant isolates characterized in this research project 
will be referred to as variants, even though meiny other drug-resistant 
lines with similar phenotype are designated mutants by other labora­
tories. It is hoped that this clarification will be kept in mind in 
order to prevent confusion later on. 
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2. Characteristics of mammalian cell lines important for mutant 
isolation 
The criteria commonly used in choosing a particular cell line for 
mutant isolation have been reviewed extensively elsewhere (Thompson 
and Baker, 1973). The advantages of using CHO cells will be enumerated 
here: 1) Compared to other established cell lines, CHO cells possess a 
relatively stable karyotype. Depending upon the clonal isolate used, 
the modal chromosome number of CHO is 21 or 20. By comparison, the 
normal hamster diploid number is 2N = 22. Although the karyotype of CHO 
is not constant, the number of chromosomal rearrangements and changes in 
chromosome number are relatively few (Norton et al., 1977; Norton, 1978). 
In other cell lines, instability of the karyotype has sometimes precluded 
the isolation of mutants and the genetic characterization of a variant 
phenotype. Also, the low chromosome number and comparatively stable 
phenotype of CHO makes cytogenetic emalysis easier and more reliable. 
2) CHO can be easily cultured in monolayer or suspension, and can 
readily be shifted from one culture system to another. This has a 
number of advantages which will become evident in the analysis of the 
cytochalasin D-resistant variants. 3} CHO cells have a relatively short 
doubling time (T^ ; 12-16 hours at 37®) and a relatively high plating 
efficiency. Thus, the time required to grow large populations of cells 
or to form macroscopic colonies after cloning is short; e.g., it takes 
just 6-8 days to clone large colonies of CHO compared to 12 days for 
mouse L cells. 4) Synchronization of CHO cells can be readily achieved 
with or without the use of chemicals. 5) A large number of auxotrophic, 
drug resistant, and temperature-sensitive mutants have been isolated in 
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CHO, facilitating hybridization and gene mapping studies. 
It should be noted that there may be disadvantages in using a 
particular cell line. For example, in attengpting to obtain a mutation 
in an allele of a multigene family, it is possible that one line may 
have lost, through rearrcuigement, segregation, or inactivation, a sig­
nificant portion of the genes of the multigene family. Other cell 
lines may express all the members of a multigene family, which may pre­
clude isolation of recessive mutations in that gene family. 
3. Selection of membrane and cytoskeletal mutants of cultured mammalian 
cells 
In order to obtain membreuie or cytoskeletal mutants, one must devise 
a selection protocol which results in the isolation of a rare variant 
from a predominemtly wild-type population. Many selection methods have 
been developed, and the method of choice may be dependent upon the type 
of mutant desired. Because the research to be described in this 
dissertation involves membrane permeability variants, only methods 
used to isolate membrane variants/mutants will be reviewed here. 
Two "types" of membrane mutants can be obtained: mutants that 
result in reduced permeability or tramsport of intracellularly active 
substances or mutations that result in altered responses to membrane-
specific agents such as ouabain or local anesthetics (Bêdcer and Ling, 
1978). 
The most common method of isolating membrane mutzmts is to select 
for drug-resistance (Baker and Ling, 1978). Two basic approaches are 
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available: single-step selection and multiple-step or enrichment selec­
tion. Single-step selection, the preferred method of selection for drug 
resistance, involves the addition of a drug to cells in culture at drug 
concentrations which are toxic or growth-inhibiting to the majority of 
wild-type cells (drug-sensitive cells). Drug-resistant variants/mutants 
are not growth inhibited or killed at, the administered drug concentra­
tion. After an appropriate period of e:^ sure to drug, drug-resistant 
variants overgrow dead and static drug-sensitive cells, and form 
visible clones or colonies. Drug-resistcint colonies are then picked 
and subcultured for further testing. Drug resistant mutants are able 
to retain normal plating efficiencies, but may or may not possess 
normal growth rates in the presence emd/or absence of drug. 
Single-step selection techniques are highly desirable because the 
length of contact with drug cem be kept to a minimum, as little as six 
to ten days. Because drug contact is reduced to a minimum emd because 
wild type parental cells require at most one "hit" with a mutagen, 
single-step selection usually results in only one or very few mutations. 
Also, the frequency of drug-resistant clones can be quantitatively 
compared in populations of mutagenized euid nonmutagenized cells. 
Multiple-step or enrichment selection procedures are required when 
a particular phenotype cannot be obtained by single-step selection 
methods. For example, in order to isolate recessive mutations in a 
multigene family or gene containing multiple alleles, all of the genes 
or alleles must be mutated. Theoretically, this would require numerous 
18 
steps since mutation frequencies at single gene loci are often on the 
""4 7 
order of 10 to 10 per cell per generation, and the maximum number 
8 9 
of cells one can work with is 10 or 10 . For example, Bradley et al. 
(1982) have demonstrated that BrdU resistance occurs after three 
discrete steps in CHO cells. 
Enrichment selection involves continuous subculture of a mass 
population of cells in ever-increasing concentrations of drug, elimi­
nating wild-type cells from the population, and enriching for drug 
resistant cells. Eventually, enough resistant cells are present in the 
population to allow the isolation of resistant clones. A number of 
membrane mutants have been isolated in this manner, including variant 
cells with altered surface antigens (Adman and Pious, 1970). 
The disadvantages of enrichment selection include: 1) prolonged 
culturing of cells in the presence of drugs or selective agents; 2) high 
probability of selecting for more than one genetic change; and 3) 
inability to measure mutation rates in the presence and absence 
of mutagens. In addition, the resulting population of resistant cells 
may contain many different types of variation, thus, requiring signifi­
cant clonal analysis of the variant population. 
Multiple-step selection entails a series of discrete single step 
selections, often with increasing concentrations of the selective agent 
at each successive step. This selection technique has many of the same 
problems encountered in enrichment selection protocols. However, 
it is possible to determine mutcuit frequencies, although with some 
difficulty. These techniques have been usëd to isolate mutants resistant 
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to many different drugs, including colchicine (Ling and Thompson, 1974) 
and methotrexate (Schimke et al., 1978a,bj 1979). Multiple-step and 
enrichment selection protocols also seem to be especially suited for 
obtaining drug-resistant variants/mutemts where resistance is due to 
gene amplification (Schimke et al., 1978a,b, 1979). 
A wide variety of membrane mutants have been isolated, including 
cells resistant to fusogenic agents (Stadler and Hanser, 1980), lectins 
(Stanley, 1980), cells possessing altered adhesive properties (Atherly 
et al., 1977), cells expressing a temperature-sensitive defect in 
endocytosis (Silberstein et al., 1975) and cells resistant to membrane 
anesthetics (Vaughan and Stadler, 1980)i 
4. Utility of membrane mutants in studying membrane structure and 
function 
Membrane mutants have been used to study a number of cellular 
functions dependent on normal membrane organization and structure. 
These functions include cellular adhesion (Atherly et al., 1977), 
endocytosis (Silberstein et al., 1975), cell fusion (Stadler and 
Hanser, 1980), Na/K ATPase (Baker et al., 1974) as well as lectin 
binding (Stanley, 1980). The cytochalasin D-resistcuit variants I 
have isolated êmd characterized are resistant to cytochalasin D and a 
number of other drugs by virtue of their reduced drug uptake and/or 
permeability. Consequently, the remainder of the review on membrane 
mutants will focus on drug uptedce (permeability and transport) and 
efflux mutcuits. 
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5. Drug uptake and permeability mutants of somatic cells 
A major function of the plasma membrane is to modulate permeability 
of extracellular macromolecules and ions. The membrane acts as a natural 
barrier to foreign molecules that may be deleterious to the cell, and as 
a sieve for molecules essential to cell survival. Thus, the cell should 
possess mechanisms whereby the exclusion efficiency of the cell membrane 
can either be enhanced or reduced, depending on the environment and 
cellular physiology. 
It has been observed that cells cem acquire resistance to a wide 
range of drugs, ^  vitro in tissue culture, situ in cemcer patients 
undergoing cancer chemotherapy (Mihich, 1963; Schimke et al., 1978a,b; 
Bertino et al., 1981), and in protozoans or insects subjected to toxic 
chemical agents (Goldstein et al., 1974). The emergence of highly drug 
resistant tumors in cancer patients originally thought to be in remission 
is quite common (Mihich, 1963; Biedler and Peterson, 1981; Schimke, 1981), 
and drug resistance has been a major obstacle in successful treatment of 
cancer by chemotherapeutic agents. Mcuiy drug-resistant tumors may have 
reduced drug uptake (permeability and/or transport) to administered 
drugs, or a more efficient efflux system for removal of the drug(s) 
(Biedler and Peterson, 1981). In order to better understcind the 
mechanism(s) responsible for this mode of drug resistance, a number of 
drug resistant mutant lines have been isolated ^  vitro (Mihich, 1963; 
Biedler and Peterson, 1981; Schimke, 1981). Mutants have been selected 
for resistance to actinomycin D (an inhibitor of DNA and RNA synthesis) , 
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adriamycin and daunorublcln (inhibitors of DNA and RNA synthesis via 
their intercalation into DNA; however, see Aldrich, 1979), vinblastine, 
vincristine, colchicine and maytansine (inhibitors of normal micro­
tubule function), cytochalasin (disrupts P-actin microfilaments) as 
well as other drugs with a variety of cellular targets (Biedler and Peter­
son, 1981; Schimke, 1981). In vitro and in vivo studies have indicated 
that, for the group of drugs just cited, reduced plasma membrane per­
meability, transport and/or increased efflux may be important de­
terminants of drug resistance. In addition, it has become obvious that 
alterations of the cell membrane resulting in drug resistance may have 
diverse and profound effects on other membrane mediated processes. 
Analysis of independently isolated, drug-res is tant uptake mutants 
has revealed some striking similarities among them. First, many drug 
resistant mutants, selected for resistance to a wide array of drugs 
in a number of different cell lines, are cross-resistant to structurally 
and functionally unrelated drugs (Skipper et al., 1972; Subak-Sharpe, 
1965; Kessel et al., 1968; Ling, 1975; Bech-Hansen et al., 1976; Ling and 
Thompson, 1974; Biedler and Peterson, 1981; Baskin et al., 1981; Baskin, 
1981). For example, the colchicine-resistant mutants isolated by Ling 
and coworkers (Ling and Thoiig)son, 1974; Ling, 1975; Bech-Hansen et al., 
1976) are also resistaint to colcemid, vinblastine, actinomycin D, 
puromycin, daunomycin, emetine, ethidium bromide, and gramcidin D. 
Concomitant with the appearance of drug cross-resistance ië the 
emergence of increased (collateral) sensitivity to local anaesthetics 
(such as procaine, tetracaine, xylocaine, cmd propanol), to steroid 
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hormones (such as l-dehydrotestosterone, corticosterone, and 5-pregnan-
3,20-dione), and to some nonlonic detergents (such as Triton-X) (Bech-
Hansen et al., 1976). 
A positive correlation between the degree of resistance to a drug 
and its molecular weight was observed in Chinese hamster variants inde­
pendently selected for resistance to actinomycin D, vincristine, or 
daunorubicin (Biedler and Riehm, 1970; Biedler cind Peterson, 1981). 
For the drugs tested, it was found that the higher the molecular 
weight of a drug, the more resistant a cell was to the drug. Ling and 
colleagues, however, found no correlation between degree of resistance 
to drug and its molecular weight in colchicine-resistant mutants of 
CHO (Bech-Hansen et al., 1976). Bech-Hansen et al. (1976) observed 
that drug cross-resistance patterns correlated with the hydrophobicity of 
drug; the more hydrophobic a drug, the greater the level of resistance 
to that drug. 
Another common characteristic of these drug-resistant mutants is 
that resistance is mediated by reduced plasma membrane permeability to 
and/or uptake of drug(s) of more efficient drug efflux (Goldstein et al., 
1966; Langleir et al., 1974; Biedler et al., 1975; Biedler and Peter-
son, 1981). Many of the drugs used in the selection of drug resistant 
variants have as their target of action either the nucleus (actinomycin 
D, adriamycin, dcinorubicin and ethidium bromide) or the cytoplasm 
(colcemid, colchicine, vinblastine, vincristine, puromycin and 
emetine). Consequently, the uptake and permeability of these drugs 
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was assayed by guantitating the intracellular accumulation of 
drugs by autoradiography and/or liquid scintillation counting. Sig­
nificantly reduced grains and/or counts were observed in the drug-
resistant variants/mutants compared to wild-type sensitive cells or 
drug-sensitive revertants. In addition, the degree of resistance to 
drug(s) was inversely correlated with the nuqùier of grains over the 
cell or the number of counts internalized by drug-resistant cells. 
These results provide convincing evidence that drug resistamce is the 
result of either reduced drug uptake/permeability or increased drug 
efflux. 
That the lesion responsible for reduced drug uptake (or increased 
efflux) is the same lesion mediating cross-resistance or collateral 
sensitivity to unrelated drugs has been demonstrated by the following 
experiments: 1) When cells are selected for increasing levels of 
resistance to a particular drug, cross-resistcmce and collateral sensi­
tivity to unrelated drugs increases to a similar degree (Ling and 
Thompson, 1974; Bech-Hansen et al., 1976; Ling, 1975; Biedler and 
Peterson, 1981). 2) Drug-sensitive revertants of drug-resistant mutants 
concomitantly lose cross-resistance and collateral sensitivity to other 
drugs (Ling, 1975; Biedler and Peterson, 1981). 3) Drug-resistant mutants 
independently selected for resistance to different drugs, such as 
vincristine and actinonycin D, display similar cross-resistance 
patterns (Biedler and Peterson, 1981). 4) Finally, the addition of 
Tween 80 or other nonionic detergents ëJaolishes or significantly reduces 
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drug cross-resistance in drug uptake mutants (Ling and Thompson, 1974; 
Biedler and Peterson, 1981; Heppel emd Hakan, 1977). The ability of 
nonionic detergents such as oVeen 80 to potentiate (increase) drug 
sensitivity is a common property of permeability mutants (Ling and 
Thompson, 1974; Heppel and Makan, 1977; Halenkov et al., 1967; Biedler 
and Peterson, 1981). 
Interestingly, some drug-resistant mutants possess cross-resistance 
to unrelated drugs even though the mode of entry of these drugs into the 
cell may be different (Biedler and Peterson, 1981). Iwo independent 
experiments demonstrate that transport of vincristine and several anthra-
cycline antibiotics (daunorubicin, adriamycin, rubidazone) is carrier 
mediated, but not actively tramsported (Bleyer et al., 1975; Skovsgaard, 
1978a,b,c). Neither active transport nor a carrier-mediated mechanism has 
been found for actinomycin D (Biedler and Peterson, 1981; Bowen and 
Goldman, 1975); Carlsen et al. (1976); See et al., 1974) found that 
in CHO cells, colchicine uptake occurs by an unmediated diffusion mode 
and that a permeability barrier to colchicine is maintained by the 
phosphorylation level (ATP) of the cell. 
Cells can limit the passage of macromolecules into the cytoplasm 
by either reducing the plasma membrane permeability to macromolecules 
which enter by passive diffusion, or by limiting transport of macro­
molecules which enter the cell by carrier-mediated or active transport. 
Both mechanisms may result in restricting intracellular access to 
certain drugs by reducing their uptake. 
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Alternatively, cells can reduce membrane barriers which are 
responsible for retention of macromolecules or increase their rate 
of transport out of the cytoplasm and into the extracellular millieu. 
The net result in either case is an increase in the net efflux of those 
macromolecules. 
In mouse leukemia P388 cells, selected for resistance to dauno-
rubicin or adriamycin and which are cross-resistant to actinomycin D, 
vincristine, and vinblastine, resistance is primarily due to an impaired 
ability to retain drug(s) (Ineiba and Johnson, 1977, 1978; Johnson et al., 
1978; Inaba et al., 1979). This would suggest that there may be a common 
efflux mechanism for certain drugs. This conclusion is based on the 
observations that: 1) Chinese hamster uptake mutants highly resistant to 
actinomycin D are very sensitive to the cytotoxic effects of actinomycin 
D encapsulated in lipid vesicles and taken up by resistant cells, and to 
actinomycin D in the presence of %feen 80 (Papahadjopoulos et al., 1976; 
Biedler cind Peterson, 1981); 2) Tween 80 and liposome-encapsulated 
actinomycin D did not, however, reverse resistance of adriamycin-
resistant P388 cells cross-resistant to actinomycin D (Inaba and Johnson, 
1977). Dano (1972) concluded that increased outward transport was 
responsible for drug resistance in mutants of Ehrlich ascites cells. 
Skovsgaarg (1977, 1978a,b,c) found evidence for both an increase in 
activity of an energy dependent drug export site(s) and nonspecific 
plasma membreine changes that result in reduced drug influx in dauno-
rubicin-resistant Ehrlich ascites cells. 
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All of the drug-resistant permeability mutemts cited thus far were 
selected by either multiple-step or enrichment selection methods. 
The method of selection is important for two reasons. First, multiple-
step and enrichment selection methods increase the likelihood of iso­
lating drug-resistant variants/mutants with more than one lesion. The 
presence of multiple mutations in a somatic cell mutant makes the 
correlation of a drug resistant phenotype to specific gene products 
extremely difficult, and also hampers the ability to separate primary 
from secondary determineints of drug resistance (for exemple, Inaba emd 
Johnson, 1977; Biedler eind Peterson, 1981). Secondly, multiple-step and 
enrichment selection apparently favors isolation of gene amplification 
variants (Schimke et al., 1978a,b). The relevance of this latter 
point will become evident after reviewing gene amplification. 
In a majority of the drug-resistauit variants/mutants described 
in this review, significant differences in growth characteristics, cell 
morphology, oncogenic potential cuad lectin sensitivity were noted 
(Biedler and Peterson, 1981). Biedler et al. (1975) noted that cells 
became more oriented and/or flattened, and increased their cell-cell 
and cell-substrate adhesiveness as cells became more resistant to 
actinomycin D, daunorubicin, or vincristine. In addition, a strong 
correlation between increased drug resistance emd decreased tumori-
genicity was demonstrated. 
Some drug-resistant lines slowly lose their drug-resistant 
phenotype (termed phenotypic instability) when cultured for long 
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periods of time in drug-free medium (e.g., one month to three years; 
Schimke et al., 1981; Biedler and Peterson, 1981). Biedler and Peter­
son (1981) isolated actinomycin D-sensitive Chinese hamster lung cells 
from actinomycin D-resistant mutants by culturing drug-resistant mutants 
in the absence of actinomycin D for three years. The drug-sensitive 
revertants were found to regain their wild-type morphology and in­
creased tumorigenicity concordantly with the loss of actinomycin D 
resistance. These results were obtained with both spontaneously-
transformed Chinese hamster lung tissue and with cell cultures from a 
hydrocarbon-induced mouse tumor (Biedler and Peterson, 1981). 
Actinomycin D-resistant Chinese hcunster cells have a diminished 
agglutinability in the presence of concemavalin A compared to the 
wild-type drug-sensitive cells (Diamond et al., 1972). Similar changes 
in lectin agglutineibility and sensitivity are found in cells that have 
lost tumorigenicity (tumorigenic revertants; Biedler and Peterson, 
1981). 
6. Biochemical correlates of drug-uptake mutants 
The phenotype of drug-uptake and -efflux muteuits includes: 
drug cross-resistance and collateral sensitivity; reduced uptake, 
binding and/or increased efflux of radiolabeled drug; reduced tumori­
genicity; altered adhesive properties; abnormal morphology; and 
aberrant growth characteristics. These observations suggest that 
differences in plasma membrane composition may be responsible for 
the drug-resistant phenotype. 
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Most animal plasma membranes are composed of about 60% protein 
and 40% lipids (Harrison and Lunt, 1980; Finean and Michell, 1981). 
Proteins and glycoproteins of the cell membrane are known to function 
as structural, enzymatic and receptor molecules; they mediate a number 
of membrane processes including cell recognition, cell fusion, cell 
adhesion, metabolite treuisport, permeability and regulation of 
growth (Gahmberg, 1981) . Thus, it is likely that qualitative and/or 
quantitative changes in membrane proteins and glycoproteins can alter 
plasma membrcuie permeability. 
To date, all known cell surface membrane proteins which are 
exposed to the extracellular surface are glycoproteins (Gahmberg, 
1981). Consequently, cell surface proteins and glycoproteins will be 
used interchangeably, and it is assumed that all surface proteins 
contain at least some covalently attached carbohydrate moieties. 
Differences in cell surface glycoproteins have been noted in the 
few drug uptake/efflux mutants that have been characterized bio­
chemically. For example, a glycoprotein(s) with a HW of 150,000 to 
190,000 was found: in colchicine-resistant mutants of CHO (the 170,000 
MW "P" or permeability glycoprotein; Ling, 1975; Carlsen et al., 1976, 
1977; Juliano and Ling, 1976; Juliano et al., 1976; Riordan and Ling, 
1979; Oebenham et al., 1982); in actinomycin 0, daunorubicin arid 
vincristine-resistant mutants of Chinese hamster lung cells (150,000 
MW; Biedler and Peterson, 1981); and in vinblastine-res is tant human 
leukemic lymphocytes (170,000-190,000 MW; Beck et al., 1979). Wild-
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type drug-sensitive parental cells as well as drug-sensitive revertants 
contained very little, if any, of the high MW glycoproteins found in the 
drug-resistant mutants. 
Peterson cuid Biedler (1978; Biedler and Peterson, 1981) observed 
that the loss of the major glycoprotein (100,000 MW) in wild-type 
parental cells was concomitant with the development of drug resistance 
and the appearance of the 150,000 MW glycoprotein in the drug resistant 
mutants. The 100,000 MW glycoprotein increased to near parental levels 
in actinomycin D-sensitive revertants. Similar results were reported 
by Juliano «md Ling (1976) for colchicine-resistant CHO cells. Two 
major CHO surface membrane glycoproteins (HWs 139,000 and 95-100,000, 
respectively) and a diffuse complex of smaller peaks in the MW rcuige of 
55,000-65,000 daltons were the major membrane glycoproteins labeled 
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with ( H)NaBH^  in the wild-type parent line. The amount of these 
labeled surface glycoproteins decreased concordantly with the appearance 
of the 165-170,000 MW glycoprotein of colchicine-resistant lines. 
Highly colchicine-resistant lines were completely devoid of the major 
wild-type membrane glycoproteins. Juliaho and Ling (1976) attribute 
the loss of the parental-type glycoproteins to the vast increase 
in the relative amount of label incorporated into the 170,000 dalton 
glycoprotein compared to other surface glycoproteins and not to 
an actual decrease in the amount of native glycoproteins. 
The level of drug-resistance was found to strongly correlate with 
the amount of 150,000-190,000 glycoprotein present (Biedler and Peterson, 
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1981; Riordcin and Ling, 1979; Beck et al., 1979). This observation 
provides evidence linking the 150,000 MW glycoprotein of actinomycin 
D-, daunorubicin-, and vincris tine-res istant mutants, the 170,000 
MW "P" glycoprotein of colchicine-resistemt mutcuits, emd the 170,000 
190,000 MW glycoprotein of vinblastine-resistant mutants with the drug-
resistant phenotype. However, Beck et al. (1979) reported that an 
increase in the 170,000-190,000 MW glycoprotein was only detectable in 
cells up to 269 times more resistant to vinblastine. Further increases 
in the level of resistance (up to 2000-fold) do not result in increased 
amounts of the high MW glycoprotein. This may be attributed to an in­
ability to detect further increases in labeling using (^ H)NaBH^  and 
galactose oxidase. Alternatively, other differences may be responsible 
for further increases in the level of drug resistance. 
Comparisons between these three reports (i.e., of high molecular 
weight glycoproteins appearing in drug-resistant variants/muteuits) must 
be made with caution. In Biedler's experiments, drug-resistant and 
drug-sensitive cells were labeled in monolayer, whereas, in the experi­
ments of Ling and Beck, the cells were labeled in suspension culture. 
Results from this laboratory reveal striking differences in cell 
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surface proteins labeled with I in monolayer as compared to sus­
pension culture (Figure 13). 
Other reports of drug-uptake mutants have linked the drug-resistant 
phenotype to changes in membrcine glycoproteins. For example, Kessel 
(1979) reported that within 30 minutes after exposure of P388 murine 
31 
leukemic cells to the anthracycline anti-tumor drug adriamycin, cell 
surface electronegativity and incorporation of radioactive fucose into 
membrane glycoproteins were markedly increased, while cell surface 
hydrophobicity decreased. P388/ADR and P388/VCR cell lines, resistant 
to adriamycin and vincristine, respectively, have an inherently greater 
incorporation of fucose than the P388 parental line. Unlike the drug-
sensitive parent cells, adriamycin and vincristine-resistant cells did not 
exhibit enhemced levels of fucose incorporation over background levels 
when adriamycin was added to the medium. The primary site of fucose in­
corporation was a membrane glycoprotein of approximately 25,000 MM. 
Drug-resistant lines were more electronegative than the parent line. 
However, 30 minutes after the addition of 10 yg/ml adriamycin, the 
parent line was slightly more electronegative than the drug-resistant 
mutants. The results suggest that wild-type drug-sensitive cells possess 
a mechanism for the detection of drug, and that immediate, short-term 
metabolic responses are available to cells to alter membrane properties 
(presumably resulting in reduced drug uptake). Drug-resistant lines 
may possess a lesion or alteration at the "drug-sensing" and/or drug-
uptake locus, resulting in a continuous state of reduced drug uptake 
or increased drug efflux. 
An altered cell surface glycoprotein fraction released by papain 
treatment of intact cells was found in actinomycin D-resistant mutant 
lines of L5178Y cells (Kessel and Bosmann, 1970). Actinomycin D-
resistant cells contained more carbohydrate, fucose, and sialic acid in 
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papaln-sensitive linkages than did the parent L5178Y line. Drug-
resistant lines have significantly higher levels of glycoprotein trans­
ferases and, greatly reduced activities of glycosidases. Glycoprotein 
transferases catalyze the formation of amino acid-sugar and sugar-
sugar bonds. 
As described previously, a number of drug-resistant mutants were 
found to have reduced tumorigenicity euid altered adhesive properties. 
Kbyama et al. (1979) analyzed the surface protein and glycoproteins of 
rat fibrosarcoma variants eidiibiting extremely high or low levels of 
tumorigenicity. The major conclusions were that: 1) variant lines 
exhibiting low tumorigenicity had a greater amount of sialylgalactosyl or 
sialyl-N-acetyl-géilactoseaminyl residues in a membrane glycoprotein of 
MW 150,000 than in the highly tumorigenic variants; 2) the less tumori-
genic clones contained well-defined microvilli on the cell surface com­
pared to the highly tumorigenic clones which lacked microvilli and 
instead contained very smooth blebs; 3} the tumorigenic revertant with 
low levels of tumorigenicity displayed altered adhesive properties and 
tended to form aggregates of cells, whereas, the highly tumorigenic 
variants did not display this characteristic. 
Bramwell and Harris (.1978a,b) reported differences in a surface 
glycoprotein of HW 100,000 in all tumorigenic lines examined, compared 
to the nontumorigenic cells from which the tumorigenic lines were 
derived. 
Yogeeswaran et al. (1978) found significcint increases in 
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sialylglycoproteins - in vitro (MW 66,000) and in vivo (MWs of 97,000, 
84,000, 74,000 and 66,000) - in mouse melanoma variant lines possessing 
a high degree of lung implantation. 
I am aware of only two drug-uptake mutants where membrane glyco-
lipids have been analyzed in wild-type and drug-resistant cells 
(Peterson et al., 1979; Biedler and Peterson, 1981; Nigam et al., 1973). 
Significant qualitative and quantitative differences in membrcine ganglio-
sides were observed in both vincristine and actinomycin D-resistant 
Chinese hamster cells (Biedler and Peterson, 1981) and also in actino­
mycin D-resistêint Syrian hamster cells (Nigam et al., 1973). Actinomycin 
D-sensitive revertants regained the full ganglioside complement charac­
teristic of control cells (Peterson et al., 1979). The changes in 
membrane glycolipids seen in actinomycin D- eind vincristine-resistant 
mutants are very similar to changes in glycolipid patterns of tumorigenic 
cells which have reverted or lost their tumorigenic phenotype (Yogeeswaran 
et al., 1978; Biedler «md Peterson, 1981). Although the early steps in 
the synthesis of glycolipids are different from those involved in glyco­
protein synthesis, later steps in glycolipid and glyprotein synthesis may 
be catalyzed by the same enzymes (Gaihmberg, 1981). Therefore, at present, 
it is not possible to determine whether changes in glycolipid and glyco­
protein structure are due to either separate genetic changes or to the 
same identical change. 
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7. A model for regulation of drug upteike/permeability derived from 
studies of drug-resistant somatic cell mutants 
The permeability or uptake of a number of drugs is regulated to or 
modulated by an energy-dependent process; these drugs include colchicine, 
puromycin, actinomycin D, etc. See et al. (1974) found that in wild-
type parental and colchicine-resistant CHO cells, uptake of (^ H) 
colchicine, puromycin, and actinomycin D was immediately stimulated by 
the addition of metabolic inhibitors such as cyanide, azide and dinitro-
phenol. Also, the amount of drug taken up in the presence of metabolic 
inhibitors was nearly identical in colchicine-sensitive and -resistant 
cells. Cyanide-induced stimulation of drug uptake could be prevented or 
reversed by the addition of metabolizable sugars such as glucose and 
ribose. Cell viability Wcis essentially unchanged at the cyanide concen­
trations used. Thus, enhanced drug permeability/uptake after cyanide 
treatment was not due to a nonspecific effect resulting from cell death 
or cytotoxicity. Furthermore, the presence of metcibolic inhibitors did 
not result in a nonspecific "leakiness" of cell membranes, because the 
uptake of thiourea and erythritol (thought to enter the cell by passive 
diffusion) was the same in drug-sensitive and drug-resistant cells and 
was unaffected by the presence of metabolic inhibitors. 
Ling (1975) demonstrated that the degree of membrane permeability in 
CHO cells is correlated with the amount of ATP inside the cell. Subse­
quently, Ling (1975) proposed a model for drug resistance whereby 
certain glycoproteins in mammalian cell membranes (such as the 165,000-
170,000 MW "p" glycoprotein) are modulators of membrane fluidity (termed 
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mmf proteins). Changes in the conformation of ramf proteins are thought 
to mediate changes in lipid fluidity, which subsequently alter membrane 
permeability to drugs. The model further proposes that the conformation 
of mmf proteins is modulated by the level of phosphorylation. This is 
analogous to other exemples where protein kinases or phosphatases alter 
protein structure and/or enzymatic activity. Ling proposes two mech­
anisms by which mmf proteins influence lipid fluidity: 1) conformational 
changes in an mmf protein(s) could directly affect the packing of lipid 
molecules within its domain, thus affecting lipid fluidity, or 2) con­
formational changes in an mmf protein(s) trigger other events which sub­
sequently lead to alterations in lipid fluidity, possibly by redistribution 
of certain lipid components. Colchicine-resistant cells are postulated 
to be altered in their mmf proteins such that their membrane fluidity 
is affected, resulting in reduced permeability to colchicine and to a 
number of structurally unrelated drugs. 
This model predicted that the 165,000 MM glycoprotein (a presumptive 
mmf) may be modified by phosphorylation. This prediction has been subse­
quently confirmed (Carlsen et al., 1977). Two high molecular weight 
glycoproteins of 165,000 (the "P" glycoprotein) and 200,000 MW were 
highly phosphorylated in two colchicine-resistant mutants, and were 
either not phosphorylated or only slightly phosphorylated in the parent 
and a sensitive revertant. Furthermore, it was claimed that the 165,000 
MW glycoprotein was present in significant amounts only in colchicine-
resistant lines, and was either absent or present in only minute amounts 
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in the wild-type parent and in colchicine-sensitive revertants. This 
latter conclusion does not necessarily follow from the data presented. 
In Figure 4 of Carlsen et al. (1977), the 165,000 MW glycoprotein is 
slightly increased in one colchicine-resistant mutant (CH C5). However, 
substantial quantities of the glycoprotein are present in the parent 
and sensitive reverteuit. Moreover, the 165,000 MW glycoprotein is 
significantly reduced in another colchicine-resistant mutant (CH C4). 
Ling and his colleagues detected the presence of protein kinase 
and phosphatase activity in membranes isolated from both mutant and wild-
type cells. Because the kinase and phosphatase activity could not be 
removed after high salt treatment, it was concluded that the protein 
kinase(s)/phosphatase(s) was an integral membrane protein. Carlsen 
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et al. (1977) were unable to label high MW glycoproteins by ( P) 
orthophosphate incorporation in whole cells ^  vivo, perhaps indicating 
that the phosphorylation of high MW glycoproteins observed ^  vitro 
was an artifact. Alternatively, the label may have been removed by a 
phosphatase during membrane isolation or, not enough label was in­
corporated to detect phosphorylation of these high MW glycoproteins. 
Carlsen et al. (1977) concluded that the mere presence of the "P" glyco­
proteins was not enough for maintaining decreased drug permeability, 
since in mutant and parental cell lines, cyanide stimulated colchicine 
uptake to nearly the same levels. Thus, more emphasis was placed on 
the importance of the phosphorylation level of the 165,000 "P" glyco­
protein, and perhaps, other glycoproteins as well. 
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Recent reports of drug-resistant mutants from mouse neuro­
blastoma cells (Baskin et al., 1981; Baskin, 1981) have suggested 
that reduced drug permeability may be due to amplification of alkaline 
phosphatase (see section: Drug resistance mediated by amplification of 
gene(s) directly or indirectly controlling membrane permeability). 
ïhus, changes in the levels of membrane phosphorylation may play a sig-
nificcint role in modifying or modulating membrane permeability in normal 
and mutant cells. 
There is cin priori possibility that a decreased plasma membrane 
permeability to drug may result from an increased fluidity of plasma 
membrane lipids (Rank et al., 1978). In a number of model systems, it 
has been shown that membrane permeetbility to passively diffusing com­
pounds is dependent on the amount of choiesterol/phospholipid in the 
cell membrane, and/or on the relative amount of unsaturated fatty 
acids (McElhaney et al., 1973; DeKruyff et al., 1973; Davis and Silbert, 
1974; Grunze and Deuticke, 1974). In each case, major changes in these 
parameters led to changes in membrane permeability. However, in the 
few instances where the phospholipids of drug permeability/uptake 
mutants have been qualitated and quantit&ted, no significant differences 
between drug-sensitive and drug-resistant cells were observed. Ling 
(1975) analyzed the lipids in the membranes of CHO parental and colchi-
cine-resistant lines. No signifient differences were observed in the 
cholesterol:phospholipid ratios (0.75 and 0,72, respectively), and the 
percent of unsaturated fatty acids were 40 and 41%, respectively. In 
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drug-sensitive yeast strains emd in isogenic, multiple drug-resistant 
strains, ho differences were observed in the mole concentration of the 
following lipid classes; phospholipid, sterol, sterol ester, triglyceride, 
diglyceride, and free fatty acid. Also, the fatty acid distribution of 
esterified and free fatty acids, and the distribution of nine phospho­
lipids Wcus the same in drug-sensitive and -resistant strains (Rank 
et al., 1978). 
All of the reports cited previously suggest that cell surface glyco­
proteins (and perhaps glycolipids), strongly influence membrane per­
meability, cell adhesion, tumorigenicity and cell surface morphology. A 
number of questions remain to be answered: 1) Are chemges in surface 
membrane glycoproteins (such as the 150,000-190,000 MW glycoproteins of 
some drug-resistêuit cell lines) directly responsible for drug-resistance 
or are they secondary to some other as yet undetected or undefined 
change? 2) Are there other factors that may regulate drug permeability 
besides glycosylation and/or phosphorylation? 3) What kinds of changes 
at the DNA level are responsible for the observed changes in cell 
surface glycoproteins? 4) The emergence of drug-resistant tumors has 
been a major obstacle in the successful treatment of cancer by chemo­
therapy, including tumors possessing decreased drug permeability and 
drug cross resistance. Can information obtained from studying ^  vitro 
models of drug resistance be used to devise better methods of chemo­
therapy? 
The first three questions cannot be cuiswered with any certainty. 
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It is reasonable to suggest that changes in cell surface proteins/gly-
coproteins leading to drug resistance arise by classical genetic 
processes, such as point mutation of a structural gene. Likely candi­
dates for gene control of membrane permeability include glycosyltrans-
ferases, glycosidases, protein kinases or phosphatases, and other genes 
that modify cell membrane proteins and glycoproteins. Changes in the ex­
pression of these gene products may readily account for the differences 
in cell surface glycoproteins in many drug uptake/permeability mutants. 
However, it is the contention of this author that many of the drug uptake/ 
efflux variants and mutants isolated ^  vitro, and in cemcer patients 
in situ, are resistant by virtue of amplification of a gene(s) regulating 
membrane permeability. Furthermore, these genes also regulate other 
cellular properties associated with the cell membrane, including; cell 
adhesion, growth, morphology and cell division. TSiis hypothesis, and 
the reasons behind it will become clearer after reviewing the litera­
ture on gene amplification as a mechanism for drug resistance. 
Suggestions on increasing the efficiency of chemotherapy will be 
made in the discussion on the properties of the cytochalasin-resistant 
variants that I have isolated. Other suggestions on increasing the 
effectiveness of chemotherapy have resulted from ^  vitro models of 
drug resistance in somatic cells (Ling, 1975; Schimke, 1981). 
In conclusion, the use of somatic cell mutants to study structure/ 
function relationships controlling membrane permeability is a promising 
approach in which to address these questions. 
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B. Gene Amplification 
1. Gene amplification and drug resistance; Amplification of dihydrofolate 
reductase in methotrexate-resistant cell lines emd tumors ; A paradigm 
for gene amplification in drug-resistant cells 
Methotrexate (MTX), also called amethopterin, is a 4-amino analog 
of folic acid (dihydrofolate) (Lehninger, 1975). MTX is highly toxic 
to cells in culture by virtue of its very strong binding to, and conse­
quent inhibition of, the enzyme dihydrofolate reductase (Nichol and 
Welch, 1950; Balis and Demcis, 1955; Wells and Winzler, 1959; Holland, 
1961; Kamovsky and Clarkson, 1963; Werkheiser, 1963; Bertino and Johns, 
1967; Huennekens et al., 1976). Dihydrofolate reductase (DHFR) catalyzes 
the reduction of dihydrofolate to tetrahydrofolate (Huennekens et al., 
1976). TetrêQiydrofolate is required for single carbon transfer reac­
tions, such as transfer of -CH^  and -CHg, which are necessary for glycine, 
purine, and thymidylate synthesis (Huennekens et al., 1976). Thus, MTX 
is lethal to cells by preventing ^  novo synthesis of key precursors of 
proteins and nucleic acids (Bertino and Johns, 1967; Schimke et al., 
1978a,b). MTX has been one of the most common antineoplastic drugs used 
in the past 25 years (Balis and Dancis, 1955; Wells and Winzler, 1959; 
Mihich, 1963; Bertino, 1979; Bertino et al., 1981). 
When MTX was used as a chemotherapeutic agent in the treatment of 
csmcer, it was observed that tumors would often arise that were resistant 
to high levels of MTX (Mihich, 1963; Bertino et al., 1981). In an 
attempt to understand the mechêmism(s) giving rise to this drug 
resistance, a variety of mouse and hamster cell lines were selected for 
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resistance to MTX. When multiple-step or enrichment selection tech­
niques were employed to isolate drug-resistant mutants, most of the 
derived resistant lines had a number of characteristics in common: 1) 
the physical and kinetic properties of the enzyme (DHFR) were essen­
tially identical in the resistant and parental cells (Hakala et al., 
1961; Kashket et al., 1964; Sartorelli et al., 1964; Hillcoat et al., 
1967; Perkins et al., 1967; Nakamurà and Littlefield, 1972); 2) an 
increase in the content of DHFR in resistant cells was demonstrated by 
immunologic and inhibitor titration studies (Friedkin et al., 1962; 
Jackson and Huennekens, 1973; Hanggi and Littlefield, 1976; Bertino etal., 
1981); 3) indirect evidence that the increase in DHFR content was due 
to an increase in the synthesis rate of DHFR (Friedkin et al., 1962; 
Bertino et al., 1981); 4) the frequency of MTX-resistant cells in the 
population was not enhemced by mutagenesis (Schindce et al., 1978a); and 
5) in some drug-resistant lines, MTX-resistance was stable in the absence 
of selective medium, i.e., the MTX-resistant lines could be cultured for 
many generations in the absence of MTX, without any significant loss of 
MTX-resistance. In many cell lines, however, MTX resistance was lost 
with time in nonselective medium euid were thus unstcibly resistant to 
methotrexate (Hakala et al., 1961; Courtenay and Robins, 1972; Schimke 
et al., 1978). It Wcis also noted that many of these same characteristics 
were observed in MTX-resistant tumor cells from patients undergoing 
chemotherapy (Schimke et al., 1978a; Schimke, 1981). 
Although many of the MTX-resistcuit cell lines and tumors were 
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Isolated in the early 1960s, little additional information was obtained 
on the molecular mechanisms underlying drug resistance. Part of the 
problem was due to the fact that many of the MTX-resistant lines were 
"unstable" and continued growth of the resistant lines in nonselective 
medium resulted in a population of cells completely or predominantly 
sensitive to HTX. As described in the section on somatic cell genetics, 
such unstably-resistant variants were undesirable euid were not con­
sidered to be true somatic cell mutants (Siminovitch, 1976). Because of 
the unstable resistance and because the resistance was apparently the 
result of em increase in the synthesis of the target enzyme, as opposed 
to a "classical" mutation such as missense, nonsense, or deletion muta­
tion, resistant lines were often dismissed as exemples of "epigenetic" 
or regulatory variants. In addition, the scientific tools for critical 
investigation of the molecular mecheuiisms responsible for HTX-resistance 
were unavailable. Consequently, further research on these drug-resistant 
variants was abandoned. 
Beginning with a paper in 1976, Robert Schimke and his colleagues 
at Stanford University reported on a series of biochemical studies of 
both stable and unstable HTX-resistant lines (Alt et al., 1976). Their 
results not only illuminated a previously unknown mechanism of drug 
resistcince in cultured cells, but also revolutionized ideas of gene 
structure and stability. 
Schimke's group first developed a method which resulted in purifi­
cation of DHFR to greater than 99%, Previous methods produced DHFR that 
was less than 10% pure (Alt et al., 1976). The isolation of highly 
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purified DHFR facilitated the development of highly specific antibodies 
to DHFR (Alt et al., 1976). In a series of papers, Schimke's group 
looked at the.synthesis and degradation of DHFR, DHFR mRNA levels in 
resistant cuid sensitive cells, and DHFR gene copy number in both 
resistant and sensitive cells. A number of conclusions were reached 
as a result of these investigations: (1) resistance to MTX was due 
to increased DHFR activity (Alt et al., 1976); (2) the increased activity 
of DHFR resulted from increased levels of DHFR enzyme in resistant cells 
(Kellems et al., 1976); (3) the physico-chemical properties of dihydro-
folate reductase from resistant lines was found to be identical to 
those from the sensitive parent (Alt et al., 1976; Kellems et al., 1976); 
(4) the increased content of DHFR in MTX-resistant cells resulted from 
enhanced synthesis rates of DHFR cuid not to a change (reduction) in turn­
over rate of DHFR (Alt et al., 1976; Kellems et al., 1976; Kaufman et al., 
1978); (5) DHFR mRNA levels increased concomitaatly with increases in 
DHFR protein (Kellems et al., 1976); (6) the increase in steady-state 
levels of DHFR mRNA was the result of increased DHFR mRNA synthesis and 
was not due to decreased turnover rates (Kellems et al., 1976); (7) 
there was no difference in the translation efficiency of DHFR mRNA from 
resistant and sensitive cells (Kellems et al., 1976); 8) the increased 
levels of DHFR mRNA were due to the selective multiplication of DHFR 
genes in MTX-resistant variants, i.e., gene amplification (Alt et al., 
1978; Kaufman et al., 1978; Schimke et al., 1978a,b). 
Although it was established that amplification of the dihydrofolate 
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reductase gene wêis the mechanism of resistance in some of the MTX-
resistant variants, the molecular structure and arrangement of the 
amplified gene in relation to stable vs. unstable resistance was 
unknown. 
2. Homogeneous staining regions and double minute chromosomes; Sites 
of gene amplification 
Resistance to high levels of MTX has previously been correlated 
with the presence of a variety of abnormal chromosome markers, all of 
which were additional to the chromosome complement of wild-type, 
MTX-sensitive cells (Biedler et al., 1963, 1965, 1975; Biesele et al., 
1959; Schrecker et al., 1962, 1963). Until the development of 
specialized chromosome banding techniques, unusual marker chromosomes 
were characterized only in terms of relative size and morphology. 
Biedler et al. (1974), and Biedler and spengler (1976a,b) were 
the first to report on the presence of am unusual staining region on 
the large marker chromosomes of MTX-resistant variants. After 
treatment with trypsin and Giemsa, known as G-banding, mitotic chromo­
somes are observed to possess short, alternate light ajid dark bands. 
These alternating bands are unique and characteristic for each indi­
vidual chromosome (Schulz-Schaeffer, 1980; Swanson et al., 1981). In 
the marker chromosomes of MTX-resistant lines Biedler et al. (1974; 
Biedler and Spengler, 1976a,b) observed a long region that lacked 
alternating bands, but instead stained homogeneously throughout the 
region. The long regions devoid of banding were called homogeneous 
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staining regions (HSRs); they have since been observed in many other 
drug-resistant cell lines, in tumors from patients undergoing chemo­
therapy, and in tumors from patients not receiving chemotherapy 
(Schimke, 1981). 
Using ^  situ hybridization with a DHPR cDNA probe, Nunberg et al. 
(1978) demonstrated that an HSR on chromosome 2 of a stable, MTX-
resistant CHO line contained amplified DHFR sequences. Further sub­
stantiation of this observation was made on stable MTX-resistéuit 1,5178 
cells (Dolnick et al., 1979). These observations have since been con­
firmed independently in many different cell lines (Schimke et al., 1981; 
Schimke, 1981). 
As of this writing, it has not been definitively established that 
amplified DHFR genes are actively transcribed; it is implicitly assumed 
that the increase in DHFR mRNA is due to transcription of amplified 
DHPR sequences. There exists, however, strong indirect evidence sup­
porting this latter idea, and this evidence will be presented later. 
Hhe possibility that at leeist a few of the dhfr genes are not 
present in the HSR has not been entirely excluded (Schimke et al., 
1978b, 1979, 1981). However, chromosome segregation experiments 
using intraspecific hybrids demonstrated that MTX resistance and high 
DHFR levels were associated with chromosome #2, which contained the HSR 
(Nunberg et al., 1978). 
After studying a number of stable MTX-reslstant lines of both 
murine and hamster origin, Schimke proposed that stcible resistance is 
due to anpllflcation of dhfr genes on a chromosome (resulting in HSR 
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formation), and that the amplified genes are physically located at the 
site of the native structural gene on the chromosome (Nunberg et al., 
1978; Schimke et al., 1979; Dolnick et al., 1979; Schimke, 1981; Schimke 
et al., 1981). Schimke also suggested that unstable resistance was mani­
fested by extrachromosomal localization of amplified genes on structures 
called double minute chromosomes or double minutes (DMs) (Kaufman et al., 
1979, 1981; Haber cuid Schimke, 1981; Brown et al., 1981; Simonsen et al., 
1981). 
Double minute chromosomes are small chromatin bodies that lack a 
centromere and can replicate autonomously (Levan et al., 1976, 1977, 
1978, 1981; Levan and Levan, 1978, 1980; Barker, 1981). DMs have been 
observed in memy unstable drug-resistant mutants and in unselected 
human and murine tumors (Barker cUid Stubblefield, 1979; Barker, 1981; 
Kano-Tanaka et al., 1982; Brodeur et al., 1980; Cooperméin and Klinger, 
1981; Balaban-Malenbaum and Gilbert, 1977, 1980a,b; Schimké, 1981). 
DMs have a characteristic dumbbell-shaped morphology (see Figure 23, 
p. 205), and can vary considerably in size (Barker and Stubblefield, 1979; 
Barker, 1982). It has been proposed that double minute chromosomes arise 
from the replication of. single minute chromosomes during S phase (Levan 
et al., 1981; Barker, 1982). Because DMs do not contain a centromere, 
they do not segregate in a Mendelian fcishion during mitosis (Levan 
et al., 1976; 1977, 1978, 1981; Levan and Levatn, 1978, 1980; Barker, 
1982). It has been observed that DMs distribute unequally and randomly 
into daughter cells, and they are often eliminated from both nuclei and 
are subsequently "lost" (Barker, 1982). It has been further proposed that 
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the appearance of mlcronuclel, a common observation in cells containing 
DMs, is the result of extranuclear packaging of nucleus-excluded DMs 
(Barker, 1981; Schimke, 1981). Unstable drug resistance is thought to 
result from extrachromosomal gene anplification in the form of DMs, 
combined with segregational loss of those DMs in cells removed from 
selective pressure (drug selection) (Schimke, 1981). 
Kaufman et al. (1979) demonstrated that in mouse S-180 and 
L5178Y cells unstably resistant to MTX, the amplified DHFR sequences 
were associated with small paired chromosomes called double minutes. 
Chromosomes from both unstable and stable MTX-resistant lines were 
isolated and separated on 20-50% linear sucrose gradients. Each frac­
tion w£is examined in the light microscope eind photographed in order 
to obtain semiquantitative estimates of the number of chromosomes and 
DMs in each fraction. DNA isolated from each fraction was then digested 
with EcoRI, the resulting fragments separated on agarose gels and Southern 
hybridized to a nick-translated DHFR probe. In the unstable-resistant 
variants, the amplified DHFR genes cosedimented with double minute 
chromosomes located at the top fractions of the gradient. However, in 
stable MTX-resistêuit lines, amplified DHFR genes cosedimented exclusively 
with rapidly sedimenting, presumably large chromosomes. This suggests 
that amplified DHFR genes in unstable resistant lines reside on double 
minute chromosomes and that stable, drug-resistant cell lines contain 
ançlified DHFR sequences on one or more chromosome(s). These results 
have been confirmed in other cell lines (Schimke, 1981). 
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Further support for the relationship between unstable resistance 
cind gene amplification was obtained by using a fluorescent activated cell 
sorter (FACS). Kaufman et al. (1978) synthesized a fluorescent deriva­
tive of MTX which retains near-normal membrcuie permeability as well as 
normal DHFR binding and inhibition properties. The fluorescent deriva­
tive of MTX (MTX-F) was used to quemtitate the amount of DHFR present in 
a cell, and to conpare this with the number of DMs in that cell. Kaufman 
et al. (1978) demonstrated that the amount of fluorescence in a cell 
was directly proportional to the amount of DHFR enzyme present; this 
amount was proportional to the cunount of DHFR synthesized and to the 
DHFR gene copy number. Using the emalyzing mode of the FACS, cell 
populations with different amounts of fluorescence, and thus different 
levels of DHFR, could be retrieved. A linear relationship was found to 
exist between mean fluorescence/cell, DHFR specific activity, and the 
synthesis of DHFR. 
Im mouse 3T6 cells possessing unstable resistance to MTX, Brown 
et al. (1981) demonstrated a strong correlation between mean fluorescence 
per cell, the number of DHFR sequences present, and the number of DMs per 
cell. When MTX-resistant 3T6 lines were grown in the absence of MTX 
for varying lengths of timB (0, 17, 34, êmd 47 generations), there was a 
corresponding decrease in the relative fluorescence per cell and in the 
percentage of cells with fluorescence levels greater than sensitive cell 
levels (91%, 71%, 46% and 22%, respectively). In addition, there was a 
corresponding decrease in the relative number of amplified DHFR sequences 
present. The mean number of DMs in 3T6-R50 cells (resistant to 50yM MTX) 
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was 28, and in 3T3-R500 cells (resisteint to 500 ym MTX) the mean number 
of DMs was more than 100. 3T6-R50 cells that had reverted to MTX-
sensitivity and to wild-type levels of DHFR were found to completely 
lack DMs. 
Kaufman and Schimke investigated the early steps in acquisition 
of MTX-resistance in CHO cells (Kaufmem and Schimke, 1981). It had 
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been previously noted that in some cell lines (e.g., mouse leukemia 
lines) MTX-resistance tended to be unstable, while in other lines 
(e.g., hamster) resistance was usually stable (Schimke et al., 1981). 
It was found, however, that resistance was unstable in the early rounds 
of selection for MTX-resistance in CHO cells (25 cell doublings in 
medium containing 0.02 yM MTX, 13 cell doublings in medium containing 
0.1 yH MTX, and 12 cell doublings in medium containing 0.5 yM MTX). 
More iiqportémtly, the loss of elevated DHFR levels was variable in 
progeny of independent subclones resistant to 0.1 yM MTX. Some sub-
clonal populations reverted essentially to sensitive enzyme levels, 
others had high enzyme levels, and still others constituted a hetero­
genous population with respect to DHFR content. Thus, a hypothetical cell 
containing 25 DMs could give rise to two daughter cells containing 
varying ratios of DMs (e.g., 0:25, 1:24, 2:23,...12:13; 13:12,...25.0). 
Other combinations are possible as well, since some DMs may be lost 
and/or sequestered in micronuclei. Schimke reported that DMs in the 
unstable MTX-resistànt CHO lines were only visible in 5-10% of the 
metapheises. Difficulties in observing DMs in hamster lines possessing 
unstable resistance have been reported by others (Schimke, 1981). 
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Kaufman et al. (1981) found that the growth rate of unstable MTX-
resistant cells, cultured in medium lacking MTX, was inversely related 
to the degree of gene amplification and the number of double minute 
chromosomes. Cells with extrachromosomal gene anqplification in the 
form of DMs had a doubling time (T^ ) significantly longer (e.g., 24 hrs 
vs. 18 hrs. or 50 hrs. vs. 21 hrs.) than the of the drug-sensitive 
parental cells or drug-sensitive revertants. The longer T^  in DM-
containing cells may result from a longer S phase due to altered repli­
cation kinetics of extrachromosomally amplified DNA. 
Brown et al. (1981) suggest that the inverse relationship between 
growth rate and the nundaer of DMs is not the result of increased levels 
of DHFR. Stable MTX-resistant subpopulations derived from originally 
unstable resistant lines can have equal numbers of dhfr genes. However 
in nonselective medium (medium without MTX) stable MTX-resistant lines 
can grow as rapidly as MTX-sensitive cells. 
To summarize, during mitosis, unstable drug-resistant cells can 
either gain or lose genes as a result of unequal distribution of DMs 
into daughter cells. Unstable resistcince results from the loss of 
extrachromosomally cimplified genes during growth in drug-free medium. 
In drug-free medium, there is continual generation of cells containing 
fewer numbers of I%s. Because of the growth advantage of cells with 
few or no DMs, these cells become dominant in the population (Kaufman 
et al., 1981; Schimke, 1981). 
Kaufman et al. (1981) found that mouse S-180 cells with unstable 
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MTX-resistêince generate stably resistant segregants after 3 years of 
continuous subculture in MTX-containing medium. Amplified DHFR genes 
in the stable MTX-resistant segregants were present on one or more 
chromosomes (in the form of HSRs) and were maintained in a stable 
state. From this observation, as well as from others, Schimke proposed 
that gene amplification first occurs extrachromosomally in the form 
of DMs (Schimke et al., 1981; Schimke, 1981). For the reasons cited 
previously, extrachromosomal gene amplification is unstable and rapidly 
lost. In Schimke's view, there exists a low level probability that one 
or more DMs become inserted into the chromosome, resulting in an HSR, 
and that this is then a stable manifestation of gene amplification. 
Schimke and a number of other investigators have presented strong sup­
porting evidence for this view (Schimke, 1981). 
However, evidence has been accumulating that both stable and un­
stable resistance may be associated with HSRs rather than with DMs 
(Biedler et al., 1980a,b; Kopnin, 1981). In CHO and Chinese hamster lung 
cells that have acquired unstable resistemce to MTX, there is a'correla­
tion between the loss of resistance to MTX and diminution in size, and 
eventual loss of an HSR (Biedler et al., 1980a,b). Similar results were 
observed in actinomycin D-daunorubicin- and vincristine-resistant Chinese 
hamster cells (Meyers and Biedler, 1981; Biedler and Peterson, 1981) 
and in Djungarian hamster and mouse L-53 cells resistant to colchicine 
(Kopnin, 1981). 
Balcdsan-Malenbaum and Gilbert <1977, 1980a,b) have proposed that 
DMs result from the loss (excision) of HSRs from the chromosome. The 
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authors fused a mouse neuroblastoma line that was devoid of DMs and that 
contained a stable HSR with emother mouse line lacking both DMs and HSRs. 
Hybrid cells were selected and found to have either an HSR at the same 
chromosomal location as the HSR-containing donor or to contain DMs, 
but not both. This implies that the cell line originally devoid of 
HSRs and DMs provided some gene(s) or sequences which were necessary 
for excision of the HSR from the chromosome of the other cell line. 
Excision of the HSR presumably results in the generation of DMS. The 
apparent mutually exclusive nature of HSRs and DMs has been reported by 
others (Biedler et al., 1980a,b; George and Powers, 1982; Barker, 1982; 
Cooperman and Klinger, 1981; Quinn et al., 1979). 
Two recent reports have further complicated the question of whether 
HSRs or DMs are associated with unstable resisteuxce. In CHO cells 
stably resistant to high concentrations of MTX, some cell lines con­
tained an HSR, while other lines did not contain any chromosomal ab­
normality (Flintoff et al., 1982). This suggests that gene cunplification 
may occur without the formation of HSRs or DMs. In cell lines highly 
resistant to MTX and devoid of any keiryological correlate of gene amplifi­
cation (such as HSRs or Mis), there was a translocation of the short arm 
of chromosome 2 onto the end of the long arm of chromosome #5. 
Interestingly, chromosomes 2 euid 5 often contain an HSR in stable, MTX-
resistemt lines. No e^ qplanation was given for these observations. 
Masters et al. (1982) isolated human cell lines (Hela BU25 and 
VAg-B) resistant to MTX by eoqiosing them to progressively increasing 
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concentrations of MTX. The authors noted a striking variedsility of 
phenotype and chromosome constitution among independently isolated 
variants. All of the resistant variants were found to have unstable 
resistance to MTX, and in all but one line, resistance was completely 
lost over a period of between 25 and 200 days. DMs were present in all 
MTX-resistant cell lines. However, Masters et al. (1982) observed that 
DMs varied greatly in number in different variants without any relation­
ship to either the level of DHFR activity, or the degree of instability 
of MTX-resistance. This is in stark contrast to the results reported by 
Schimke and his colleagues using mouse cell lines unstably resistant to 
MTX. Masters et al. (1982) proposed the existence of another set of DHFR 
genes in MTX-resistant variemts of Hela cells which are associated with 
regular chromosomes, and which may be unstable in the absence of selec­
tive pressure. 
Thus, the question of whether unstable resistance is associated with 
DMs or HSBs has not been resolved. Some evidence has been presented for 
both views, and it is probable that both rais and HSRs can be sites of 
unstable resistance. Differences in HSR stability may be species 
specific euid may also depend on the particular cell line used, the gene 
being amplified and other factors. Determination of the molecular mech­
anisms underlying stable vs. unstable resistance may have significance to 
cancer chemotherapy and in understeuiding mechanism(s) of gene amplifica­
tion. 
There is some uncertainty regarding the location of an HSR in 
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relation to the an^ lified structural gene. Biedler and Spengler (1976a,b) 
observed an HSR on one honolog of chromosome 2 in Chinese hamster lung 
cells resistant to MTX. Roberts et al. (1980), using chromosome mapping 
techniques, assigned the dhfr gene in sensitive CHO cells to the long 
arm of chromosome 2. This is the Scune location Nunberg et al. (1978) 
reported for the HSR in stable MTX-resistant CHO cells. Schimke et al. 
(1979) suggested that stable, amplified genes in resistant cells were 
present at the same site as the native structural gene in the sensitive 
parent. It was further proposed that the amplified genes were present 
on only one homolog of the two paired chromosomes. 
These observations, supported by Dolnick et al. (1979) in a stable 
resistant mouse L5178Y cell line, were later contradicted by Schimke 
et al. (1979).  ^situ hybridization of a DHFR probe to clonal deriva­
tives of MTX-resistant mouse Ii5178Y lines revealed multiple chromosomal 
sites of gene amplification. Two intensely radioactive chromosomal sites 
were detected, as well as a third less intense locus. Also, one chromo­
some with an amplified region was reduplicated, probably as a result of 
mitotic nondisjunction. Similar observations have been reported by 
others; e.g.. Bostook et al. (1979) reported on a highly MTX-resistant 
mouse melanoma line with expemded regions (HSRs) on 5 different chromo­
somes . 
The dhfr gene is one of the few amplified genes to be mapped. Thus, 
information on the chromosomal location of other amplified genes is 
lacking. From the evidence presently available, it can be tentatively 
concluded that an HSR (amplified gene) is located preferentially at the 
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site of the structural gene, but can be located at numerous positions 
along the same chromosome, and/or on other chromosomes. This implies 
that the HSR, or more specifically, the amplified genes, possess limited 
"mobility". 
Usually, only one allele of one chromosomal homolog is amplified. 
The significance of this observation is unknown. 
It hés been repeatedly observed that the size of the angilified 
region is of much greater magnitude than necesséury for the amount of 
gene amplification observed. Nunberg et al. (1978) first suggested that 
the DNA sequence ai%)lified in MTX-resistant cell lines appeared to be far 
larger than required for coding of the dhfr gene. In CHO cells with 
stable MTX resistance, the HSR on chromosome 2 comprised about 3.5% 
g 
of the CHO karyotype, or about 1.6 x 10 base pairs. The HSR consisted 
of a repeating DNA sequence, as evidenced by silver grains along the 
length of the HSR after situ hybridization to a dhfr probe. The 
repeating sequence was calculated to be on the order of 500-1000 kilo-
bases. The HSR of stable MTX-resistant mouse L5178YR lines represents 
0 
about 5% of the total genome, and thus about 2.3 x 10 base pairs (there 
g 
are an estimated 4.6 x 10 base pairs in mouse cell DNA). Hybridization 
3 
of cellular RNA and DNA to a ( H) cDNA dhfr probe indicated that dhfr gene 
number had been amplified approximately 300-fold over drug-sensitive 
levels. Thus, the average repeat unit in the MTX-resistant mouse line 
was approximately 800 kilobase pairs. 
Based on the degree of DHFR gene amplification and the number of 
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double minutes in unstable MTX-resistant S-180 and L5178Y lines, Kaufman 
et al. (1979) calculated that each double minute chromosome contained be­
tween 1 and 5 DHFR sequences. However, it was noted that there was a 
great deal of heterogeneity in the size of DMs and it was not known whether 
differences in DM size were due to different degrees of chromosome con­
densation or heterogeneity in DNA content. In a later report, it was 
estimated that there were between three and four copies of the dhfr 
gene per DM in mouse 3T6 cells unstably resistant to MTX, and between 200 
and 1000 kilobases of DNA per DM (Brown et al., 1981). The size of the 
native structural dhfr gene is reported to be between 32 and 35 kilobases 
(kb) in size (Nunberg et al., 1980). Thus, a significant amount of DNA 
of unknown structure and function resides in DMs and HSRs. Schimke and 
his colleagues reported that DHFR was the only protein overproduced in 
all gene amplified cell lines examined (Brown et al., 1981). 
Bostock and Tyler-Smith have investigated the size and structure of 
HSRs and DMs in stable cind unstable MTX-resistant mouse lymphoma EL4 
and mouse melanoma PG19 cells (Bostock et al., 1979; Bostock and Clark, 
1980; Tyler-Smith and Alderson, 1981; Tyler-Smith and Bostock, 1981; 
Bostock and TVler-Smith, 1981). Bostock et al. (1979) observed the 
progression of chromosomal changes associated with each incremental 
increase in MTX resistance during selection. Numerous chétnges in chromo­
some number and arrangement were observed in the early stages of selec­
tion, including an increase in the length of certain chromosomes. It 
was suggested that some form of recombination process was responsible for 
57 
the initial increase in dhfr genes on a particular chromosome. Ring 
chromosome formation appeared to play an important role in later stages 
of gene anplification. In some ring chromosomes, they observed "dupli­
cations" of the staining pattern around the ring. At the last two 
selective concentrations of MTX (3 x 10 M and 10 M) very few ring-
containing cells were observed. Instead, abnormally long, linear 
chromosomes were seen with staining properties similar to those of ring 
chromosomes. It wêis concluded that the abnormal chromosomes arose by 
breakage of ring chromosomes and subsequent stabilization, producing the 
-4 5 marker chromosomes characteristic of cells resistant to 10 M MTX 
-4 
(PG19T3;MTX^  ^ M). It was further suggested that all five marker 
Q-4 
chromosomes present in PG19T3:MTX^  M, in which cells are 30,000-fold 
more resistant to MTX and possess an approximately 1000-fold increase in 
intracellular DHFR activity, were derived from a common precursor chromo­
some by a combination of excheuige and duplication events. 
-4 
When marker chromosomes from PG19T3;MTX^ ° M were stained for 
constitutive heterochromatin (C-banding) by Hoechst 33258 staining, the 
HSRs were C-band positive (Bostock et al., 1979). Using a modified de-
naturation-renaturation technique, it had been previously found that the 
HSRs of human neuroblastoma cells did not contain C bands, while HSRs 
of Chinese hamster cells resistant to methasquin (a quinazoline anti-
folate) stained similarly to heterochromatic arms of Chinese hamster 
sex chromosomes (Biedler and Spengler, 1976a,b). Chinese hamster sex 
chromosomes, unlike the C-banding centromeric heterochromatin, are 
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deficient in repetitive DNA, emd the basis for the positive staining 
is unknown. 
Bostook and Clark (1980) found that the HSRs of MTX-resistant 
mouse melanoma PG19T3 cells contained an excess amount of DNA over that 
e^ qpected if duplication of only the dhfr sequence had occurred during 
selection for resistance to MTX. The HSRs of the marker chromosomes were 
C-band positive and similar in staining to that of normal mouse centro-
meric heterochromatin. However, the dense staining of the HSR after C-
banding was not uniform throughout. At high magnification, the HSRs 
were found to consist of many C-bands linked closely together. Also, the 
HSRs fluoresced brightly when treated with Hoechst 33258, as does centro-
meric heterochromatin. Taken together, these two staining properties 
suggest that some of the "extra" DNA contained in the HSR may be simple 
sequence DNA similar to the satellite DNA sequences of mouse centromeric 
125 heterochromatin. Purified mouse satellite DNA, labeled with I by 
nick translation, was hybridized situ to metaphase chromosomes of cells 
resistant to 10 M MTX. High concentrations of silver grains over the 
HSRs of all marker chromosomes were observed, with fewer silver grains 
localized at the centromeric regions of normal autosomes. A semi­
quantitative estimate of the relative amount of satellite-like DNA 
in the HSRs, obtained by counting silver grains over chromosome spreads, 
revealed that about 39% of the grains localized over HSRs. 
Satellite DNA is detectable from the rest of the bulk DNA by 
centrifugation in a neutral CsCl density gradient. Using this technique. 
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the authors found a strong correlation between the level of MTX-resistance 
in a MTX-resistant line, the total amount of satellite DNA in that cell 
line, and the amount and size of the HSR(s). 
Using the fluorescence plus Giemsa (PPG) technique, the C-banding 
regions of man, mouse, and kangaroo rat show asymmetric staining after 
chromosomes had completed one S phase in the presence of bromodeoxyuri-
dine (BrdU; Bostock and Clark, 1980). iHie asymmetry is supposedly a 
direct or indirect result of the bias of thymidine content between the 
-4 
conplementary strands of satellite DNA. PG19T3:MTX^  M cells possess 
asymmetry after one round of replication in the presence of BrdU. How­
ever, the asymmetry is unusual in that there are alternating light and 
dark "dots" between chromatids. The authors suggest that, if asymmetric 
staining is indeed the result of a bias in thymidine content, then the 
bias in thymidine content of the complementary strands of the satellite­
like DNA in each chromatid could have been generated in one of two ways: 
1) the HSR might be composed of repeating units which include a section of 
satellite-like DNA having one strand richer in thymidine content than its 
conçjlementary strand. The alternating pattern may have arisen at an 
early stage of the duplication event by an inversion. Alternatively, an 
inverted structure was already present in the original PG19T3 cells and 
subsequent duplications only increased the nundser of alternating se­
quences ; (2) the asymmetry in the HSR was originally limited to only 
one strand of DNA and subsequent sister chromatid exchcuiges (SCE), 
occurring after BrdU incorporation, resulted in the observed asymmetries. 
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However, after two rounds of replication in the presence of BrdU, measure­
ments of the frequency of SCE revealed that the frequency of SCE per unit 
length of chromosome was significeintly lower in the marker chromosomes 
than in normal chromosomes. Similar results have been found in hetero-
chromatic regions of chromosomes of the Indicin muntjac and kangaroo rat. 
Thus, complex asymmetries observed in HSRs of MTX-resistant mouse mela­
noma cells are probably due to ëin inherent and constant property of the 
DMA in the HSR. 
Bostock and Clark (1980) concluded that the repeating unit in the 
HSR was very large compared to the size of the DHFR mRNA (1600 bases) or 
the length of DNA coding for DHFR (32-40 kilobases, including intervening 
sequences). In MTX-resistant PG19T3 cells, a large amount of "excess" DNA 
in the repeating unit is satellite-like. However, there is also ap­
proximately 10^  bp of nonsatellite DNA. 
Thus, the observation that there is more DNA in HSRs and DMs than 
required for the level of gene amplification has been reported in; stable 
MTX-resistant mouse lymphoma EL4 cells (Bostick and Clark, 1980), CHO 
cells (Nunberg et al., 1978), and in L5178Y cells (Schimke et al., 1981); 
and in unstable MTX-resistant mouse S-180 cells (Brown et al., 1981) and 
others (Schimke, 1981). 
The molecular structure of anplified DNA from MTX-resistant 
mouse lymphoma EL4 cell lines has been analyzed (Tyler-Smith cind 
Alderson, 1981; Tyler-Smith and Bostock, 1981; Bostock and Tyler-
Smith, 1981). DNA restriction fragments from 5 independently 
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isolated cell lines resistant to high levels of MTX reveal that the 
restriction fragment pattern is unique in each independently isolated line 
but the same within that cell line. This is true for amplified DNA in 
the form of HSRs and DMs, and has been confirmed in independent isolates. 
The authors concluded that amplification of the DHFR gene occurs in two 
steps. First, the amplified unit is generated by a DNA rearrangement 
process, probably a recombination event. Secondly, the amplified unit 
is increased in number but the structural integrity of the amplified unit 
is maintained. 
As alluded to earlier, there exists substantial indirect evidence 
that amplified DHFR genes, either in the form of DMs or HSRs, are 
actively transcribed. First, the correlation of increased levels of 
DHFR mRNA and protein with the presence of DMs suggests that the ampli­
fied sequences are transcribed. %is conclusion is further supported by 
the observation that DHFR enzyme and mRNA levels decrease concomitantly 
with the loss of MTX resistance and the elimination of DMs. Also, the 
size of an HSR has similarly been correlated with MTX resistance, DHFR 
levels and DHFR mRNA levels. 
Analysis of chromatin structure from MTX-resistant L5178Y-R cells 
by two-dimensional hybridization mapping of nucleosomes suggested that 
dhfr genes were transcriptionally active (Barsoum et al., 1982). 
Schimke and his colleagues have provided strong evidence that 
amplified genes are transcribed and expressed. A 3T6 mouse fibroblast 
line was e:qx)sed to progressively increasing concentrations of MTX. 
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Three MTX-resistant subclones were isolated with different degrees of 
resistance: 3T6-R5, resistant to 5 yM MTX; 3T6-R50, resistant to 50 viM 
MTX; and 3T6-R400, resistant to 400 yM MTX. The 3T6-R400 cell line was 
derived from 3T6-R50 cells. As described previously, MTX-F (a fluorescent 
conjugate of MTX) was used to demonstrate a strong correlation between 
DHFR levels, DHFR synthesis, and dhfr gene copy number. A linear 
relationship was found between the fluorescence units in a particular 
cell or population, the level of DHFR protein and mRNA, and the number 
of DMs (amplified sequences) (Kaufman et al., 1978; Brown et al., 1981). 
3T6-R50 cells had a high fluorescence level, indicative of elevated 
levels of normal DHFR. However, 3T6-R400 cells resistant to a much 
higher level of MTX (400 VIM vs. 50 yM) exhibited fluorescence patterns 
similar to MTX-sensitive cells. This is just the opposite of what was 
expected. The anomalous behavior of R400 cells was shown to be due to 
amplification of an altered (mutated) DHFR (Haber et al., 1981; Haber and 
Schimke, 1981, 1982). The mutated DHFR possesses a 270-fold reduction 
in MTX binding affinity, and a decrease in turnover number by 20 for the 
reduction of dihydrofolate to tetrahydrofolate. Haber and Schimke 
(1981) were unable to reproduce the emergence of 3T6-R400 cells with 
altered DHFR from the original 3T6-R50 population. All derivatives 
obtained had very high fluorescence levels and increased levels of wild-
type DHFR. From this observation, they concluded that the mutated 
gene was not present in the precursor 3T6-R50 population. 
Haber and Schimke (1981, 1982) proposed that cells which had 
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amplified the mutated dhfr gene would have a selective growth advantage 
over cells that had amplified normal dhfr genes. The selective growth 
advantage results from the fact that cells containing mutated dhfr would 
require a lower level of amplification, and thus fewer DHs, due to a sig­
nificantly reduced binding affinity for MTX by DHFR. Because of the 
inverse relationship between growth rate and number of double minute 
chromosomes (Kaufman et al., 1981; Brown et al., 1981) cells amplifying 
a mutated DHFR would be selected over those amplifying a wild-type DHFR. 
This was confirmed by experiments where equal mixtures of 3T6-R400 and 
3T3-R500 cells (which are resistant to 500 pM MTX but express high levels 
of a wild-type DHFR) were cocultivated. The original 50:50 mixture could 
be analyzed by the FACS, because each population had a very distinct, non-
overlapping fluorescence pattern. By 50 cell doublings in 400 yM MTX, 
the proportion of 3T6-R400 cells had risèn to 95% of the population, 
confirming the selective advantage of cells with a mutation in DHFR. 
Results from other ezqperiments suggested that the DHFR mutation 
occurred in a dhfr gene located on a DM, and not in the chromosomal 
dhfr gene. Furthermore, the mutation occurred sometime after selection 
for 3T6-R50 cells and before the emergence of the 3T6-R400 line. These 
results strongly suggest that amplified dhfr genes located on DMs are 
transcribed and expressed. 
The extensive review on gene amplification as a mechanism for MTX-
resistance in cell lines and in tumors is not meant to imply that gene-
amplification is unique to MTX resistance. MTX-resistance by 
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amplification of dhfr genes is the best characterized example of a general 
phenomenon involving gene amplification in response to drug treatment 
(Schimke, 1981). 
3. Other examples of drug resistance due to gene amplification of the 
target enzyme 
The following is a summary of some of the established or proposed 
examples of drug resistance due to gene amplification of the target enzyme. 
This list is probably not complete as there may be examples of drug-
resistance mediated by gene angplification of which this author is un­
aware. Also, the number of reports on this mode of drug resistance has 
greatly expemded within the last year. Examples of drug-resistance 
mediated by gene ait^ lification include (the cell line(s) in which the 
drug-resistant mutant was isolated is given at the beginning of the 
author citation); (1) An^ lification of DHPR in response to MTX selec­
tion or challenge with other antifolates such as methasquin. (2) Amplifi­
cation of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase (a membrane-
bound enzyme controlling cholesterol synthesis) by stepwise selection in 
increasing concentrations of compactin. Compactin is a competitive in­
hibitor of HMG-CoA (CHOKl, Ryan et al., 1981; Chin et al., 1982; Faust 
et al., 1982). (3) By selection in increasingly toxic concentrations 
of cadmium, cell lines have been isolated which have eunplified the 
metallothionein-I gene (Friend leukemia cells, mouse sarcoma S-180 cells. 
Beach and Palmiter, 1981; Mayo and Palmiter, 1982). Metallothioneins are 
small, cysteine-rich proteins that bind heavy metals such as Cd, Zn, Cu, 
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Ag, and Hg, and are thought to play an important role in zinc homeostasis 
and heavy metal detaoxification (Brady, 1982). (4) The gene for ribo­
nucleotide reductase has been amplified in response to challenges with 
increasing concentrations of arabinosyl cytosine and the deoxynucleo­
sides of adenine, thymidine, and guanine (mouse 3T6, Meuth and Green, 
1974). A second method, using hydroxyurea as a selective agent, has 
facilitated isolation of cell lines that have an^ lified ribonucleotide 
reductase (CHO, Lewis et al., 1978). (5) Complex U, the last 2 of 6 
enzymes for de novo synthesis of UMP (and consisting of orotate phosphori-
bosyl trêinsferase and orotidine-5'-phosphate decarboxylase) has been 
amplified in an SV40-transformed Syrian hamster line. The method of 
selection consisted of es^ sing cells to increasing concentrations of 
pyrazofurin and 6-azauridine, both inhibitors of complex U (Padgett 
et al., 1979; Suttle and Stark, 1979). (6) Cell lines resistant to in­
creasing concentrations of N-(phosphonacetyl)-L-aspartate (PALA, a 
transition-state analog inhibitor of aspartate carbaitylase) have been 
isolated. PALA-resistcuit cells have amplified the Complex A gene, which 
codes for the first three enzymes involved in de novo synthesis of UMP. 
The three enzymes, also called CAD, are carbonyl-P synthetase, aspartate 
transcarbamylase, and dihydroorotase (Syrian hamster, Wahl et al., 1979? 
Padgett et al., 1981, 1982a,b). The amplified CAD genes have been 
studied extensively, and the results confirm observations made on the 
amplified DHFR genes. It has been found that the average unit of amplifi­
cation is many times the size of the functional gene, and that the 
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amplified region is usually located at the site of the structural gene 
but may also be found at other sites along the same chromosome or on other 
chromosomes. One significant difference between CAD gene amplification 
and DHFR gene amplification is that the e:qpanded regions on chromosomes 
containing amplified CAD genes stain normally with trypsin-Giesma; i.e., 
no HSR regions are evident. (7) DL-a methylornithine is a competitive 
inhibitor of ornithine decarboxylase (ODC). Amplification of ornithine 
decarboxylase in rat hepatoma cells has been observed after stepwise 
selection in DL-a-methylomithine (Mamont et al., 1978). (8) Thymidylate 
synthetase has been amplified in cell lines selected against increasing 
concentrations of 5-fluorodeoxyuridine (mouse neuroblastoma, Carlin et al., 
1974; Baskin et al., 1975; mouse 3T6 cells, Rossana et al., 1982). (9) 
A trifunctional protein is apparently overproduced in cells selected for 
resistance to 5,11-methenyl-tetrahydrohomofolate. The cells overproduce 
GAR transformylase and AICAR transformylase (Padgett et al., 1981). 
(10) Deoxycoformycin, a specific inhibitor of adenosine deaminase 
(ADA) was used to select for cells that overproduce ADA (Debatisse 
et al., 1981; Hoffee et al., 1982). The frequency of rat hepatoma 
cells that are resistant to deoxycoformycin cuid overproduce adenosine 
deaminase, can be enhanced by mutagenesis (Debatisse et al., 1981). 
In addition, the types of chromosome anomalies typically observed in 
stable and unstable MTX-resistant cell lines, HSRs and DMs, are absent 
in deoxycoformycin-resistant cell lines. However, the highest increase 
in ADA level is 30-fold in one dCP-resistant line. Biedler et al. (1980a,b) 
have observed that in Chinese hamster sublines resistant to low levels of 
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MTX, and possessing increases in DHPR activity of 50-fold or less, no HSRs 
were visible. Instead, MTX-resistant lines with moderate increases in 
DHFR activity characteristically contain chromosomal segment(s) with 
abnormal banding patterns. In fact, a recent report demonstrates that 
HSRs are absent in the early stages of dhfr gene amplification, and 
that abnormally banded chromosomes are associated with early events 
(Lewis et al., 1982). One of the dCP-resistant lines containing a 20-
fold increase in ADA level has an unusually rearranged chromosome with 
a variable staining region. Thus, absence of an HSR in the stable dCF-
resistant cells may be e:qplained by the low level of dCF resistance. 
Alternatively, these results could be explained by a mutation in a regula­
tory sequence leading to increased transcription of the ada gene without 
any chêuige in ada gene copy number. Such a mutation would result in 
increased levels of ADA protein and mRNA but no change in gene number. 
Determination of which explanation is correct must await cloning of the 
ada gene. 
It is noteworthy that a genetic disorder, hereditary hemolytic 
anemia, has been associated with adenosine deaminase. Patients with 
this disorder express erythrocyte levels of ADA 45-70 times the level 
seen in normal controls (Hoffee et al., 1982). Purified enzyme from 
normal individuals and a patient with hereditary hemolytic anemia display 
the same physical, chemical and kinetic properties. This suggests that 
the defect results in increased levels of a structurally normal ADA 
enzyme. Isolation and characterization of dCF-resistant mutcints in vitro 
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that express increased levels of normal ADA may shed some light on the 
mechanism of hereditary hemolytic anemia and, may facilitate the develop­
ment of proper remedial therapy. (11) A recent report on the amplification 
of the enzyme arginino-succinate synthetase (AS) may be another example 
of increased levels of protein and mRNA without any increase in gene 
copy number (Su et al., 1981a,b). A human cell line was selected 
against increasing concentrations of canavanine, an inhibitor of AS. 
Canavanine-res is tant cells overproduce mRNA and AS protein, but pre­
liminary evidence indicated no increase in gene copy number for AS. 
In a recent review, argininosuccinate synthetase-res is tant lines have 
been included as an example of drug-resistance mediated by gene amplifica­
tion (Padgett et al., 1981). Such a conclusion is obviously premature, 
and argininosuccinate synthetase-resistant mutants as well as others such 
as dCF-resistant mutants may represent still another new category of 
drug-resistant mutants. (12) Overproduction of normal or mutant 
asparagine synthetase has been reported (Géuitt et al., 1980; Andrulis 
and Siminovitch, 1982) in CHO. cells after stepwise selection in B-
aspartyl hydroxamate. B-aspartyl hydroxamate is an amino acid analog and 
a competitive inhibitor of asparagine synthetase. (13) Mutants resistant 
to mycophenolic acid (MPA) overproduce IMP 5'P-dehydrogenase (Huberman 
et al., 1981). In this case, the frequency of MPA-resistant, IMP 5'P-
dehydrogenase-overproducing cells could be increased by the mutagen N-
methy1-N'-Nitro-N-nitroso-guanidine. Thus, this may be another example 
of a mutation in a regulatory sequence resulting in increased transcription 
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of mRNA. (14) Cells overproducing aryl hydrocarbon hydroxylase have 
been isolated (Miller and Whitlock, 1981). The method of selection was 
unique in that the FACS was used to measure the metabolism of benzo(a)-
pyrene (BP, a carcinogenic, polycyclic aromatic hydrocarbon) in indi­
vidual, viable mouse hepatoma (Hepa) cells and, to physically select 
variants with either markedly elevated or markedly decreased ability to 
metabolize BP. The technique involved exposing cells to low, non­
toxic concentrations of BP (25nM) and measuring the rate of dis­
appearance of BP fluorescence. Disappearcunce of BP fluorescence was 
due solely to metabolism of the carcinogen by aryl hydrocarbon hydroxylase. 
(15) Hypoxanthine-guanine phosphoribosyl transferase (HGPRT) mutants are 
resistant to 6-thioguanine cuid are HAT sensitive (Thompson cuid Baker, 
1973). Isolation of HAT-resisteint revertants of HAT CHO cells resulted 
in the selection of some cell lines overproducing a mutant HGPRT (Melton 
et al., 1981). This last example of gene amplification, where an auxo­
trophic revertant is selected that has amplified a mutated gene, may be 
a fairly common mechanism for reversion from auxotrophy in cultured cells. 
(16) Criscuolo and Krag (1982) have isolated CHO cells resistant to tuni­
camycin, a tight-binding inhibitor of the first step in glycosylation of 
asparagine-linked glycoproteins. Step-wise selection in increasing con­
centrations of tunicamycin facilitated retrieval of tuniccimycin-res is tant 
mutêints possessing a 15-fold increase in the activity of UDP-N-acetyl-
glucoseamine:dolichol phosphate transferase, the first enzyme in the 
dolichol-mediated pathway. 
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Roberts and Axel cotransformed a truncated, promotorless thymidine 
-f" — — 
kinase (tk) gene with a wild-type APRT gene into APRT tk mouse L cells 
(Roberts and Axel, 1982). After selecting for APRT'^ 'tk transformants, 
and thus cells that had taken up and presumably integrated the APRT"*" 
tk plasmid, the authors then selected for tk -variant subclones. Blot 
hybridization experiments revealed that the tk^  variants had arisen by a 
20-40-fold ang)lification of not only the defective tk gene, but also the 
+ — 
APRT gene as well. Although the truncated tk gene lacked its normal 
primary promoter sequences, it was concluded that several alternative 
transcription sites exist around the gene, some of which are used only 
after the primary promoter has been deleted. Alternatively, there may 
exist a weak promoter responsible for an aberrant tk mRNA transcript. In 
either case, amplification of the defective tk gene allows enough expres­
sion of aberrant tk mRNA to produce sufficient tk enzyme, thus the 
cells are functionally tk^ . 
In some APRT tk plasmids, a well-defined collection of cloned 
PBR322 sequences were inserted. Eight independent tk revertants were 
isolated and the DMA from each cut with a number of restriction enzymes, 
allowing each integrated pBR segment to be displayed as a unique band. 
The bands were separated on an agarose gel and hybridized to their respec­
tive probes. The results demonstrated that the amplification unit varied 
in size from 40 to greater than 200 kb. In addition, each amplification 
unit was unique; no two tk^  subclones amplified the same subset of bands, 
although there was a common subset of four bands amplified in all clones. 
One clone amplified only the four bands, while the other 7 clones amplified 
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the four bands plus a variable number of other bands unique to each line, 
îhis suggests that there is a common point, or origin of amplification 
and that amplification proceeds outwards for varying distances. This con­
clusion is identical to that of Bostock and Clark (1980) regarding 
amplification of dhfr and surrounding DNA sequences in MTX-resistant mouse 
melanoma lines. Similar observations have been made on the chorion genes 
and surrounding sequences during developmentally regulated amplification in 
Drosophilla oocytes. 
4. Drug resistance mediated by anglification of gene(s) directly or in­
directly controlling membrane permeability 
Until recently, examples of drug resistance mediated by gene amplifi­
cation were limited to amplification of the gene (enzyme) which the 
drug acted on and inhibited. However,'Baskin et al. (1981; Baskin, 
1981) have isolated drug-resistant C-46 mouse neuroblastoma cell 
lines where resistance is believed to be mediated by amplification 
of a gene(s) which reduces membrane permeability to the drug. Neuro­
blastoma cells were selected for resistance to increasing concentrations 
of maytansine (a microtubule inhibitor), vincristine (a microtubule 
poison), adrianycin (intercalates DNA and inhibits DNA replication and RNA 
synthesis), or Bakers antifol (an antifolate similar in action to MTX). 
It was found that variants resistant to any one of the drugs just listed 
were cross-resistant to other structurally cind functionally distinct 
drugs. As described in the section on membrane permeability mutants, 
cross-resistance to structurally and functionally distinct drugs is a 
common attribute of drug upteJce and/or permeability mutants. Reduction 
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in membrane permeability in the drug-resistant neuroblastoma cells was 
confirmed in experiments measuring the uptake and accumulation of radio­
labeled vincristine, colchicine and Bakers antifol. Drug-resistant lines 
displayed a significant reduction in radiolabeled drug accumulation 
despite normal binding to cell extracts. 
A number of similarities exist between the neuroblastoma drug-
uptake mutants and MTX-resistant cell lines described earlier. As in 
MTX-resistance, initial drug-resistant isolates were genetically un­
stable, rapidly reverting to drug sensitivity when grown in nonselective 
(drug-free) medium. The reversion rate was 0.05 per cell division (Baskin 
et al., 1981). Drug-resistant sublines with stable phenotype emerged 
after prolonged drug selection. Maytansine-resistant lines C-46-MT-1 
(resistant to 1 ng/ml), C-46-MT-2 (resistant to 10 ng/ml), and C-46-MT-3 
(resistant to 50 ng/ml) had a significantly longer (24 to 38 hrs) com­
pared to the drug-sensitive pareht and a sensitive revertant of MT-2 
(MT-2-R, 20 hrs). C-46-MT-1 and C-46-MT-2, propagated in maytansine 
for 2 weeks and 8 months, respectively, exponentially lost drug-
resistance upon removal from selective medium. A stable 7-fold resistant 
subline of the largely unstable 240-fold resistant C-46-MT-2 line emerged 
during culture in nonselective medium and remained stable even after 12 
months of further growth without drug. C-46-MT-3, 1200-fold more 
resistant to maytanisne, was conqpletely stable. No DMs were observed 
in roetaphases of the parental line (40 metaphases examined) or in any 
of the stable drug-resistant lines. C-46-1 exhibited a 300% increase in 
modal chromosome number, from 77+3 to 320+14, as well as displaying 
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numerous double minute chromosomes. The DMs were not quantitated due to 
difficulty in detecting them ëunong more than 300 chromosomes in each 
metaphase. C-46-MT-2 had a normal number of chromosomes and had a mean 
of 10.5 DMs per cell. However, there was a great deal of heterogeneity 
in the distribution of DMs between individual cells; 55% of the cells had 
no DMs and the remaining 45% had an average of 22 DMs. The 7-fold 
stably-resistant revertant had a normal chromosome number and very few 
DMs (1.0-0.2). No mention was made of the presence of HSRs in stable 
or unstable drug-resistant mutants. 
The initial report of Baskin et al. (1981) may have been mis­
leading. Baskin (1981) later reported that DMs were observed in the 
early isolates of only one drug resistant population, MT-1 and MT-2. 
Neuroblastoma lines resistant to Bakers antifol (C-46-BAP-R), vincristine 
(C-46-VC-R), adricut^ cin (C-46-ADR-R), and 6-mercaptopurine {C-45-6MP-R) 
were devoid of DMs. In all drug-resistant lines, resistance fell with 
a half life of 10 days in the absence of selection. In addition, after 
prolonged growth in drug containing medium, all drug-resistant lines de­
veloped sublines with stable resistance. Due to a number of similar 
characteristics beween permeability mutants of mouse neuroblastoma lines 
with those of MTX-resistant mutants, it was concluded that drug-
resistance and cross-resistance wcis mediated by gene «mplification. The 
amplified gene is proposed to directly or indirectly control membrane 
permeability or uptake of drug. 
Baskin et al. (1981) hypothesized that the amplified gene proposed 
to modulate drug permeability was a membrane phosphorylase, phosphatase. 
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glycosyItransferase or glycosidase. All of these enzymes are thought to 
play a significant role in membrane permeability. Two-dimensional-sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (2D-SDS-PAGE) of proteins 
from sensitive parental cells and from an unstable MT-resistant cell 
line revealed no differences, at least among the 200 most abundant pro­
teins visible. 
Baskin (1981) found many biochemical changes in drug-resistant 
lines compared to the sensitive parent or sensitive re vertant. 
For example, drug-resistant variants were hypersensitive to several 
glycosylation inhibitors. Differences in plasma membrane composition 
included: 1) an alteration in the overall labeling of membrane glyco-
3 3 
proteins and glycolipids of all mutants with ( H) fucose and ( H) 
galactose; (2) the specific deletion of one 100,000-m.w. penultimate 
galactosylated cell surface protein from ADR-R, MT-R, cind BAF-R; (3) 
the presence of a 12-fold elevation of cholesterol-ester in VC-R; (4) 
12-fold elevation of the GD ganglioside in MT-R and VC-R lines; (5) 
lower overall ganglioside levels in ADR-R and BAF-R; (6) increases or de­
creases of vitro galactosyl transferase activities; (7) loss of 30-80% 
of many lysosomal emd nonlysosomal glycosidases and hydrolases in all 
mutants; and (8) 20-150-fold increases in alkaline phosphatase activity 
in ADR-R, BAF-R, VC-R and 6-MP-R mutcuits and a 50-fold reduction in MT-R. 
It was concluded that only changes 7 and/or 8 may have any causal role 
in drug resistance due to the fact that: chemges (1) and (2) could be 
produced in drug-sensitive parental lines without perturbing subsequent 
drug resistance; the persistence of changes (4) and (5) in a drug-
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sensitive revertant; the distinct possibility that changes 1-5 could be 
caused by (7) or (8) ; and the supposition that a common change would 
most simply explain cross-resistance. 
Amplification of alkaline phosphatase was the most tantalizing 
mechcuiism underlying resistance in the neuroblastoma permeability 
mutcints. This hypothesis was strengthened by the observation that 
alkaline phosphatase activity and lysosomal hydrolases are inversely 
regulated (Hosli, 1977). Thus, high AP activities might be responsible 
for the observed reduction in lysosomal enzyme activity. However, the 
hypothesis that amplified AP underlies drug-resistance suffers from two 
major contradictions. First, the maytansine-resistant mutants have a 
50-fold reduction in AP activity. Secondly, 6-mercaptopurine-resistant 
mutants are not cross-resisteuit to ADR, MT, BAF, or VC, yet possess 80-
fold more AP activity. There may be logical explanations for these dis­
crepancies, but until they are resolved the idea that anqplification of the 
AP gene is responsible for the observed drug-resistant phenotype is 
purely speculation. 
A more tenable choice for a mechanism underlying drug-resistance 
was the low lysosomal hydrolase activities, especially B-galactosidase, 
N-acetylglucoseaminidase and .arylsulfatase. Activities of these enzymes 
are low in all mutants except 6-MP-R and the inaytansine-sensitive 
revertant. 
Meyers and Biedler (1981) found a 19,000 dalton peptide, identified 
by 2-0 gels, that is synthesized in increased amounts in vincristine-
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resistant Chinese hamster cells. Only trace amounts of the peptide are 
found in wild-type parent cells and in a revertemt line produced after 
culturing a vincristine-resistant line in drug-free medium for two 
years. A similar protein was also overproduced in a vincristine-
resistant mouse line and in two vincristine-resistant human neuroblastoma 
cell lines. All vincristine-resistant mutants exhibit reduced permeability 
to vincristine and cross-resistance to other drugs. Thus, reduced drug 
permeability and/or uptake is responsible for vincristine resistance. 
Meyers and Biedler (1981) suggest the peptide overproduced in the 
different vincristine-resistance lines is somehow associated with the 
microtubules, and not with reduced drug permeability/uptake. No evidence 
has been presented for this idea, and the relationship between the over­
produced peptide and vincristine resistance is unknown. However, there 
is a good correlation between the presence or absence of the over­
produced peptide, vincristine resistance, and the presence or absence of 
an HSR or DMs. The simultaneous amplification of target enzyme and re­
duced membrane permeability for drug is not without precedence. Re­
sistance to MTX in some cell lines has been shown to be due to both 
amplification of DHFR and reduced uptake of MTX (Bertino et al., 1981). 
Thus, it is possible that vincristine-resistant variants described by 
Meyers and Biedler have reduced permeability for vincristine, and have 
also amplified a peptide which is associated with vincristine binding by 
microtubules. 
Meyers and Biedler (1982) have recently found significant differences 
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in phosphoproteins between vincristine-resistant and -sensitive lines. 
One major difference is the significantly increased phosphorylation of an 
18,700-dalton protein. This report may be another indication of the 
relationship between changes in the activity of protein kinases/ 
phosphatases and reduction in drug uptake. 
Other examples of drug-resistance due to changes in membrane 
permeability have been reviewed earlier. Because the drug-resistant 
variants were derived by stepwise selection, were often unstable, and had 
a number of physiological and biochemical characteristics in common, 
it is not unreasonable to suggest that many of the drug-uptake mutants 
share a common underlying mechanism of resistance. One possible mechanism 
for controlling drug uptctke and/or efflux is by gene an^ lification 
(Schimke, 1981). Most of the reports of drug uptake/efflux mutamts and 
drug-resistant tumors occurred before 1980, and thus before the establish­
ment of gene amplification aa a mechanism for altered drug uptake and efflux. 
C. Cytochalasin 
Cytochalasins are fungal metabolites noted for their striking, yet 
diverse, effects on cells in culture (Carter, 1967, 1972). These effects 
include: inhibition of cytokinesis (cell division) but not karyokinesis 
(nuclear division); inhibition of cell motility; disruption and altera­
tion of normal cellular morphology; promotion of nuclear protrusion and 
in some cases, total enucleation of the cell; inhibition of wound healing 
éuid clot retraction ^  vitro; inhibition of cytoplasmic streaming in plant 
cells; inhibition of endocytosis and exocytosis (although in some instances, 
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exocytosis or cell secretion is greatly enhanced in the presence of cyto-
chalasin); eind many other effects as well (Tanenbaum, 1978; Miranda et al., 
1974a; Godman et al., 1975; Rathke et al., 1975; Godman and Miranda, 
1978; Yahara et al., 1982). The effects of cytochalasin on cells in 
culture are readily and rapidly reversible upon removal of cytochalasin 
(Tanenbaum, 1978; Yahara et al., 1982). 
Cytochalasin B was the most widely used congfener of cytochalasin 
in early physiological and morphological studies on mammalian cell 
responses to cytochalasin. In addition to all of the effects on cells 
in culture ascribed to cytochalasin, CB was found to be one of the 
strongest known inhibitors of glucose transport, supplanting phlorizin 
as the inhibitor of choice in studies on glucose transport (Kletzien 
et al., 1972; Kletzien and Perdue, 1973; Plagemann et al., 1978). 
Three different theories have been proposed to e^ lain the mechanism 
of action of cytochalasin on cells in culture. It was noted that many 
of the cellular processes sensitive to cytochalasin were microfilament-
mediated. That is, the functions that were inhibited or altered by cyto­
chalasin were known or thought to require an intact microfilament (F-
actin) system. This notion became especially prevalent after a paper 
by Wessels et al. (1971) in which it was noted that microfilament 
morphology was disrupted by addition of cytochalasin to cells in culture 
and, that microfilament structure was completely restored after removal 
of cytochalasin. Also, microfilament-dependent processes were completely 
inhibited in the presence of cytochalasin and these processes were 
recovered in the eUbsence of cytochalasin. 
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Unfortunately, as a result of the paper by Wessels et al. (1971), 
there was a strong tendency to assign an essential role for an intact 
microfilament system to any cellular process inhibited by or otherwise 
altered by the addition of cytochalasin. S. B. Carter, one of the co-
discoverers of cytochalasin, summed up the problem cogently; "In spite 
of the lack of adequate evidence, the microfilament theory of cyto­
chalasin action came to occupy a dominant position which in my view has 
thrown the literature on this subject out of balance. Many experiments 
were designed and interpreted as though the theory had been fully es­
tablished. The cytochalasins were no longer used to investigate the 
biological processes with which they interfered; rather, they were used 
to examine the possible role of microfilaments in these processes" 
(Carter, 1978). 
In all branches of science, there are those that are skeptical of 
the prevailing paradigm(s) accepted by most investigators in a particular 
field. In keeping with this tradition, not everyone agreed on the 
mechanism of action of cytochalasin. A few investigators proposed 
that cytochalasin exerted most of its effects on cells nonspecifically 
by its strong inhibition of sugeur transport (Blumenik, 1971; Estensen, 
1971; Estensen and Plagemann, 1972).. This hypothesis no longer 
has êmy adherents because of the following evidence: (1) Some cyto­
chalasins, such as cytochalasin D (CD) are more potent in inhibiting 
microfilament-mediated functions than CB, but do not inhibit sugar 
transport (Plagemann et al., 1978). (2) A derivative of CB has been 
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synthesized, dihydrocytochalasin B, which does not inhibit sugar trans­
port but which still retains its characteristic effects on cellular 
microfilaments and microfilament-controlled processes (Atlas and Lin, 
1978). (3) Other potent inhibitors of sugar tremsport, such as phlorizin, 
do not evoke the morphological and physiological changes elicited by 
cytochalasin. 
A third theory of cytochalasin action is that cytochalasin exerts 
its effects nonspecifically at the level of the plasma membrane, perhaps 
by altering the properties of proteins embedded in the lipid bilayer 
(Spooner, 1973, 1978). It is proposed that CB acts specifically with the 
glucose transport site embedded in the membrane and that all cyto-
chalasins cause detachment or disruption of microfilaments inserted 
into the plasma membrane. This theory, which is not presently accepted 
and which has always been championed by just a few researchers such as 
Spooner, has never been disproved. It is a theory which has been very 
difficult to prove or disprove (Plagemann et al., 1978). 
Recently, a great deal of ^  vitro biochemical evidence has been 
gathered which conclusively demonstrates that cytochalasin acts on 
microfilaments by binding to the net polymerizing end ("barbed" end) 
of F-actin filaments, inhibiting further polymerization (Bray, 1979; 
Lin et al., 1980; Lin and Lin, 1980; Flanagan and Lin, 1980; Grumet and 
Lin, 1980a,b; Broym and Spudich, 1979; Selden et al., 1980; Maclean-
Fletcher and Pollard, 1980; Brenner and Korn, 1979, 1980). It is 
known that there exists a net polymerizing end in F-actin filaments, 
analogous to treadmilling in microtubule assembly from tubulin subunits 
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(Cleveland, 1982). According to Lin, Pollard and others, cytochalasin 
blocks the addition of actin monomers to the net polymerizing end, 
resulting in a new steady state which favors net depolymerization of 
F-actin filaments. Still others propose that the primary effect of 
cytochalasin is the disruption of F-actin filament-filament interactions 
and/or the fragmentation and breakage of F-actin filaments (Schliwa, 
1982; Hartwig and Stossel, 1979). 
Evidence is accumulating that the action of cytochalasin on F-
actin filaments vitro is responsible for the action of cytochalasin 
on cells in culture. First, the relative effectiveness of different 
congeners of cytochalasin in evoking characteristic changes in cellular 
morphology and physiology is identical to their ability to disrupt F-
actin filaments in vitro (Yahara et al., 1982). Secondly, F-actin fila­
ments are disrupted (broken) after treatment of detergent-extracted 
BSC-1 cells with CD (Schliwa, 1982). Finally, cellular proteins with 
cytochalasin-like activity have been isolated and identified in human 
platelets (Grumet and Lin, 1980) and in other cell types (Schliwa, 
1981). This latter result implies a functional, physiological role for 
cytochalasin-sensitive sites on F-actin filaments. 
Thus, it is proposed that the vitro actions of cytochalasin on 
F-actin filaments occurs in cells vivo. It has not been definitively 
established, however, that all or any of the effects of cytochalasin 
in vivo result from inhibition of F-actin polymerization, disruption 
of filament-filament interactions or breakage of F-actin filaments. 
In spite of the overwhelming biochemical evidence that cytochalasins 
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disrupt normal microfilament properties ^  vitro, and presumably vivo, 
it is still possible that at least some, and perhaps many of the ef­
fects of cytochalasin are membrane-mediated. 
1. Isolation of somatic cell mutants resistant to cytochalasin 
There have been two independent reports of the isolation of cyto-
chalasin-resistant variants. In one case, selection of CB-resistant 
variants was facilitated by a difference in the response of normal and 
transformed mouse cells to CB treatment (Kelly and Sambrook, 1973, 1975; 
Kelly, 1975). Kelly and Sambrook (1973) reported that 3T3 cells treated 
with 5 yg/ml CB became binucleate but then ceased DNA synthesis. No 
further increase in the number of nuclei was observed after four days 
in the presence of 5 yg/ml CB. On the other héuid, at the same concen­
tration of CB, SV40-transformed derivatives of 3T3 (SV3T3) continued to 
synthesize DNA and to generate cells with ever-increasing numbers of 
nuclei. In addition, the plating efficiency of SV3T3 cells diminished 
markedly; plating efficiencies of 100% are common in untreated SV3T3 
cells, while cells treated for one day in 5 yg/ml CB had a plating 
efficiency of 14% and a plating efficiency of one percent after four 
days in CB. 
CB-resistant cells were isolated by culturing an SVT2 line in 
5 yg/ml CB for one week, during which time most of the cells detached 
from the substrate. Cells surviving the first selection were grown for 
ten days in nonselective medium and then es^ osed to 5 yg/ml CB for one 
5 
week. CB was removed and surviving cells (1 in 10 ) were allowed to grow 
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into colonies. Three different morphological types were observed and 
several colonies of each morphological type were picked for further 
characterization. None of the colonies divided when grown in the 
presence of 5 lig/ml CB for two to four days but exhibited a pattern of 
response to CB identical to that for untransformed 3T3 cells {3T3 cells 
not treated with SV40). The SV40 T antigen was not detected in CB-
resistant variants but was readily detected in the parent line. The 
CB-resistant phenotype was stable for at least 50 generations, but 
after 5 months, 5-10% of the CB-resistant cells were T-antigen positive. 
No mechanisms of resistance was ever postulated for the CB-resistant 
variants, and neither the microfilaments nor the membrane of CB-
resistant variants were ever characterized. 
Another laboratory reported the isolation of CB-resistant rat liver 
epithelial variants of WIRL cells (Futzrath and Brownstein, 1978). 
CB-resistcmt variants were selected by their ediility to divide in 2 
and 5 yg/ml CB, concentrations of CB which inhibit cytokinesis in CB-
sensitive cells. CB-resistant variants were polyploid and partially 
unstable. It was tentatively concluded that resistance was due to a 
cell surface alteration resulting in reduced CB permeability. The 
varicmts possessed altered adhesive properties cind were no longer able 
to grow in multilayers or in soft agar. The authors reported a reduction 
in the number of high-affinity CB binding sites in the CB-resistant 
variants compared to transformed and untrans formed parent cell lines. 
No evidence exists for the metcJaolism of cytochalasin by cells in 
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culture (Tannenbaum, 1978). However, Brownstein and Connors (1981) 
reported that incubation of CB with cultured mammalian cells results 
in the appearance of an altered CB in the medium. The "modified" CB 
derivative no longer inhibits glucose transport but does alter F-
actin polymerization. 
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III. MATERIALS AND METHODS 
A. Cell Lines and Culture Conditions 
CHO AK412 cells were cultured in minimal essential medium 
(oMEM; GIBCO) containing 10% fetal calf serum, 100 units/ml penicillin 
and 100 yg/ml streptomycin. This medium is designated a-NS (a-non-
selective). Variant cell lines were maintained in stock culture in 
both aNS and in oMEM containing 1 yg/ml cytochalasin D (selective 
medium: aS-lCD). All cell lines were routinely grown at 37°c in 5% 
COg, and were subcultured by trypsinization and appropriate dilution. 
In some experiments, cells were grown in suspension culture in either 
250ml, 500ml or 1000ml spinner culture bottles containing either a-NS 
or aS-lCD. 
B. Single-Step Selection for Cytochalasin 
Resistant Véuriémts 
1. Without mutagenesis 
6 2 10 cells were plated in each of ten 75cm tissue culture flasks 
containing 20ml of a-MEM and the selective concentration of CD or CB 
(.5 or 1 yg/ml CD, 5 yg/ml CB). The cells were kept in selective medium 
for 14-28 days. In some experiments, cells (10^  total) were kept in the 
original medium for the duration of selection. In other experiments, 
the selective medium weis removed every four days and replaced with 20 
ml of fresh medium containing the same selective concentration of CD or 
CB. At 7, 14, 21 and 28 days after initial plating, each flask was 
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examined visually for the presence of visible clones, which are char­
acteristically opaque, white circles on an otherwise clear background. 
Also, each flask was examined under an inverted phase contrast micro­
scope for the presence of 10 or more cells closely aligned (presumptive 
clones). At that time, the morphological types of cells were noted 
(e.g., CD or CB-sensitive cells vs. CD or CB-resistant cells: see 
Results for description of cytochalasin-resistant and -sensitive 
morphology). At the end of 14, 21, or 28 days, if no visible clones 
were detected, all flasks were stained with 0.5% crystal violet. This 
was done in order to detect any clones that may not have been observed 
by single inspection. 
2. With mutagenesis 
6 2 10 cells were plated in a 75cm fleisk containing 20ml of a-NS. 
After 5 hrs, the a-NS was removed and replaced with OMEM containing 200-
627 Jig/ml ethylmethanesulfate (EMS). After 16-18 hrs, the mutagen-
containing medium was removed and the cells were washed 5X with a-NS to 
remove any residual EMS. Cells were then cultured in 20ml of a-NS for 
7 days to allow fixation of any mutations in the population (i.e., the 
time of fixation (T^ ,) was 7 days). During this time, cells were sub-
cultured when necessary in a-NS (usually 2-4 days after removal of muta­
gen) . After 7 days, cells were plated in the appropriate concentration 
of CD or CB. and handled in the same way as for nonmutagenized cells. 
2 2 Control flasks (10 cells/25cm flask, total of 5 flasks) were set up 
at the time of mutagenesis and after the to determine the percent 
survival. 
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C. Enrichment Selection of Cytochalasin 
D-resistant Variants 
CD variants were obtained by an enrichment selection procedure in­
volving 16 cycles of growth with drug, followed by outgrowth in drug-free 
6 2 
medium. First, 10 cells/75 cm -culture flask were grown in aS-1 CD for 
4-6 days. The aS-1 CD medium was then removed, the cells were washed 3 
times with aNS, and fresh aNS medium was added. These cells were grown 
2 
to confluency (2-5 days) and then subcultured into two, 75-cm flasks 
at a concentration of 3 x 10^  per flask. The population again was grown 
to confluency in aNS, and the cycle repeated by dividing this regrown 
population into two, 75-cm flasks, each containing 1 x 10 cells in aS-1 
CD. The gross morphology of cells was routinely examined with phase con­
trast on a Zeiss inverted microscope. 
D. Isolation of Resistant Variants 
After 16 rounds of selection, more them 95% of the cells in the 
treated population were resistant to 1 Hg/ml CD. This population was 
diluted and cloned in nonselective medium (a-NS) in microtiter dishes 
(Costar, 96 well). Wells containing one attached cell were marked; cells 
2 in the resulting clone were picked, grown to confluencey in 25-cm 
flasks in a-NS, and then tested for resistance to 1 yg/ml CD by 
determining cloning efficiency. In some experiments, the resistant 
variant lines were further "purified" by recloning in 1 yg/ml CD, or 
else by cloning in nonselective medium. In the latter case, nonselective 
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medium was removed and medium containing 1 Mg/ml CD was added. The clones 
were examined 1-4 hours later, and those clones demonstrating complete 
CD resistance were picked for further testing. 
E. Cloning Efficiency Tests for Quantitation 
of Drug Resistance 
2 2 
For each experiment, cells near confluency in 25cm or 75cm flasks 
were harvested with trypsin, counted in an electronic particle counter 
2 (Coulter, Model ZBl), and diluted appropriately. As a control, 5, 25cm 
flasks were inoculated with 100 cells/flask in 5 ml of a-NS. For each 
2 
variant tested, five, 25cm flasks were inoculated with 100 cells each, 
and 5 ml of selective medium containing various concentrations of CD 
or other drugs (e.g., cytochalasin B, colcemid, actinomycin D, procaine 
HCL, etc.). Seven to 14 days later the clones were stained with 0.5% 
crystal violet and counted. In some cases (e.g., as the cloning ef­
ficiency decreased in higher concentrations of drug), greater numbers 
of cells were used as inocula (10^  to 10®). Cloning efficiency is al­
ways expressed as percent of control (in identical inoculum plated in 
nonselective medium). 
F. Chromosome Analysis 
1. Determination of modal chromosome number 
Cell cultures were prepared for chromosome analysis by a modifica­
tion of the method of Chen (1970). Cells in logarithmic growth phase 
(at least 10® cells) in 75cm^  flasks were incubated in 0.1-0.2 pg/ml 
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colcemid for 2-12 hours. This treatment arrests dividing cells in meta-
phase. Following incubation in colcemid, cells were removed with trypsin 
and pelleted by centrifugation at 1200 r.p.m. for 5 minutes (240 x g). 
The cell pellet was resuspended by gentle repeated pipetting in 3 ml 
of hypotonic KCl (0.075 M; room temperature). Cells were incubated 
in hypotonic KCl for 8 minutes. The cells were then centrifuged for 
5 minutes at 600 r.p.m. (approximately 60 x g). All but 0.5 ml of the 
supernatant was removed by aspiration and the cells were gently resuspended 
in the remaining KCl by gently bubbling through a Pasteur pipette. Approxi­
mately 3 ml of chilled (4°C) Camoy's fixative (one part glacial acetic 
acid:three parts absolute methanol) were added dropwise to the cell sus­
pension. After 10 minutes in Carnoy's fixative the cells were centrifuged 
at 600 r.p.m. for 6 minutes. The supernatant was removed and the pelleted 
cells were resuspended in 3 ml of cold Carnoy's fixative as described. 
At the end of the second fixation (10 minutes), the cells were centri­
fuged at 600 r.p.m. and all but 0.25 ml of the supernatant was removed 
by aspiration. The cells were gently resuspended in the remaining 
supernatant and two to three drops of the cell suspension were added to 
a cold, wet slide (stored in cold distilled water). The drops were 
quickly blown to spread the cell preparation as widely as possible. 
Slides were air-dried (at leeist 15 min), stained with aceto orcein (20 
min) (1.5 grams of orcein with 100 ml 65% acetic acid), destained with 
ethanol-HCl (1 min) (1 ml of IN HCl in 100 ml absolute ethanol), and 
treated for 5 min each with two changes of absolute ethanol. The slides 
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were then air-dried for 10 itiin, and treated in two changes of xylene (5 
min each). Coverslips were mounted with Pennount (diluted 1:1 with 
xylene). 
2. Trypsin-Giemsa banding of chromosomes 
Trypsin-Giemsa banding was a modification of the method by Seabright 
(1971). Cells in metaphase were prepared exactly as just described. 
After the cells were applied to slides, the slides were dried on a 
slide-warming tray (50-60®) for approximately 24 hours. The slides were 
then immersed in Coplin jars containing the following solutions: 
(1) Two washes in phosphate-buffered saline (PBS; pH 6.8) for 1 minute in 
each wash; (2) trypsin solution (Stock trypsin solution: 1.25 g of 
Difco 1:250 trypsin in 200 ml of distilled water that has been acidified 
to pH 2.5 with concentrated HCl, 1 ml of this trypsin stock was added 
to 49 ml of PBS and adjusted to pH 7 with 0.2 M Na^ HPO^ ), slides were 
immersed in trypsin for 5-30 seconds; (3) two rinses in PBS, 1 min each 
rinse; (4) Giemsa staining solution for 5-10 min (2 ml Giemsa (Fisher) 
in 50 ml of PBS); (5) two rinses in distilled water. Slides were then 
air-dried and observed under oil immersion. 
G. Analysis of Monolayers for % 
Polynucleate Cells 
Cells in monolayer were stained with Giemsa and then maintained in 
the original flask under a small quantity of buffer, without further 
dehydration or fixation, for examination by bright-field microscopy. 
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H. Determination of Culture Doubling Time 
The doubling time (T ) of the parental and variant cell lines was 
d 
calculated after determination of cell number increase in populations 
of at least 2 replicate cultures. Cell number was ascertained either 
by electronic particle counting or by ^  situ counting. For ^  situ 
counting, 6 areas were chosen at random and permêuiently marked on the 
back of the culture flask; cell number in these areas was followed daily 
by microscopic inspection using an ocular grid previously calibrated at 
a specific magnification (160X). The size of each of the 6 areas counted 
2 Wcis 0.563 mm , and the minimum number of cells counted at the beginning 
of a growth curve was 500. Growth curves derived from ^  situ data 
accurately duplicate growth curves based on Coulter counting. 
I. Sceuining Electron Microscopy 
Cells were inoculated on 9 x 55 mm plastic coverslips in 16 x 93 
mm plastic Leighton tubes (Costar). Semiconfluent or confluent cells 
in the appropriate medium were fixed for one hour in 3% glutaraldehyde, 
phosphate buffered at pH 7.4. The covers lips were washed 3X with buffer, 
post-fixed in 1% OsO^  in phosphate buffer (pH 7.4) for one hour, and then 
washed 3X, 20 min each wash, with buffer. The cells were dehydrated in a 
graded ethemol series (25 to 100%) and then taken through a graded series 
of ethanol:Freon 113 mixtures until 100% Freon was reached. The cells 
were critical-point dried, mounted on copper stubs, and sputter coated 
with gold:paladium (300-500Â). The cells were examined under a JSM-35 
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sccinning electron microscope at 15kV. 
J. Binding Assay 
CD-displaceable binding of [^ HJCB was measured by using the method 
of Magargal and Lin (1980). For determination of [^ H]CB binding to cell 
extracts, cells were grown to confluency in 150-mm plastic tissue culture 
dishes, washed 3X with cold PBS, and then scraped off gently with a 
rubber policeman. The cells were centrifuged, resuspended in buffer A 
(10 mM Tris-HCl, pH 7.8, 0.1 mM CaCl^ , 0.5 mM ATP, 0.01 mM PMSF, 0.1 mM 
B-mercaptoethanol) and homogenized by 50 strokes with a tight (B) 
pestle of a 7 ml Bounce homogenizer (Vitro). The homogenate was 
centrifuged at 200,000 x G for 30 min, and the supernatant removed and 
saved. The pellet was homogenized in buffer A and centrifuged as before. 
The binding of [^ H]CB to the combined supernatants (soluble-extract 
fraction), and pellet (laembrane-particulate fraction), was determined 
both in the presence and absence of excess unlabelled CD by the acid 
precipitation assay of Lin and Lin (1980). First, protein concentration 
in the soluble extract and pellet fraction was determined by the Hartree 
(1972) modification of the Lowry method. Protein from the extract 
(0.36-0.4 yg) from the pellet fraction (0.3 yg) was combined with 
10 yl of O.IM MgClg, DMSO to 1% or less total volume, the appropriate 
concentration of [^ H]CB (final concentrations, 10 ^  to 10 ®M) with or with-
—A 
out unlabelled CD (4x10 M final concentration), and enough buffer A to 
give a total volumè of 0.5 ml. Unlabelled CD was added as a control for 
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nonspecific binding. The contents, in glass vials, were vortexed, in­
cubated for 10 minutes at room temperature (RT), and then 30 yl of 
saturated Na^ PO^  was added to each tube. The tubes were centrifuged 
at 6000 RPM for 10 minutes, RT, in a Beckman J-21B centrifuge using a 
JS 7.5 rotor. The supernatant was removed, added to 3.5 ml Triton-
tol and counted in a liquid scintillation counter. The pellet was 
dissolved in 3.5 mis of Omnitoi and counted. 
For whole cell binding measurements, cells were grown to confluency 
in 60-mm plastic tissue culture dishes and then washed 3X in serum-free 
L-15 medium (GIBCO). [^ H]CB in L-15 was added to the culture dishes 
"^ 0 "A (final concentrations, 10 to 10 M) and cells were incubated for 20 
minutes at 37 °C, either with or without an excess of unlabeled CD (4 x 
10 ^ M) as a control for nonspecific binding. The medium (supernatant) 
was removed, saved, and 1 ml of IN NaOH was added to each plate. The 
plates were wrapped in Parafilm and refrigerated for 2 days or until 
cells were solubilized. 0.1 ml of the L-15 medium (supernatant) was 
prepared and counted as for the supernatants of the cell extracts. 
The plates were rinsed thoroughly with the 1ml NaOH and 0.1 ml removed 
for protein determination. In addition, aliquots of 0.4 ml were re­
moved, added to liquid scintillation vials containing 7.0 mis of Triton-
tol and 10 yl of glacial acetic acid, and then counted. 
1. Data analysis 
The data were plotted by the method of Scatchard (1949) in which the 
specific binding/unbound on the ordinate (y-axis) is plotted against 
specific binding on the abscissa (see Results). Specific binding is the 
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total radioactivity bound minus the radioactivity bound in the presence 
of em excess of unlabelled CD (nonspecific binding). 
A) Whole cell binding assay 
1) Bound counts (NaOH precipitable) 
counts per minute (CPM) 
(% efficiency) (0.4)(specific activity of [^ H]CB 
2) Unbound or free (i.e., those counts in the supernatant) 
CPM 
(% efficiency)(0.1)(specific activity) 
The answer is in moles. This is converted to picomoles and 
divided by the amount of protein in the sample to give 
pmoles bound/mg protein. 
B) Cell extract binding assay 
The equations were the same as in the whole cell binding assay 
with the exception that there was no factor (i.e., 0.4) 
the denominator of the bound counts because the whole pellet 
was counted. The supernatant or unbound fraction was 
calculated as in the unbound fraction of whole cells. 
K. Radiolabeling of Membreme Proteins 
125 (1) [ IJ-Lactoperoxidase-catalyzed iodination of cell surface 
proteins, (a) Monolayer - lodinations were performed on 100 mm plates 
by a modification of the procedure of Hynes (1973) as described by Pauw 
and David (1979). Plates were rinsed 5 times with Pucks saline G (room 
ten^ erature) and incubated in 4 ml of this buffer without phenol red 
125 but including 200 yci carrier-free sodium [ I] iodide (New England 
Nuclear or Amersham, specific activity 100 mCi/ml. 
The reaction was initiated by the addition of 20 yg/ml 
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lactoperoxidase (Sigma: LPO; EC 1.11.1.8) and 0.1 unit/ml glucose oxidase 
(Sigma: GOP; EC 1.1.3.4). A stock solution of 1 mg/ml lactoperoxidase 
in water was prepared and stored at -20®C. After 15 minutes at room 
tenperature, the iodination medium Wcus removed and the cells were rinsed 
4 times in cold (4'C) Pucks saline G containing 10 M Nal, but lacking 
glucose and phenol red. 
7 8 (b) Suspension - 10 -10 cells in exponential phase in spinner 
culture were pelleted and washed 5 times in Pucks saline G euid then re-
suspended in 5 ml of this buffer containing 300 yCi of carrier-free sodium 
125 ( I] iodide. "The reaction was carried out as for monolayer cells and 
-4 
the cells were washed 5 times in cold Pucks saline G containing 10 M 
Nal, but lacking glucose and phenol red. 
125 
No incorporation of [ I] into surface membrane proteins was de­
tectable if either lactoperoxidase, glucose oxidase or glucose was 
omitted. 
2. Labeling of cell surface glycoproteins with [^ H] NaBH^  
Suspension - 10^ -10^  cells in esqsonential phase in spinner culture 
were pelleted and washed 3X in phosphate buffered saline (PBS), pH 6.0, 
4*C. After the third wash, the PBS was aspirated off and the cells were 
incubated with 25 units of Vibrio cholera neuraminidase (Calbiochem) at 
37"C for 30 min with gentle agitation. Next, the cells were washed 3X in 
PBS (pH 7.0, room temperature) and then resuspended in 100 yl of PBS (pH 
7.0) containing 10 units of galactose oxidase (Sigma). The cells were 
incubated for 2 hrs (RT) with gentle shedcing. They were then washed 3X 
with PBS, pH 7.4 and resuspended in 0.5 ml of PBS, pH 7.4 to which 1.0 raCi. 
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of [ H] NaBH^  in O.IN NaOH (New England Nuclear, 6 Ci/mmol) was added. 
The reaction mixture was incubated for 30 min at RT and the cells were 
then washed 5X with PBS, pH 7.4. Cell pellets were resuspended in 5 ml 
of cold TEA buffer (0.1 mM triethanolamine, pH 7.2, 0.25 M sucrose). 
The plasma membrane was then isolated as described in section L. 
3. Metabolic labeling of glycoproteins 
Metabolic labeling of glycoproteins was performed by incubating 
cultures with I^ H]-fucose (2.0 yci/ml) or [^ H]-glucosamine (0.2 yci/ml) 
for 48 hours in oMEM plus 10% dialyzed fetal calf serum. After labeling, 
the medium was removed, cells were washed 3-5X with cold PBS, pH 7.4, 
and then scraped off of tissue culture plates with a rubber policeman. 
Cells were pelleted and then resuspended in 5 ml of cold 0.25 M sucrose, 
0.1 mM triethanolamine buffer pH 7.2, and then prepared as described 
in section L. 
L. Membrane Preparation 
All cells, whether in monolayer or suspension were eventually sus­
pended in 5 ml 0.25 M sucrose, 0.1 mM triethanolamine, pH 7.2. Cells 
were homogenized by 30-40 strokes with the tight (A) pestle of a 7-ml 
Dounce homogenizer (Vitro). The homogenate was centrifuged at 2200 x g 
for 10 minutes. The supernatant was then centrifuged at 108,000 x g for 
2 or more hours in an SW 39 rotor to pellet membranes. Pellets from 
125 [ I]-labeled membranes were counted in a Nuclear Chicago gamma counter. 
Aliquots of solubilized membrane preparations (see Section L: Poly-
acrylamide Gel Electrophoresis) from [^ H]-labeled membrane glycoproteins 
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was done in a Becknan (LS lOOC) liquid scintillation counter using a 
£^ H] window. All operations were performed at 4®C and all membrane 
pellets were stored at -20"C until electrophoresis. 
M. Polyacrylamide Gel Electrophoresis 
SDS-polyacrylamide gels were prepared according to the method of 
Laemmli (1970). Slabs were 1.5 mm thick and were either linear gradients 
of 10-15% polyacrylamide with 5% stacking gels; or 7% polyacrylamide 
with 4% stacking gels. Protein molecular weight standards (BioRad, 
myosin, 200,000; galactosidase, 116,250; phosphorylase B, 92,500; bovine 
serum albumin, 66,200; ovalbumin, 45,000; carbonic anhydrase, 31,000; 
soybean trypsin inhibitor, 21,500; and lysozyme, 14,400) were used to 
estimate the molecular weights of electrophoretically separated pro­
teins. The logarithm of molecular weight of the standards was plotted 
against the distance migrated on the gel (in mm). A best fit line was 
drawn through the points and the MW of an unknown band was determined 
by measuring the distance migrated on the gel. The approximate MW of 
an unknown band was extrapolated from the line constructed from the 
standards. 
Membrane pellets were solubilized by boiling for 2 minutes in 
sanple buffer consisting of 2% SDS, 10% glycerol, 6.25% mercaptoethanol, 
and 61 mM Tris, pH 6.8. Volumes of samples containing equal dpm were 
loaded onto each lane in the slab and electrophoresis was performed 
at a constant current of 20 mA/gel for 4-5 hours. Gels were fixed 
3 (labeled either by [ H] NaBH^  or metabolic labeling) were spotted on 
Whatman filter paper, precipitated with cold 10% TCA, air-dried, and 
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washed in cold 100% ethanol and then ether. Filter papers were counted 
in liquid scintillation vials containing 10 ml of Omnifluor. Counting 
in a solution of 50% methanol, 7% acetic acid and dried. Dried gels were 
placed in direct contact with Kodak X-Omat AR film opposite a Cronex 
Lightning Plus Intensifying Screen (DuPont) and incubated at -95"C for 
1-4 days. Gels containing I^ H]-labeled samples were prepared for 
fluorography by the method of Bonner and Laskey (1974) before drying. 
These dried gels were placed in contact with Kodak X-Omat AR film and 
incubated at -95*C for 14-60 days. 
N. Isolation of Sensitive 
Revertants 
Subpopulations of 100 cells from a freshly recloned Cyd -variant 
line were cloned in ONS in 25-cm flasks. At the time of this subcloning, 
the largely CD-resistant population, derived from a single resistant cell, 
had been grown in nonselective medium for approximately 15 population 
doublings and had a cloning efficiency of 85-100% in CD. After 7-10 
days, when clones were easily visible, the nonselective medium was 
gently removed and replaced witli aS-lCD. The cells are incubated in CD 
for 1-4 hours and then examined with phase contrast microscopy. The 
morphology of CD-sensitive clones are distinctive and unmistakable com­
pared to CD-resistant clones (see Results). Clones with CD-sensitive 
2 
morphology were picked and transferred to 25-cm flasks and grown to 
confluency for further testing. In some cases, CD-sensitive revertants 
were subcloned and inspected again in the manner just outlined. Some 
experiments involved using twice-purified CD-sensitive subclonal lines. 
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IV. RESULTS 
A. Rationale 
When this project was begun in 1978, the major goal was to isolate 
CHO AK412 mutants resistant to cytochalasin D and/or cytochalasin B. 
There were two important reasons for undertaking this research: (1) to 
attempt to define the primary ^  vivo target of cytochalasin, and (2) to 
use cytochalasin as a tool to select for F-actin microfilament mutants, 
since the predominêmt theory on the mechanism of cytochalasin action 
in vivo was that cytochalasin acted specifically on the F-actin micro­
filaments. 
As mentioned previously, until 1979 or 1980, the belief that cyto­
chalasin exerted its effects on cells in culture by somehow binding to 
and disrupting F-actin microfilêunents was accepted as fact, even though 
no definitive evidence for this hypothesis existed. 
My plan of research involved the following: (1) to select for and 
isolate CHO AK412 mutants resistant to CD or CB; and (2) to characterize 
the CD and/or CB-resistant mutants biochemically. It was felt that the 
biochemical lesion conferring cytochalasin resistance would be the primary 
target of cytochalasin action. Thus, this approach might allow confirma­
tion or contradiction of the prevailing theory of cytochalasin action. 
If my results confirmed the theory, and selection for cytochalasin 
resistance resulted in the isolation of cells with a mutation in the F-
actin microfilament system, then the second goal of my research would be 
achieved. There is currently no other method to select for mutants of 
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the microfilament system, although recently F-actin mutants were found 
by molecular biological methods. Isolation of microfilament mutants 
would be an extremely useful and informative approach to studying .the 
relationship between ^  vivo cytoskeletal structure and function. Such 
an approach has been quite fruitful in studying microtubule structure 
and function (by selecting for somatic cell mutants resistant to colchi­
cine or other microtubule poisons). 
Initially, single-step selection for CD eind CB resistance was used. 
These atteinpts at isolation of cytochalasin-resistant mutants were uni­
formly unsuccessful. One problem in selecting for cytochalasin resistance 
is that at the concentrations at which all of the biological effects of 
cytochalasin are manifested, cytochalasin is either not toxic or only 
slightly toxic to cells in culture. Although higher toxic concentra­
tions of CD or CB could be used, it was concluded that this method 
would not be desirable. Consequently, an enrichment selection method 
was used to successfully isolate AK412 variants resistant to 1 yg/ml 
CD. The CD-resistant variants were characterized physiologically, cyto-
genetically, morphologically, and biochemically. The results of these 
experiments are presented in this section. 
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B. Dose Response of CHO AK 412 Cells to Cytochalasin D 
and Cytochalasin B 
1. Background 
The first step In selecting for somatic cell lines resistant to a 
particular drug Involves determination of the concentration(s) of drug 
to use In selection, and characterization of the salient morphological 
and/or physiological responses at the selective drug concentration(s). 
One method of determining an appropriate selective concentration of drug 
is to construct a dose-response curve. Two general methods are avail­
able for measuring the dose-response of wild-type parent cells to a 
particular drug: measurement of plating efficiency, or measurement of 
growth rate in the presence of drug (Thompson êind BêUcer, 1973). A 
plating efficiency assay is preferable because it allows evaluation of 
population heterogeneity throughout a dose range and is also a more sensi­
tive indicator of the minimum dose(s) necessary to kill wild-type cells 
(Thompson and Baker, 1973). A plating efficiency assay also allows 
detection of any unusually resistant clones (Thompson and Baker, 1973). 
When this project was begun, two different congeners of cytochalasin 
were used, cytochalasin D (CD) and cytochalasin B (CB). CD and CB were 
chosen because they were used in more them 98% of previous studies on 
the biological effects of cytochalasin on cells in culture and micro­
filaments vitro. In addition, CD and CB are the most availcible and 
least expensive cytochalasins prepared commercially. 
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2 2. Plating efficiency at 10 cells 
The dose response of CHO AK412 cells to CD and CB was measured by 
2 determining•the plating efficiency with 10 cells. As demonstrated in 
Table 1, CHO AK 412 cannot form colonies in concentrations of CD greater 
than 0.2 lig/ml CD and in concentrations of CB greater than 0.7 yg/ml CB. 
3. Plating efficiency in CD at higher cell concentrations 
a. Density dependence Some effect of cell density on the ability 
of cells to clone in a given concentration of CD was observed. For 
2 3 
example, no clones were formed in 0.2 yg/ml CD when 10 or 10 cells 
4 5 
were plated, but some clones were observed when 10 or 10 cells were 
plated at this same drug concentration (Table 2). It was difficult to 
interpret the results when 10^  cells were plated because, by 2-3 days 
after plating in 0.2-0.4 yg/ml CD, cells were overlapping and/or con­
tiguous, and it was not possible to distinguish single cell background 
from cell colonies. 
The dependency of plating efficiency on cell density at a particu­
lar drug concentration is a common problem encountered in plating 
efficiency assays. A number of mechéinisms have been suggested to explain 
this phenomenon (Thompson and Baker, 1973). There are several selection 
methods available to circumvent the problem of cell density effects. 
2 4 For instance, it is possible to use low cell densities (10 -10 cells/ 
2 75-cm flask) to select for drug resistant variants. However, if this 
method is used, there is a problem of working with a large enough cell 
population (10^ -10® cells) that will allow isolation of a rare variant/ 
Table 1. Plating efficiency of 10 CHO AK 412 cells in cytochalasin D and cytochalasin B 
Concentration of cytochalasin D (yig/ml) 
Control .01 g/ml CD .05 0.1 0.5 1.0 
Average number of 
clones 82.4 71.8 85.4® 70.6^  
Relative cloning 
efficiency 87.1 103.6 85.7 
Control 0 .2  0.3 0.4 0.5 0 . 6  0.7 
Cloning 
efficiency 74.4 77.8 68.8 62.8 33.4 11.2 
Relative cloning 
efficiency 105 92 84 45 15 
% multinucleate 
cells in clone 1-3 5-10 30-50 80 90 100 
Average of 
cells/clone 500 500 100-200 50-100 8-50 4-20 
Clone size and thus average number of cells/clone is smaller than control. 
C^lones are slightly smaller than 0.05 Vg/ml CD clones, approximately 30% of the cells are 
large, round and multinucleate and approximately 70% are spindle-shaped cells. 
A^ll cells are large, rounded and multinucleated, no spindle-shaped cells were observed. 
'^ These were not counted as clones because less than ten cells were clustered and all cells 
were large and multinucleate. 
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mutant (occurring at rates of 10 -10 per cell per generation) from a 
predomincuitly wild-type cell population. The nunOaer of flasks or tissue 
culture dishes required to achieve a reasonable cell number would be 
prohibitive. 
Another alternative is to use concentrations of drug above the 
level where any cell density effect is observed. Sometimes, this pro­
cedure requires multistep or enrichment selection (Baker and Thompson, 
1973). 
b. Variation in plating efficiency The data in Table 2 also show 
that there is variation between experiments in the ability to clone at a 
given concentration of CD (0.2 lig/ml CD) at slightly different cell densi-
4 2 2 4 2 
ties (10 cells/25-cm flask, 400 cells/cm , 0 clones; 10 cells/75-cm 
2 flask, 133 cells/cm , 19 clones). Such variation is not unexpected, since a 
slight error in any step involved in making a particular concentration of 
CD may have profound effects on the ability of cells to plate in CD. For 
example, the error in preparing a stock solution of 0.2 yg/ml CD may be as 
much as ^  .02 yg/ml (a 10% error, which is reasonable considering the 
steps involved in meiking up a stock solution at this low concentration). 
2 
Because 10 cells are unable to clone at 0.2 yg/ml CD, it is reasonable 
to expect a difference in the ability of cells at higher concentrations 
4 (e.g., 10 cells) to clone in .18 yg/ml CD as opposed to .22 yg/ml CD, i.e., 
they may be sensitive to minor fluctuations in concentration when near 
the threshold of their tolerance. Secondly, the sensitivity of cyto-
chalasin is known to be dependent on the physiological state of the cell 
Table 2. Density dependence of plating efficiency of CHOAK412 cells in cytochalasin D 
Concentration of cytochalasin D (yg/ml) 
Experiment 1^  Control 0.2 yg/ml CD Q.3 lig/ml CD 0.4 Wg/ml CD 
Cells per flask^  10^  10^  10^  10^  10^  10^  lo'* 10^  10^  10^  
Relative cloning 
efficiency - 00 0° 000000 
Experiment 2^  0.2 yg/ml CD 0.3 yg/ml CD 0.4 yg/ml CD 
Cells per flask® 10* 105 10® lo'* 10^  10® 10* 10^  10® 
Average number 
of clones 19^  7.5^  TNTC^  0 0 TNTC^  0 0 TNTC^  
Relative cloning 
efficiency .002 .0008 - 0 0 - 0 0 
C^ontrol cloning efficiency was 86.2. 
Cells per 25-cm^  flask. 
few spindle-shaped cells present but no clones. No spindle-shaped cells were observed 
at higher concentrations of CD. 
Control cloning efficiency was 84. 
0 2 Cells per 75-cm flask. 
T^en or more cells in well-developed clone after 14d. 
T^oo numerous to count because of overlapping cells. 
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(Godman and Miranda, 1978). For example, the sensitivity to cytochalasin 
varies with the cell cycle; cells are most sensitive to cytochalasin in 
and least sensitive from mid S thorugh most of (Miranda et al., 1978a,b). 
Finally, nondialyzable serum components are known to nonspecifically bind 
cytochalasin (Tannenbaum, 1978). Thus, the exact amount of cytochalasin 
available to cells may also depend on the lot of fetal calf serum used 
and the level of cytochalasin-binding components in the serum. 
4. Toxicity of CD 
A major problem encountered in selecting for cytochalasin resistance 
is the fact that biologically active concentrations of CD and CB are not 
completely cytotoxic to CHO AK412 (Table 3), although colony formation may 
be prevented (as demonstrated in Tables 1 and 2). As with many other 
cell lines (Godman and Mircmda, 1978), CHO cells remain viable (as meas­
ured by the ability to exclude the dye trypan blue) for at least 14 days 
in concentrations of CD from 0.2 to 1 yg/ml. 
One importcint effect of CD or CB on cells over a period of 7-14 days 
or longer is the generation of very large, multinucleate cells (Table 3); 
e.g., the majority of cells have three or more nuclei after 7 days in 
1 yg/ml CD. It is doubtful whether such large, polynucleate cells could 
form colonies in nonselective medium (Rocs emd Davidson, 1980). it was 
not possible to quantitate the plating efficiency of cells cultured for 
prolonged time periods in CD because: (1) as cells become large and 
multinucleate, it becomes extremely difficult to remove them from the 
Table 3. Time course of response of CHO AK 412 to 1 yg/ml CD 
Days in Number of nuclei % Multi- % Cell 
1 yg/mi CD 1 2 3 4 5 6 7 8 9 10 nucleates survival 
0 494 3 1 1 0 0 0 0 0 0 1.2 97 
1 345 129 19 3 1 1 2 0 0 0 31 98 
2 205 244 37 2 6 3 0 0 0 0 58.8 89 
4 15^  268 190 18 2 2 3 1 1 0 97.0 86 
7 0 137 277 79 3 1 3 0 0 0 100.0 74 
9 3= 104 146 210 16 15 0 1 1 4 99.4 79 
12 N.D. N.D. 48 
14 2 16 885 145 127 86 17 0 0 22*^  99.6 46 
®Some cells counted as trypan blue positive were stained only at the site of a protruding 
nucleus. 
b 
Some cells may be mononucleate by virtue of enucleation of other nuclei. 
c 
Very small, mononucleate cells, probably karyoplasts. 
'^ any cells contain all or mostly micronuclei. 
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substrate with trypsin, even with longer periods of treatment with trypsin, 
(2) one of the effects of cytochalasin is nuclear extrusion (Poste and 
Lyon, 1978). Extruded nuclei, termed karyoplasts, contain varying amounts 
of cytoplasm. These may reattach and become viable mononucleate cells. 
Thus, prolonged culture in cytochalasin results in the continuous 
generation of new, potentially viable mononucleate cells. 
From the data on dose response to CD and CB, it was concluded that 
0.5-1 yg/ml CD, and 5 yg/ml CB would be useful selective concentrations 
of cytochalasin. At these concentrations, all of the typical biological 
effects of cytochalasin are elicited, including inhibition of colony 
formation in drug sensitive cells. However, as previously described, 
these concentrations of cytochalasin do not cause cell death in CHO 
AK412. Inhibition of colony formation by CD or CB, presumably results 
from the inhibition of cytokinesis. 
C. Single-Step Selection for CD 
and CB Resistance 
The methods used for single-step isolation of CHO variants resistant 
to CD or CB are described in Methods and Materials. The goal of single-
step selection is the isolation of one or more clones (at least 10 and 
usually 50 or more cells closely aligned and containing mononucleate 
cells with normal morphology) from a background of cytochalasin sensi­
tive cells (i.e., cells that are large, multinucleate and exhibiting 
an abnormal morphology (see Section D: Primary Effects of Cytochalasin 
D on CHO AK412)). However, single-step selection for resistance to 0.5 
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or 1 ug/ml CD and 5 pg/ml CB did not allow the isolation of CD or CB-
resistant clonal variants (Table 4, data not shown for CB). All cells 
in each 75-cm^  flask (10® cells/flask) became large and multinucleate 
and displayed the morphology typical of cytochalasin-sensitive cells 
(see Figures 1 and 2). A number of selective conditions were varied 
in order to optimize single step selection. These included varying the 
length of incubation in the presence of CD or CB; 1) with or without 
replenishment of selective medium; and 2) with or without prior 
mutagenesis with EMS (from 200 to 627 yg/ml). The results suggest that 
the frequency of resistance to 0.5-1 yg/ml CD (emd 5 yg/ml CB) is 
"7 less than 10 . Consequently, a multiple-step enrichment technique was 
used to successfully isolate CHO variêuits resistant to 1 yg/ml CD (for 
discussion of single-step and multiple-step or enrichment selection, 
see section: Mutagenesis and Mutant Isolation). 
D. Primary Effects of Cytochalasin D on CHO AK 412 
In order to permit con^ cirison of CD-sensitive parental cells with 
AK412 variants resistant to 1 yg/ml CD, CD-induced morphological and 
physiological changes observed in CD-sensitive cells will be detailed 
first. These major changes will also be conqpared with descriptions 
of the visible effects of cytochalasin on other cell lines (Godman and 
Miranda, 1978). 
The first visible effect of cytochalasin on cells in culture, 
generally occurring in the remge of 0.25 to 1 yg/ml CD, is the cessation 
Table 4. Single-step selection for cytochalasin D resistance 
CHO AK412^  CD Number of Total # EMS Frequency of 
subclone concentration clones of cells mutagenesis drug resistance 
(S.C.) observed treated clones/surviving cells 
S.C. 1 1 lig/ml CD 0 10 none <10-7 
S.C. 1 1 Jig/ml CD 0 10 ' 200 yg/ml^  <5.2 X 10-® 
S.C- 1 1 yg/ml CD 0 10^  627 yg/ml° <8.0 X 10-5° 
S.C. 1 0.5 yg/ml CD 0 10^  none <10-7 
S.C. 1 0.5 yg/ml CD 0 10^  200 yg/ml^  <5.2 X 10-®^  
S.C. 1 0.5 yg/ml CD 0 10^  627 yg/ml° <8.0 X 10-5° 
I^dentical results were observed for three other subclones of AK412, although the percent 
survival after mutagenesis and at the time of selection varied somewhat. 
P^ercent survival after mutagenesis, 52%; 86% plating efficiency after a of seven days. 
P^ercent survival after mutagenesis, 8%; 74% plating efficiency after a of seven days. 
Figure 1. Time course of visible effects of 1 Ug/ml CD on CHO 
((1) Before CD addition, (2) 30 seconds after CD addition, 
(3) 1.5 minutes later, (4) 2 minutes later, (5) 5 minutes 
and (6) 10 minutes after adding 1 Pg/ml CD. Note formation 
of blebs and general contraction of the cells. This has 
already occurred by 30 seconds after CD addition. Phase 
contrast, X1280) 
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Figure 2. Visible effects on CHO after 24 hrs in 1 pg/ml CD 
((1-3) Representative fields of CHO in nonselective 
medium. Cells are almost exclusively mononucleate, and 
are either bipolar or triangular in morphology. The 
round refractile cells seen in 1 and 2 are probably 
mitotic cells, (4-6) AK 412 cells cultured in 1 yg/ml CD 
for 24 hrs. Note predominantly polynucleate cells and 
presence of numerous retraction fibers. In many cells 
the nucleus protrudes above the plane of the cell. 
Phase contrast, X1040) 
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of menibrcme ruffling and other cellular movements (Godman and Miranda, 1978 
1978). However, observation of membrane and cellular motion requires 
time-lapse cinematography which was not performed in this study. 
The next characteristic effects of CD on cultured cells are: 1) 
retraction of cell margins, 2) the formation of retraction fibers (i.e., 
previous sites of cell to cell or cell to substrate contact remain after 
retraction of cell margins), 3) formation of zeiotic knobs or "blebs", 
4) withdrawal of cell surface microvilli, and 5) the nucleus begins to pro­
trude above the plane of the cell (see Figures 1-3). All of these effects 
occur within the first 30 seconds to one minute after CD addition, and 
these changes progress over a period of 10 to 15 minutes. During the 
séune time period, there is a marked alteration and redistribution of mem­
brane-associated microfilaments (Godman and Mirêmda, 1978). 
At longer time periods, the zeiotic knobs cluster to form small 
aggregates or bouquets (1-2 hours), which later coalesce to form a single 
large bouquet over the protruding nucleus (4-5 hrs) (Figure 3). Later on, 
many of the cells will arborize or flatten, assuming a somewhat discoid 
apolar morphology, which resemble a sunny-side-up egg (the nuclei 
corresponding to the yolk). This last response varies from cell to cell 
in a population; some cells remain penocuiently contracted while others 
arborize. 
Figure 3. Sccuining electron micrographs of CHO cells in monolayer, 
before euid during es^ sure to 1 Pg/ml CD ((1) Before CD 
addition. Nbte numerous microvilli, XI,100, (2) 1 minute 
(3) 2 minutes, and (4) 24 hrs after addition of 1 V>g/ml 
CD. Note immediate loss of microvilli and formation of 
blebs. By 2 minutes some nuclei have begun to protrude. 
Retraction fibers are evident by 1 minute, (2) and (4), 
XI,100, (3), X780)) 
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E. Isolation of CHO AK 412 Variants Resistant 
to 1 yg/ml CD 
An enrichment selection method was used which relied upon the fact 
that one of the major effects of cytochalasin on cultured cells is the 
inhibition of cytokinesis (cell division) but not karyokinesis (Schroeder, 
1978). The net result of culturing cells in CD-containing medium is the 
accumulation of large, polynucleate cells in the population with increasing 
time periods in CD medium. A typical time course of multinucleation in 
the presence of 1 lig/ml CD is shown in Table 3. In one experiment, 
1 lig/ml CD produced 90% polynucleates in 30 hrs and more than 99% by 6 
days. It will be recalled that the morphological and physiological 
effects of cytochalasin are readily reversible (see section: Cytochalasin). 
However, induction of polynucleate cells is not reversible, and highly 
multinucleate cells normally do not divide in nonselective (drug-free) 
medium (Boos and Davidson, 1980). Therefore, any mononucleate cells in 
a predominantly polynucleate population would have a selective growth 
advantage in nonselective medium. This is the basis of the enrichment 
selection technique developed in this laboratory to isolate CHO variants 
resistant to CD and/or CB. It was designed to enrich for cells that remain 
mononucleate and divide in the presence of CD because of resistance to 
the inhibitory effect of CD on cytokinesis. 
CD-resistant variemt lines were obtained by cycling cell populations 
(initially 10® cells) through several 4 to 6 day pulses of 1 Pg/ml CD 
(Figure 4). Next, selective medium was removed, the cells washed three 
Figure 4. Enrichment selection procedure for cytochalasin D-resistant 
variemt populations (see Materials and Methods for details) 
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a. CHO: 10® cells/75-cm^  
20 ml medium containing 
1 yg/ml CD (as-lCD). 
(Round lA) 
(4-6 days) 
b. Wash (x3) with ttNS. 
Add; 20 ml aNS. 
(Round lB-1) 
d. Start selection process C. Subculture-3 x 10^  cells/ 
again by subculturing  ^ 75-cm^  20 ml aNS. (Growth to 
into aS-lCD. confluence) (Round lB-2) 
(Beginning of another 
round, e.g.. Round 2A) 
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times with nonselective medium to remove residual CD, and then nonselective 
medium was added (Figure 4b). The cells, predominantly polynucleate, were 
allowed to grow to confluency in nonselective medium once more (Figure 
4c). Ihe two cycles of outgrowth in nonselective medium enriched for 
cells that remained mononucleate, and were presumably CD-resistant, during 
the initial challenge with 1 pg/ml CD. Cells that escape CD-induced 
multinucleation divide at normal rates in nonselective medium and will 
rapidly outgrow polynucleates. 
Continuous challenge of cells with 1 pg/ml CD for 4-6 days, followed 
by two rounds of outgrowth in nonselective medium produced a population 
enriched in cells that remained mononucleate cuid divided in the presence 
of 1 yg/ml CD. There were 16 successive rounds of drug treatment and out­
growth over a time period of 181d. Populations in the drug treatment 
phase of each round were examined by phase contrast microscopy. Drug-
resistémt cells were defined by the following morphological criteria: 
(1) retention of spindle-shaped, mononucleate gross morphology; and (2) 
the apparent ability of cells to divide, as evidenced by areas of clonal 
growth. Cells with drug-resistant morphology were rarely detected in 
the earliest rounds of selection, but by rounds 6 to 8, occasional cells 
of this type were clearly visible. In round 12A, many cells with apparent­
ly noxrmal morphology.could be seen, some occurring in pairs suggestive 
of cell division (Figure 5). In round 13A, 7-10 cell clones were 
observed (Figure 6). 
Resistant cell lines were obtained by cloning single cells from 
round 16A as described in Materials and Methods. A total of 9 drug-
Figure 5. Light microscopy of round 12A cells in 1 lig/ml CD 
(These pictures were taken 48 hours after CD addition. 
Note spindle-shaped cells (s) and areas where there are 
two or more spindle-shaped cells together (*), perhaps 
indicating cell division. Phase contrast, X800)) 

Figure 6. Light microscopy of round 13A cells, 48 hrs after addition 
of 1 yg/ml CD (Note clones of spindle-shaped cells (S), 
some containing little "knobs" or blebs on the cell 
surface. Pheise contrast, X850) 
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resistant clones were isolated and designated Cyd^  (cytochalasin D 
resistant). The nine Cyd -variéints were immediately frozen for storage, 
R 
and three of them, Cyd -8, -10, -20, were chosen at random for further 
testing. 
F. phenotype of Resistance Lines 
1. Cloning efficiency and doubling time 
R A number of differences between the Cyd -variants and AK412 parental 
cells were immediately noted and are summarized in Table 5. The Cyd^ -
variants have a T^  of 24-39 hours and a cloning efficiency of 86 to 92% 
in otS-lCD, while cells of the parental line fail to divide at all in this 
concentration of drug. The T^  of the variemts is, however, longer than 
that of the parent line during growth on nonselective medium; these 
p 
doubling times are 18 to 23 hrs for the Cyd -variants cind 14 hr for CHO 
AK412. Many drug-resisteint variants and mutants, where resistance is 
mediated by gene amplification, have longer doubling times in non­
selective medium compared to the drug-sensitive parent (see review on 
gene amplification). However, there may be other reasons for a prolonged 
doubling time in nonselective medium. 
2. Multinucleation in Cyd -variants and Cytokinesis 
One of the most striking attributes of the Cyd -variant phenotype 
is that 5 to 10% of the cells in frequently transferred stock popula­
tions are multinucleate (TcJ)le 5 and Figures 9, 10), compared to .5 to 
1.5% for AK412 pcurental cells. At least some of the multinucleate cells 
Table 5. Summary of Cyd -variant phenotype 
Cell line 
Population T^  
aNS as-lCD 
% Multinucleate 
cells in aNS 
Relative cloning 
efficiency in aS-lCD 
Modal chromosome 
number 
AK412 14 0 1.0 0 20® 
R b b c d Cyd -8 18 29 9.2 92 20 
cyd^ -10 19 36 8.9 88 20 
Cyd^ -20 23 38 10.1 86 20 
®At least 50 metaphases were examined for each determination. 
T^ested within 33 cell generations after transfer to nonselective medium. 
P^ercent at 24h after transfer; 31 generations after isolation. 
within 14 generations after isolation. 
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in each transfer may possibly have been carried over from previous sub­
culture. However, most originate ^  novo since there is a constantly re­
curring high percentage of multinucleate cells in fully CD-resistant 
populations even though multinucleate cells usually do not divide (Roos 
and Davidson, 1980). Also, the percentage of polynucleate cells increases 
over time in nonselective medium, increasing more than 2-fold in 7 days. 
Three mechanisms cam be postulated to account for the increase in 
multinucleate cells in Cyd -variant populations: (1) a partial lesion 
or defect in cytokinesis (cell division), resulting in a certain 
probability, p, that a cell will undergo an cUoortive cell division; (2) 
an increase in the rate of spontaneous cell fusion; or (3) micronucleation, 
a phenomenon commonly associated with unstable drug resistance (see re­
view on gene an^ lification and Schimke et al., 1981). As will be 
seen shortly, the Cyd -variants are unstably resistant to CD. How-
ever, the nuclei in polynucleate Cyd -variant cells are predominantly in 
the size range of normal nuclei (see Figures 9, 10) and micronuclei are 
approximately one-tenth the size of "normal" nuclei. 
Results from two experiments suggest that multinucleate cells 
which originate in Cyd -variemt cultures probably arise from a partial 
lesion in cytokinesis, rather them from em increased frequency of 
spontaneous fusion. If the Vcuriant defect resulted in greatly enhanced 
rates of spontaneous cell fusion, one might also expect to observe a 
heightened ability to fuse in response to a fusogenic agent. However, 
after treatment with 50% PEG 1000 (Davidson and Gerald, 1976), the fusion 
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response of the Cyd^ -variants is exactly like that of the parent (i.e., 
the fusion index of CHO was 52.9%; Cyd^ -8, 44.9%; Cyd^ -10, 54.3%; and 
Cyd^ -20, 52.0%). 
A second experiment showed that there is no significant difference 
in the rate of spontaneous cell fusion in the variants compared to the 
parental cells. The AK412 parent (HPRT and glyA ) and each of three 
Cyd^ -variants (also HPRT and glyA^ ) were cocultivated (Wright and Shows, 
1979) with the CHO cell line 51-11, which is HPRT^ , glyA . The number 
of spontaneous hybrids on selective medium, HAT minus glycine, was quanti-
tated and it was found that hybrid clones occurred at a frequency of 
-5 1.4 X 10 in mixtures of AK412 with 51-11, and at frequencies of 7.8 x 
10 ® to 2.3 X 10 ^  in mixtures of Cyd^ -8,-10, and -20 with 51-11. The 
results from this experiment suggest that the increase in multinucleate 
cells is not the result of an increase in the rate of spontaneous cell 
fusion among Cyd -variant cells. However, the results from this experi-
ment are not conclusive, since it is plausible to envision Cyd -variants 
possessing enhanced fusion ability only with other Cyd^ -variant cells. 
R Cell lines other than the Cyd -variants might not possess the requisite 
cell surface changes necessary for enhanced fusion. Unequivocal proof 
that the cause of increased multinucleation results from a partial 
lesion in cytokinesis requires time lapse photography of a consider-
able number of Cyd -vêiriant cells. However, the two experiments just 
described provide indirect evidence that the mechanism underlying 
enhanced multinucleation is not due to increased rates of spontaneous 
cell fusion. 
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In terms of the phenotypic characteristics presented in Table 5, 
there are no significant differences among the three variant lines 
chosen at random for further study. This is not unea^ ected since all 
clonal lines may be descendemts of one cell in which alteration to CD 
resistance occurred in an early enrichment cycle preceding isolation. 
In some experiments, therefore, only one or two variants are tested; 
these are probably representative of the group. 
R 3. Stability of the Cyd -phenotype 
For tests of phenotypic stability, the CD-resistant phenotype was 
defined as the ability of all cells in Cyd -variant subpopulations to under­
go cytokinesis and form colonies in the presence of 1 yg/ml CD. If the 
R Cyd -varieuit phenotype is stable, the ability of cells to clone in 
1 yg/ml CD should be independent of the number of generations the 
Cyd -variant population wets subcultured in nonselective medium. Initial 
tests indicated that the Cyd -variant phenotype was unstable in the absence 
R 
of selective pressure (Table 6). As seen in Table 6, Cyd -variant popu­
lations grown in nonselective medium gradually lose their resistance to 
CD, demonstrated by the declining cloning efficiency in 1 yg/ml CD. How-
ever, similar populations of Cyd -variants, continuously subcultured in 
medium containing 1 yg/ml CD, maintain cloning efficiencies in 1 yg/ml 
CD unchanged from that of the original Cyd -variant isolates. 
In order to better quantitate the kinetics of loss of CD-resistance 
with time in nonselective medium, Cyd -8, -10, emd -20 were subcultured 
continuously on nonselective medium and cloning efficiencies on as-lCD 
Table 6. Loss of stability of variants on nonselective medium 
Variant 
Estimated number of 
generations on 
nonselective 
medium^  
Cloning efficiency 
(C.E.) of variant 
grown on  ^
nonselective medium 
C.E. of variant 
grown in 
selective 
medium^  
CYD^ -8 
CYD^ -10 
45 
52 
63 
66 
43 
53 
62 
65.8 
22.0 
13.7 
13.0 
52.2 
25.2 
12.5 
N.D. 
N.D. 
91.6 
N.D. 
92.8 
79.6 
111.7 
CYD*-20 62 35.9 126.6 
This applies to the cloning efficiency of the variant on nonselective medium. At 
generation 27 the variant was then cultured continuously in 1 yg/ml CD as well as in non­
selective medium. 
C^loning efficiency relative to control plated on nonselective medium. 
*^ Not determined. 
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were determined at weekly intervals for more than 70 generations (Figure 
7). In additionf the and % multinucleates of the three variants were 
measured at weekly intervals. This was done to determine whether 
CD-resistance is related to or correlated with the longer doubling 
time and increased multinuclearity of the Cyd^ -variants. 
The cloning efficiency of the Vjariant lines in 1 yg/ml CD was 85 
to 100% for 20 to 25 cell generations after isolation and purification. 
Then, from generation 25 to 67, a logarithmic 50% decrease in CD re­
sistance was observed every 13 to 15 cell generations. However, after 
cell generation 67, there was an extremely rapid loss of resistant cells 
from the population so that the cloning efficiency declined from 10 to 
20% to less than 1% in 6 days. 
R 
Concomitant with the loss of CD resistance in the Cyd -variant 
lines, there was a decrease in the percent of multinucleate cells and' 
T, to control levels (Figure 7> inset). This latter observation is shown 
d 
in the inset to Figure 7, where the T^  of the control/T^  of the 
variant is plotted against the nundaer of generations in nonselective 
medium. The ratio of T, control/T. variant is initially less than one, 
cL a 
since the doubling time of the Cyd -variant is initially longer (T^  
of 18-20 hours) than that of the AK412 parent (T^  of 14 hours). The 
doubling time of the Cyd -variants in nonselective medium decreases, 
becoming closer to that of the AK412 parent. Consequently, the ratio 
of T^  control/T^  variant approaches 1. 
The data demonstrate conclusively that the Cyd -variant phenotype 
Figure 7. Cloning efficiency on OS-ICD of Cyd -variant sublines grown in nonselective 
medium for 80 generations after isolation (Cloning efficiency in aS-lCD was 
determined weekly ( — Cyd -8; , Cyd —10 j , Cyd^ 20; except % 
multinucleates, Cyd^ lO; CHO AK 412) (insert: upper, frequency of multi­
nucleate cells in a Cyd^ -10 population grown in nonselective medium; lower, 
decrease in for 3 Cyd®-variant sublines grown in nonselective medium) 
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is unstable in the absence of selective pressure. The ability to 
R 
clone in 1 lig/ml CD, a meeusure of the Cyd -variant phenotype, is lost 
after approximately 75 generations in nonselective medium. One inter­
pretation for the kinetics of loss of CD resistance in Figure 7 is 
that there are two "events" involved in the loss of the Cyd -variant pheno­
type. The first event, which occurs at a lower rate than the second, 
results in a logarithmic loss of CD-resistance. The second event results 
in a precipitous loss of CD-resistance. 
The other two phenotypic characteristics associated with the Cyd -
phenotype, a longer T^  in nonselective medium and a higher percentage 
of multinucleate cells, are also associated with the lesion conferring 
CD resistance. This was demonstrated by the concordant loss of all three 
phenotypic characteristics in nonselective medium (Figure 7). 
It's possible that reversion to CD sensitivity from a fully CD-
resistant population was due to contamination with CHO AK412 wild-type 
cells, followed by selection for the wild-type cells in nonselective 
medium. However, routine laboratory procedures for cell cultivation are 
designed to prevent cross contamination of cell lines. Genetically 
marked lines, cultivated separately but simultaneously for months, show 
8 
no evidence of marker gain from other stocks in more than 10 cells 
tested in several instances. The possibility that CD-sensitive cells 
R ' 
arose in the Cyd -variant lines because of contcunination by AK412 is, 
therefore, highly unlikely. In addition, phenotypic instability was 
observed in Cyd -variants cloned twice in either selective or nonselective 
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medium. Because subclones were derived from single cells, and because 
some of the subclones arose in medium containing 1 yg/ml CD in which 
Ak412 cannot clone, contamination with AK412 is highly remote. 
One criterion of a "true" somatic cell variant is stable inheri­
tance of phenotype (see pp. 12-14). However, it was also demonstrated 
that the criterion of phenotypic stability does not apply to some cases 
of drug-resistance mediated by gene amplification (Schimke et al., 1981). 
In addition, there are cases of drug-resistance due to epigenetic mech­
anisms where resistance was not stably transmitted to daughter cells 
(e.g., "enzyme induction" in some MTX-resistant cells; Bertino et al., 
1981). It was thus important to determine the mechanism(s) underlying 
unstable resistance to CD in Cyd -varieuit lines. 
Population instability in regard to continued cloning competence 
in the presence of cytochalasin D can be accounted for in either of two 
ways: (1) segregation of CD-resistant and CD-sensitive subtypes, fol­
lowed by eventual loss of fully CD-resistant cells in the population due 
to a selective advantage for the CD-sensitive phenotype; (2) a gradual, 
uniform loss of cytochalasin resistance from each cell of the popula­
tion over time. The first of these situations would require the 
occurrence of a genetic event (e.g., mutational reversion, chromosome 
segregation, mitotic crossing over or unstable gene amplification) for 
the reappearance of cytochalasin-sensitive cells in the original 
cytochalasin-resistant population. It would also require that the 
phenotype of CD-resistant cells show poor selective fitness in com­
parison to CD-sensitive revertants. 
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The alternative explanation implies a gradual loss from each cell 
of some cellular component temporarily induced by the selection method. 
In this instance, each cell in the population would have less chance, 
progressively, of overcoming the CD effect and dividing to form a clone. 
This latter model would be consistent with an assun^ tion that CD-resistance 
represented some type of epigenetic phenomenon. Furthermore, this latter 
mechanism might be analogous to epigenetic induction of DHFR levels by 
selection in MTX (see pages 8-9). The rate of loss of CD resistance in the 
Cyd -variants closely approximates the rate of loss of drug resistance 
in other cases of unstable gene an^ lification (many weeks or months) and 
is unlike the rate of loss of MTX-resistance in epigenetic induction 
of DHFR (a few days to one week; Bertino et al., 1981). 
Three experiments were performed which clearly demonstrate that the 
R 
observed reduction in cloning efficiency (displayed by Cyd -variant 
populations continuously subcultured in nonselective medium) is a 
product of segregation of cytochalasin-sensitive and fully CD-resistant 
cell types, combined with negative selection against CD-resistant cells. 
R 
In the first experiment (Table 7), Cyd -8, -10, and -20 were recovered 
from frozen samples of the original isolates, and then grown in non­
selective medium for 39 generations. At the time, the cloning efficiency 
in 1 yg/ml CD for each variant was determined (Cyd -8, 65%; Cyd -10, 
55%; Cyd -20, 32%). Cytochalasin-res is tant clones were picked (1 per 
experimental flask, 5 flasks/experiment) from this same cloning on 
2 
as-lCD. Each subclone was grown to confluency in a 25-cm flask on 
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Table 7. Restoration of full CD-resistance by subcloning 
How subclones were isolated 
Variant grown on Subclones picked from 1 yg/ml 
nonselective medium C.E. expt. CD flasks C.E. of expt. (39 
(39 generations) generations) determined 
Variant subclones 
grown on nonselective C.E. expt. on 
medium until confluent each of the subclones 
If segregation of resistant and sensitive cells then C.E. 
should be very close to initial variant (i.e., C.E. = 100%) 
If the resistance is lost on a per cell bcisis, then expect 
C.E. equal to or less than variant C.E. at 39 generations 
Variant C.E.® on 1 yg/ml CD C.E.® of random subclones 
(39 doublings) on 1 yg/ml 
CYD^ -8 64.9 83.7 
i::: 
83.5 
CYD^ -10 54.9 83.7 
82.4 
CYD^ -20 32.2 96.6 
::: 
92.2 
C^loning efficiency relative to control plated on nonselective 
medium, 
b Average CE of subclones. 
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nonselective medium. Each subpopulation was then challenged again 
with 1 pg/ml CD and the cloning efficiency determined. It was found 
that the plating efficiency of the populations from each of the newly 
derived subclones had been restored to values typical of originally 
isolated, fully resistant variants (Cyd^ -8, 84-100%; Cyd^ -10, 84-
95%; Cyd -20, 86-97%). In other words, plating in the presence of 
drug "purified" the population by selecting for fully drug-resistant 
cells. If loss of drug resistance in the 39-cell generation popu­
lation had occurred equally in all cells, the cloning efficiency 
of the isolated subclones should have been similar to that of the 
parent population, e.g., around 30-65% rather than 84-100%. 
In the second es^ eriment, the cloning efficiency of Cyd^ -subpopu-
lations after 15 generations of growth in nonselective medium was 
correlated with the actual proportion of drug-resistant and drug-sensitive 
subclones derived from the same subpopulation (Table 8). A total of 24 
subclones were randomly picked from control flasks of each variant 
derivative line (clones growing in aNS). These subclones were seeded in 
duplicate in 24-?well microtiter dishes and allowed to grow for two days 
in nonselective medium before the addition of selective medium (as-lCD). 
Ohe subclonal populations were grown for 96 hours in aS-lCD and scored 
as drug-resistant or drug-sensitive. If 80-100% of the cells retained a 
spindle shape, remained mononucleate, and continued to undergo cell 
division to confluency, the population wets designated cytochalasin 
resistant. Subclonal populations were counted as drug-sensitive if 
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Table 8. Cloning efficiency of subclones vs. % resistant 
Method used for comparing cloning efficiency (C.E.) with % resistant 
subclones 
Variant grown on 
nonselective 
medium a-NS 
(15 generations) 
(Reduced C.E. 
on 1 yg/ml CD) 
C.E. e:)qpt. 24 
clones picked _ 
at random from 
nonselective 
medium (a-NS) 
Subclones 
grown on 
UNS in 
microtiter 
dishes-2 days 
24 subclones challenged 
individually with 1 yg/ml CD 
clones checked for resistance 
1 and 4 days later 
If segregation of sensitive and 
resistant cells, % resistant should 
derivative population C.E. 
If loss of resistance on a per cell 
basis, all subclones should have some 
resistance 
Phenotype of subclones^  
isolated from cxNS 
Cell line C.E.* (1 yg/ml CD) 
s® d 
Cyd^  
% Resistant 
subclones 
Cyd^ -8 71.0 6 18 75 
Cyd*-10 83.5 6 18 75 
Cyd*-20 81.3 3 20 87 
C^loning efficiency relative to control on nonselective medium. 
^^ ubclonal populations grown for 96 hr in as-lCD were scored as 
drug resistant if 80-100% of the cells retained spindle shape, remained 
mononucleate, and continued to undergo cell division to confluency. 
Subclonal populations were scored as sensitive if nearly all cells 
exhibited typical cytochalasin-sensitive morphology and became multi­
nucleate with no attendant increase in cell number. 
N^umber of cytochalasin D-sensitive cells (clones). 
N^umber of cytochalasin D-resistant cells (clones). 
141 
nearly all cells exhibited typical cytochalasin-sensitive morphology 
and became multinucleate with no attendant increase in cell number. The 
data in Table 8 show that the % resistant subclones, derived by cloning 
on nonselective medium, agrees quite nicely with the cloning efficiency 
of variant subpopulations plated on selective medium. For example, the 
p 
81% cloning efficiency of Cyd -8 is closely reflected in the 87% resistant 
phenotypes among the 20 Cyd -8 subclones tested. If there had been a 
loss of resistance on a per cell basis, one would expect all of the sub­
clones to be identical and partially resistant. 
If loss of CD resistance occurred gradually in all cells, it would 
be expected that cloning efficiency in CD would be concentration de­
pendent, i.e., the ability to clone would be greater at lower drug 
doses when cloning efficiency on 1 yg/ml CD had been greatly reduced. 
However, it was found that when the cloning efficiency of Cyd -20 on 
1 ng/ml CD was decreased significemtly, the ability of that same variant 
population to clone in the presence of 0.8 yg/ml, 0.6 yg/ml and 0.4 yg/ml 
was essentially identical (e.g., 1 yg/ml CD, 19,6%? 0,8 yg/ml CD, 15.8%; 
0.6 yg/ml CD, 15.4%; 0.4 yg/ml CD, 19.9%). This experiment was repeated 
three times with identical results (Table 9). This finding clearly does 
not support the "gradual loss" hypothesis. 
Since segregation and loss of fully drug-resistant cells from the 
Cyd -variant cell lines is well-demonstrated, there must be strong 
selection against this phenotype. As shown in Table 5, the variant 
population produced as many as 10% new multinucleate derivative cells 
in each early passage. Results from the cell fusion and cocultivation 
Table 9. Cloning efficiency of variant populations in decreasing concentrations of CD 
„ ., ^ . Concentration of Cytochalasin D (yg/ml) 
Control 1 yq/ml  ^ 6^ .4 
CHO 
Cloning efficiency^  70 0 0 0 0 
Relative cloning 
efficiency - 0 0 0 0 
Cyd^ -20 
Cloning efficiency 103.6 20.3 16.3 16 20.7 
Relative cloning 
efficiency - 19.6 15.8 15.4 19.9 
Cyd*-10 
Cloning efficiency 86.6 3.6 4.3 2.3 3.6 
Relative cloning 
efficiency - 4.1 5.0 2.7 4.2 
Cyd^ -8 
Cloning efficiency 70.6 14.2 15.8 13.4 14 
Relative cloning 
efficiency - 20.1 22.4 19 20.9 
1^0^  cells/25-cni^  flask. 
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experiments suggest that cytokinesis may not be completely normal for all 
cells of the variant population although approximately 90% of cells over­
come this barrier and form normal clones in cytochalasin. Also, the 
population doubling times of variants were 4-6 hours slower than the 
doubling time of the parent. In Figure 7 (inset: shown for Cyd^ -10), it 
can be seen that the % multinucleate cells declines cuid the doubling time 
decreases, as the percent of CD-resistant cell types in the variant 
population declines. Either of these attributes would produce a selec-
tive disadvantage for the drug-resistsmt Cyd -variant cells, but even 
together, they may not entirely account for the rapid loss of this cell 
type. Other, as yet undetected, difficulties associated with the Cyd^ -
variant phenotype might also be responsible for poor fitness. 
The increased of vcuriant populations in nonselective medium may 
singly be due to the increased number of multinucleates and polyploids 
R present. Whether this is the case, or whether each Cyd -variant cell 
takes longer to traverse the cell cycle, has not been determined. 
It should be noted that the Cyd^ -variants share a number of charac­
teristics common to unstable drug-resistant variants/mutants where 
resistance is mediated by gene amplification (see pp. 38-77); (1) the 
Cyd -variants, like other gene amplified, drug-resistant mutants, were 
isolated by multiple-step or enrichment selection; (2) Cyd^ -variants have 
a longer in nonselective medium compared to the AK 412 parent; and 
(3) the Cyd -phenotype is lost with time in nonselective medium, re­
sulting in the generation of a CD-sensitive population indistinguishable 
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from the CHO parent line. In other cases of unstable drug-resistance 
mediated by unstable gene amplification, drug-resistant cells are at a 
selective disadvantage compared to drug-sensitive segregants. The 
selective disadvantage is solely attributable to the longer of 
drug-resistant cells in nonselective medium (Kaufman and Schimke, 1981). 
Therefore, the observed loss of CD resistance with time in nonselective 
medium can readily be explained by mechcinisms already demonstrated to 
operate in other dirug-resistant varicuits/mutants. The additional dis­
advantage of a partial lesion in cytokinesis may further alter (increase) 
the rate at which CD-resistance is lost from a fully CD-resistant popula­
tion. 
In summary, the apparent "loss" of drug resistance in Cyd -variemt 
populations is due to segregation of CD-sensitive cells (from the CD-
resistant population) which have a selective growth advcmtage in medium 
lacking CD (nonselective medium). The recovery of full cytochalasin 
resistance by cloning demonstrates cellular inheritance of the drug-
resistant phenotype. This is consistent with a genetic basis for CD 
resistance. 
1^  
Instability of the Cyd phenotype must be taken into account in all 
experiments. Each test of variant characteristics, e.g., cross-resistance 
studies, I^ H]CB-binding studies, etc., is always performed with 
variant populations from frozen samples of original isolates, or with new 
subclonal populations isolated in one step after recloning in either 
selective or nonselective medium. 
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4. CD-displacable, [^ H]C3 binding assay 
There are three basic mechanisms which can mediate cellular re­
sistance to a drug which acts in trace llularly: (1) a chêurige or mutation 
in the enzyme or structural component to which the drug binds, resulting 
in altered binding affinity and/or altered response to drug; (2) the 
presence of an enzymatic activity which breaks down or otherwise modifies 
the drug structurally so that the drug can no longer bind and/or act on 
its primary target; and (3) reduced uptake and/or increased efflux of drug 
due to changes in the plasma membrane. In the latter case, affinity of the 
drug for its intracellular target is unaltered, only its ability to 
reach the target is diminished. Such variants or mutants have been called 
drug permeability, drug uptake, drug tremsport or drug efflux mutants, 
depending on the exact nature of the membrane lesion. 
A number of methods are available for distinguishing mechanisms 
(1) and (2) from mechanism (3). These include radiolabeled drug-uptake 
studies, measurement of drug cross-resistance, euid measurement of the ef­
fect of permeabilizing agents, such as Tween 80, on drug uptake and/or 
drug toxicity. All three methods were used to investigate the molecular 
nature of CD resistance in Cyd^ -variants, and all three generated the 
same conclusion; resistance to cytochalasin D in the Cyd^ -variants is 
due to a lesion in the cell membrane resulting in reduced CO permea­
bility and/or CD upteJce. 
It has been demonstrated that the ^  vitro binding site of all 
cytochalasins, including both CD and CB, is the F-actin microfilament 
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system (see pp. 77-84). There is good evidence that this is probably the 
in vivo target of cytochalasin as well. In all ^  vitro and ^  vivo 
studies thus far, CD is much more potent than CB in inhibiting 
microfilament-mediated processes and in disrupting microfilament 
structure (Tanenbaum, 1978). Thus, CD has a greater binding affinity 
for F-actin filaments than does CB. In addition, only CB has been 
demonstrated to bind to and inhibit sugar transport sites. 
The differences in CD and CB binding to microfilaments was utilized 
to quantitate any differences in binding of [^ H]CB to. CD-sensitive and 
3 -9 
CD-resistemt cell lines. Concentrations of [ H]CB from 10 M to 
"6 
10 M were incubated with either intact cells or cell extracts (mem­
brane and soluble extracts assayed separately) in the presence and 
absence of an excess of unlabeled CD (4 x 10 ^ M). Specific binding 
3 
of [ H]CB was defined as the embunt of radioactivity displaced by an 
excess of cold CD. 
The results of the CD-displacable binding of [^ H]CB to intact 
cells and cell extracts were analyzed by the graphical procedure of 
Scatchard (1949), Table 10 and Figure 8. The dissociation constants 
(Kg's) and number of binding sites are summarized in Table 10. In 
intact cells, there is a 4-fold reduction in the number of binding 
R 
sites in Cyd -10 conpare with AK412 (6 vs. 24 pmole/mg protein), al­
though cells of both lines have similar K.'s for [^ H]CB. There is 
a 
no apparent difference in the number of binding sites or in cell 
extracts (soluble fraction and membrane pellet) of AK 412, compared 
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P 
with Cyd -10. Inasmuch as the only demonstrable difference between 
parent and variant occurred in the comparison of whole cells rather 
than of soluble extracts and membrane pellets, the data suggest that 
the alteration responsible for cytochalasin B resistance results from 
reduced permeability emd/or uptcGce of CB. 
The Cyd -variants are 10-15 fold more resistant to CD and at 
least 2-fold more resistant to CB (i.e., Cyd^ -variants are cross-
resistant to CB). It is reasonable to assume that the lesion mediating 
CD resistance is the same one mediating CB resistance (see Discussion). 
Thus, the results of the (^ H)CB binding assay can be further extra­
polated to explain CD resistance. Therefore, resistance to CB and 
CD is due to a reduction in the number of binding sites for , or per­
meability to CB cuid CD. 
5. Cross-resistance to other drugs 
Because the previous experiment indicated that the Cyd -variants 
may be cytochalasin D permeability êind/or uptake variants, cross-
R 
resistance of the Cyd -variants to a number of other drugs having dif­
ferent structures and sites of action was tested. Pleiotropic cross-
resistance is a common characteristic of other drug permeability 
variants/mutants (see pp. 18-25). The drugs tested included actino-
mycin D (which intercalates into DNA and inhibits DNA and RNA synthesis), 
colcemid (a microtubule poison), cytochalasin B, and procaine (a membrane 
anaesthetic). The results (Têûale 11) are expressed in terms of rela­
tive cross-resistéuice, which is defined either as the D^ v^ariants/D^  ^
Table 10. CD-âisplaceable binding of [^ HlCB to intact cells and cell extracts 
Whole cell-binding Fractionated cells 
K Number of  ^ Membremes-particulate Soluble extract 
Cell line binding sites^  fraction fraction 
Number of . Nuiriier of 
d binding sites^  d binding sites^  
AK412 3.8 -7 X 10 24 2.4 X lo-s 2.4 ND^  
ND ND 1.6 X 10-8 2.8 1.2 X 10-* 1.3 
Cyd^ -lO 3.7 -7 X 10 6 2.9 X 10-8 2.9 NA 
3.2 -7 X 10 5.1 1.5 X 10-8 1.6 0.9 X lo"® 1.7 
p^ rooles/mg protein. 
N^ot determined. 
Figure 8. Scatchard plot analysis of the binding of [ H] cytochalasin B to CD-displaceable 
sites ((A) binding of [%]CB to soluble extracts of Cyd^ lO (A) and AK412 (A), and 
to membrane pellets of Cyd^ lO (o) and AK412 (•). %e nearly horizontal lines 
might be due to low affinity binding of [^ H]CB to G-actin. (B) Binding of I^ HJCB 
to intact cells of Cyd^ lO (•) and AK412 (o). The number of binding sites is de­
termined by dividing the X intercept by the amount of protein used in the assay 
(see Table 10). The concentration of [%]CB and unlabeled CD are described in 
Methods and Materials) 
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Table 11. Relative cross-resistance of Cyd^ -Vcuriants to other drugs 
Cell line CD^  CB^  Colcemid^  Actinonycin Procaine^  
AK412 1.0° 1.0 1.0 1.0 1.0 
Cyd^ -S 18.2 1.9 5.8 9.9 0.45 
Cyd*-10 15.0 2.2 7.0 12.2 0.41 
Çyd^ -20 ND 1.6 5.8 11.0 0.45 
R^elative cross-resistêuice is expressed as the ratio of variant/D^  ^AK412. 
R^elative cross-resistance is expressed as the ratio of varieuit/D^  ^AK412. 
F^ive determinations were made for each data point on all dose-response curves. 
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AK412 or variants/Dg^  AK412; and are the drug concentrations 
that reduce cell survival, as measured by plating efficiency, to 10% 
R 
or 50%, respectively. It was found that the Cyd -variants are cross-
resistant to actinomycin D (10 to 12-fold), colcemid (5.8 to 7-fold) 
and CB (1.6 to 2.2-fold). The Cyd^ -variants show increased sensitivity 
to procaine (approximately 2.2-fold more sensitive to procaine). 
6. Potentiation of CD toxicity by Tween 80 treatment 
Tween 80, at concentrations up to 100 yg/ml, is nontoxic to CHO 
AK412. The presence of this nonionic detergent increases permeability 
of colchicine resistant cells to actinomycin D, colchicine, and other 
drugs (see pp. 20-24). The ability of Tween 80, as well as other per-
meabilizing agents, to reverse drug resistance and cross resistance in 
drug-resistant mutants is «mother characteristic of drug permeability 
and/or uptake mutants. 
The CD resistance of one of the varieints, Cyd^ -8, was tested in 
the presence eind absence of 100 Ug/ml Tween 80. The cloning efficiency 
1^  
of Cyd -8 in aS-lCD plus Tween 80 was reduced to 1%, although plating 
efficiency in aS-lCD alone was 70%. This 70-fold reduction was not due 
to toxic detergent effects because the control cloning efficiency in 
medium without CD but with 100 yg/ml Iteeen 80, was 93%. Further 
data from Cyd^ -10 and Cyd^ -20 (Table 12) cleeurly suggest that the cyto-
chalasin-resistant lesion in the Cyd -variants involves a membrane 
barrier to drug permeability. 
To summarize thus far, experiments (described in sections 4, 5 and 6), 
Table 12. Potentiation of CD toxicity by Tween 80 
Control 1 yg/nil 1 yg/ml CD & 100 yg/ml 100 yg/ml CD Tween 80 Tween 80 
Cell line 
CHO , 
C.E.b 
R.C.E.° 
Cyd*-10 
C.E. 
R.C.E. 
Cyd^ -20 
C.B. 
R.C.E. 
67.8 
84.5 
63.6 
0 
0 
73.8 
87.3 
53.6 
84.3 
0 
0 
2.4 
2.8 
0.4 
0.006 
69.6 
102.7 
86 
101.8 
61.4 
96.5 
d 2 2 10 cells/25-cm flask; 5 flasks/es^ eriment. 
C^loning efficiency (C.E.). 
R^elative cloning efficiency. 
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demonstrate conclusively that CD resistance in the Cyd -variants is due 
to reduced CD uptake, most likely resulting from reduced membrane 
permeability to CD. CD-resistance does not result from altered or reduced 
F-actin microfilament binding (section 4}. Although the possibility 
remains that CD resistance could be mediated by increased CD efflux, this 
mechanism is highly unlikely in the Cyd -variants. First, Tween 80 
(100 yg/ml) conpletely abolishes CD resistance (section 5), unlike the 
results observed for drug-efflux mutants (see pp. 20-25). Secondly, no 
efflux mechanism has been demonstrated for any cytochalasin congener in 
any cell line, and all data to date suggest an ATP-dependent, passive 
diffusion mode for cytochalasin uptake (Tamnenbaum, 1978). The Cyd -
varicmts are cross-resistant to at least two structurally and functional­
ly distinct drugs (experiment 5) and more sensitive to the membrane 
anaesthetic procaine; nearly identical results are observed in a host 
of other drug permeability/uptake variants amd mutemts (see pp. 20-25). 
In fact, one of the colchicine-resistant mutants of Ling êuid co-workers 
has similar levels of cross-resisteuice to colcemid and actinonycin D 
(cell line S1-2LA, 6.5-fold more resistant to colcemid, 10-fold more 
resistant to actinomycin D, Ling and Thompson, 1974). 
Thus, enrichment selection for CD resistance has resulted in the 
isolation of CHO AK412 variants with em hypothesized lesion conferring 
resistance to CD as well as cross resistemce to four different drugs 
and increased sensitivity to another. Three questions are generated 
by the results described thus far. (1) What other cheinges in membrane 
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fiinction (besides reduced drug permeability) result from the change in 
membrane structure leading to CD resistance? (2) What structural change(s) 
at the membrane level are responsible for the Cyd^ -phenotype? (3) What 
change(s) at the DNA level (genotype) resulted in the Cyd^ -phenotype; 
i.e., what gene(s) confers CD-resistance? Is this same gene(s) responsible 
for the other reported characteristics of the Cyd^ -variants ? 
The remainder of the experiments to be described attempt to answer 
these three questions. With respect to question (1), one change in 
function, cytokinesis, has been correlated with the change in membrane 
structure mediating CD resistance. The fact that multinucleation is 
lost concordêuitly with loss of CD resistance (Figure 7) implies that 
CD-resistance, and a partial lesion in cytokinesis, result from the same 
lesion. There are a number of other functional and structural differ-
R 
ences between the Cyd -variants and their AK 412 parent line. These 
will be detailed in the following experiments. 
7. Cell surface morphology of Cyd -varicuit cells 
Significant differences in cell surface morphology between the 
Cyd -variants and AK 412 cells are readily observable. Differences in 
cell surface morphology were observed with light and sceuining electron 
microscopy, and the results are shown in Figures 9-12 and summarized in 
Table 13. 
In the light microscope, a number of differences are immediately 
R 
apparent. First, Cyd -variant cells have a much higher percentage of 
multinucleate cells in nonselective medium compared to the AK 412 parent 
Table 13. Summary of observations on cell surface morphology In CHO and Cyd -^variants 
CHO Variamts 
Cyto- Blebs Micro- Nuclear Retraction Cyto- Blebs Micro- Nuclear Retraction 
kinesis (zeiosis) villi protrusion fibers kinesis (zeiosis) villi protrusion fibers 
IN NONSELECTIVE MEDIUM 
LM 
SEM 
+ 
NA 
NA 
+ 
IN SELECTIVE MEDIUM (CD) 
U4 - + NA 
SEM NA 
+ 
+ 
+ 
+ 
+ 
NA 
+ 
NA 
(<1% Of 
CHO) 
NA 
(<55% Of 
CHO)^  
NA 
(clearly 
retained 
on some 
cells) 
N^A - not applicable. 
A^pproximate comparison of number of microvilli per 10 cm^  areas at 2000X. Cells and cell 
areas chosen at reuidom. 
Figure 9. Light micrographs of AK 412 wild-type and Cyd -variant 
cells. ((A) AK 412 in aNS (x750). (B) Cyd®-10 in qNS. 
Note multinucleate cells M (x700). (C) AK 412 in tts-lCD 
for 72 hr. Retraction fibers P, protruding nuclei N, blebs, 
binucleate, and multinucleate cells are evident (x750). 
(D) Cyd^ -10 grown in aS-lCD for many weeks. Note that 
nuclei are not protruding and that the cells are primarily 
mononucleate and bipolar. Blebs B are evident (x760). 
(E) A resistant ceil, R, among a background of sensitive 
cells after 11 rounds of selection. The cells have been 
in 1 Ug/ml CD for 24 hr (x400). (F) Clonal areas, RC, of 
resistcuit cells in round 13, 72 hr in 1 Ug/ml CD (x370)) 
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Figure 10. Light microscopy of Cyd -variant lines in nonselective 
and selective medium. ((1) Cyd®-8 and (2) Cyd^ 20 in 
nonselective medium (medium without CD). Note presence 
of polynucleate cells (arrows). (3) Cyd^ -8 and (4) 
Cyd®^ 20 cells in 1 yg/ml CD. Cells in 1 ]Jg/ml CD are 
much more bipolar and slightly smaller (contracted) when 
compared to cells in nonselective medium. Cell in the 
upper right corner of (4) has 2 large zeiotic blebs 
on either side of the nucleus) 
09T 
Figure 11. Scanning electron micrographs of AK 412 and Cyd -variants in 
the presence and eibsence of 1 yg/ml CD ((a) AK 412 in aNS. 
Numerous microvilli and some blebs are evident (x620), (b) 
Cyd^ 20 in aNS. Cellis are bipolar, and both blebs and 
microvilli are very speirse (x836). (c) Higher magnifi­
cation of AK 412 in aNS. Microvilli (MV) and blebs 
(B) are evident (xl990). (d) Higher magnification of 
Cyd®-20 in aNS. The cells have no blebs and few micro­
villi (x2460). (e) AK 412 treated with 1 lig/ml CD for 
36 hours. The cells are conpletely devoid of micro­
villi and the primary surface feature is the foci of 
blebs and/or retraction fibers (arrow). Nuclei are 
protruding in two cells (xl280). (f) Cyd®-8 treated with 
1 pg/ml CD for more than 10 generations. The microvilli 
are very sparse; only the cell at the upper right has many 
microvilli. Numerous blebs are present (xl250)) 
Y 

Figure 12. Scanning electron micrographs of Cyd -10 before and during 
change of growth medium from selective (1 ug/ml CO) to 
nonselective (without 1 lig/ml CD) ((1) Cyd -10 grown 
in yg/ml CD for 2 months. Note numerous blebs and lack 
of microvilli (x600). (2) Cyd -10 two minutes after 
change from selective to nonselective medium. Blebs 
have disappeared emd microvilli "stubble" is visible 
(xlOOO). (3) Same as (2) (x400). (4) Cyd^ -lO 12 hrs 
after change from selective to nonselective medium. Cells 
are devoid of blebs but normal microvilli still are not 
evident (x440)) 
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(Table 5 and Figures 9 and 10). This observation has been previously 
described. Secondly, none of the characteristic morphological changes 
induced in CD-sensitive cells (pages 109-117 and Figures 1-3) are 
observed in Cyd -variant cells with one exception, bleb formation 
(Table 13). The Cyd -variant cells do not form retraction fibers, 
contract, or extrude nuclei in the presence of 1 yg/ml CD (compare 
Figure 9C and D). In addition, the Cyd -variants retain the cibility 
to divide in 1 Mg/ml CD, as evidenced by the clonal areas in Figure 
9D and Figure 10-3 and 4. However, the Cyd^ -variemts do form blebs 
characteristic of CD-sensitive cells (e.g.. Table 13 and Figures 9-12). 
Another apparent effect of CD on Cyd -variant cells is the induc­
tion of strong bipolar, fibroblastic morphology (Figure 9, compare B 
R 
and D, and Figures 10 and 12). In the absence of CD, Cyd -variant 
cells assume any number of random shapes similar to that of wild-type 
CHO AK 412. However, upon addition of 1 Pg/ml CD, all cells assume a 
"tightened" bipolar shape, perhaps indicative of some kind of contrac­
tion and/or microfilament reorganization. A similar observation has been 
made in the SEM. In Figure 12, Cyd -10 cells that have been grown in 
1 Mg/ml CD are shown. Cells in CD are bipolar, and cell-cell contacts 
are made only at the tips of cells, or by alignment of one cell next 
to another. However, within 2 minutes after removal of CD, cells are 
no longer strictly bipolar and cellular processes (Icimellopodia) are 
extended to make contact with other cells. This change is even more 
pronounced by 12 hours after removal of CD (Figure 12-4). 
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micrograph also serves to illustrate the rapid reversal of CD-induced 
effects on cells in culture. 
Observations with both the light and scanning electron micro­
scope indicate that cell-cell contact is significantly enhanced in 
Cyd -variant cells compared to the wild-type parent. This conclusion 
is supported by the observation that there is a strong proclivity for 
cell-cell association and clonal formation in Cyd -variant cells that 
is independent of the initial cell density. This observation, however, 
is only empirical, and has not been quantitated. 
A number of differences in cell surface morphology are observable 
R 
only with the SEM. In the absence of CD, Cyd -varieuit cells have at 
least 50% fewer microvilli compared to AK 412 (Figure lla-d). Zeiotic 
blebs are a normal surface feature of CHO AK 412 cells which vary in 
R 
number during the cell cycle, however, they are absent in Cyd -variant 
cells (compare Figure 11a and c with b eind d). In Figure 12, it can 
be seen that zeiotic blebs, present in abundeuice in Cyd -10 cells 
cultured in 1 pg/ml CD, rapidly disappear upon removal of CD, 
Like AK 412 cells, Cyd -variant cells immediately form zeiotic blebs 
in 1 yg/ml CD (Figure IIF). Although there is some aggregation of the 
blebs in clusters, it does not approach the level of clustering observed 
in CHO AK 412 (con^ )are Figure lie and f as well as Figure 12-1). 
Microvilli, which are immediately withdrawn upon CD addition to 
CD-sensitive cells, are retained in Cyd^ -variànt cells after addition 
of 1 yg/ml CD. However, the number of microvilli are greatly reduced 
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in Cyd^ -variant cells in nonselective medium. Additionally, the micro-
villi of Cyd -variant cells may possess slightly different morphology 
from microvilli of AK 412. 
To summarize, there are significant differences in cell surface 
morphology between the Cyd^ -variants and the AK 412 from which they were 
R derived. Although Cyd -variant cells are resistant to most of the ef­
fects of cytochalasin, including cell retraction, nuclear protrusion, 
microvilli withdrawal and inhibition of cytokinesis, they are still 
sensitive to the zeiotic bleb-inducing effect of CD. This observa­
tion can be explained in one of three ways. First, bleb formation may 
involve disruption of microfilcunents inserted into the membrane, as 
opposed to microfilaments dispersed throughout the cytoplasm. To 
disrupt membrane-inserted or -attached microfilaments, cytochalasin 
may only need to enter the mendsrsme. To disrupt cytoplasmic-situated 
microfilaments, cytochalasin may have to pass through the membrane; the 
ability to do so being greatly restricted in Cyd -variemt cells. 
Secondly, bleb formation may be a much more sensitive effect of cyto­
chalasin. That is, the concentration of cytochalasin necessary to 
ellicit bleb formation may be lower than that necessary to cause cell 
retraction, nuclear protrusion, and other common cytochalasin-induced 
effects. The increased sensitivity to bleb formation may result from 
either fewer microfilaments necessciry for CD-induced disruption to 
ellicit bleb formation or the presence of a subset of microfilaments 
which bind cytochalasin with greater affinity. In either case, the end 
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result is the requirement of a lower concentration of CD necessary to 
evoke bleb formation compared to the other effects of CD. Finally, it 
is possible that bleb formation is not a microfilament-mediated event. 
Bleb formation may result from interaction of cytochalasin with the 
plasma membrane. If this is the case, then bleb formation is a sepa­
rate effect of cytochalasin, as is inhibition of glucose transport 
by CB, and is not dependent on disruption of F-actin microfilaments. 
As of yet, it has not been possible to delineate which of these three 
explanations is valid. 
The induction of a strongly bipolar shape after CD addition to 
Cyd -variant cells can also be explained by the three hypotheses just 
presented. Because cell shape is so dependent on microfilament arrange­
ment, the last possibility is highly unlikely. That is, the change in 
cell shape induced in CD-resistant cells probably results from the 
interaction of CD with a specific subset of microfilaments and not from 
a nonspecific effect on the plasma membrane. 
The membrane lesion conferring CD resistance, drug cross-resistance, 
and a partial defect in cytokinesis also appears to result in a signifi-
cant change in cell surface ultrastructure. Specifically, Cyd -variants 
are unable to form zeiotic blebs in nonselective medium and also form 
fewer, more abnormal, microvilli. Also, the microvilli formed by 
Cyd -variant cells are altered in morphology compared to microvilli 
of wild-type CD-sensitive cells. 
The microvilli that are present on Cyd -variant cells in nonselective 
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medium are not withdrawn upon addition of 1 lig/ml CD. This is sur­
prising because microvilli are known to contain F-actin microfila­
ments which terminate in the membrane at the top of the microvilli. 
Yet, at least some microfilaments are probably disrupted as evidenced 
by the change in cell shape after CD challenge (and perhaps bleb forma­
tion after CD addition). 
8. Adhesive properties of Cyd^ -varicUit cells 
A number of empirical observations as well as data from three 
1^  
experiments^  suggests that Cyd -variant cells possess altered adhesive 
properties compared to AK 412: (1) As seen in light micrographs, cell-
cell contacts are more common among Cyd -variant cells than among CHO 
parental cells (Figures 9-12). The increased cell-cell adhesion seems 
to be independent of cell concentration but has not been quantitated. 
(2) Normally, when CHO cells are completely confluent and have depleted 
the medium of necessary nutrients, they round up and detach from the 
plastic or glass substrate. However, when Cyd^ -variants overgrow, they 
still remain attached to the substrate. Often, they will lyse, but 
the cell periphery is still attached to the plastic substrate. This 
observation suggests that Cyd -variant cells adhere more tenaciously 
to the surface substrate than AK 412, although other interpretations 
are possible as well. (3) Consistent with the observation in (2), it 
was observed that Cyd -variant cells take a longer time to detach 
than AK 412 during incubation in trypsin. This observation was 
quantitated by measuring the rate of detachment of AK 412 cells and 
170 
Cyd -variant cells with time in the same concentration of trypsin (Table 
14). These data are semi-quantitative because of the numerous variables 
and problems encountered in an experiment of this type. First, the 
quality of trypsin varies from batch to batch. Second, the length of 
time at room temperature or 37° influences the quality of trypsin 
since trypsin is self-degrading. Third, the batch of fetal calf serum 
used may affect the results, since macromolecules present in the 
serum are thought to influence cell substrate attachment. The 
R longer time required to detach Cyd -variant cells may simply 
reflect the increase in large, multinucleate cells, which are harder 
to detach from the substrate. (4) The rate of reattachment to plastic 
R 
substrate after trypsinization is slower among the Cyd -variants com­
pared to AK 412. This is demonstrated in Table 15, where the rate at 
R 
which AK 412 and Cyd -20 cells attach to the surface of the tissue 
culture flask (at one minute time intervals) is shown. The results of 
these e:q>eriments are subject to several caveats. First, these experi­
ments were repeated several times with early isolates of Cyd^ -variant 
lines, and the results from these experiments were identical. However, 
in experiments performed about a year later, no differences were ob-
p 
served in attachment rates between AK 412 and Cyd -varieuits. This could 
R be the result of variation in the Cyd -phenotype during subcloning in 
R 
combination with unintentional selection for Cyd -variants with attach­
ment properties similar to those of AK 412. Alternatively, the dis­
crepancy in results could be due to differences in the brand of tissue 
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Table 14. Rate of detachment by trypsin of AK 412 and Cyd^ -variants 
from tissue culture flasks 
Minutes after 
addition of 
2 ml % Cells detached from substrate Experiment 
trypsin Cyd^ -8 Cyd'^ -lO Cyd^ -20 
1 
2 
3 
4 
5 
21.4 
32.7 
44.0 
76.0 
100.0 
15.2 
26.8 
31.2 
40.0 
63.5 
13.8 
16.6 
22.2  
42.0 
57.0 
5.4 
17.0 
2 2 . 8  
37.6 
65.0 
1 
2 
3 
4 
5 
3.5 
12.1 
26.0 
41.3 
60.5 
3.9 
6.9 
15.0 
25.7 
35.0 
1 
2 
3 
4 
5 
6 . 2  
18.0 
36.0 
52.3 
100.0 
3.3 
5.7 
16.4 
22.3 
29.0 
1 
2 
3 
4 
5 
5.5 
9.0 
25.4 
51.6 
77.0 
6.5 
9.0 
16.2 
27.6 
38.0 
2^ X 10^ cells/25-•cm^  flask. 
6^ X 10^ cells/25-•cm^  flask. 
°7 X 105 cells/25- 2 •cm flask. 
S X 105 cells/25- 2 •cm flask. 
Table 15. Rate of attachment to substrate by AK 412 and Cyd^ -20 
Time after addition of cells to 25-cm^  flasks (minutes)^  
0 5 10 15 20 25 30 35 40 
Cell line 
CHO 
% Cells 
attached 0% 54.8 52.3 86.1 93.2 91.7 92.6 96 96.3 
Cyd^ -20 
% Cells 
attached 0% 45.5 47.5 48 74.1 78.5 83.9 88.7 90.3 
1^.0 X 10^  cells/25-cm^  flask were added to each of 16 flasks and incubated at 37*. At the 
time intervals listed, duplicate flasks were removed, the medium removed and the flask rinsed with 
1 ml of CXMEM. The number of cells remaining in the medium, and thus not attached to the plastic 
surface, was determined by counting two 1 ml aliquots from each flask in a Coulter counter. 
Cells attached was calculated by determining the number of cells remaining suspended in OMEÎI 
at each time goint. The number of cells in oiMEM was divided by 1.0 x 10 (the amount of cells added 
to each 25-cm flask) to determine the % of cells not yet attached to substrate. This number was 
subtracted from 100% to give the % of cells attached. 
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culture flask and fetal calf serum used in the early experiments (i.e., 
GIBCO fetal calf serum and Falcon flasks in the first group of experi­
ments, HY-CLONE fetal calf serum and other brands of flasks in later 
experiments). (5) Cyd -variants are more resistant to three lectins, 
PHA, Con A, êind WGA, compared to the wild-type parent. This 
experiment was done only once and must be repeated in order to make the 
evidence conclusive rather than tentative. Decreases in lectin sensi­
tivity have been reported in other drug permeability mutants (Biedler 
and Peterson, 1981). 
In conclusion, empirical observations, as well as results from 
these three experiments, suggest a difference in the adhesive properties 
of the Cyd -variants compared to AK 412. Changes in cellular adhesion 
have been observed in some drug permeabi11ty/uptake mutants (Biedler 
and Peterson, 1981). 
9. Changes in membrctne fragility in the Cyd -variants 
In the course of preparing membrane pellets for biochemical analysis 
(see Methods and Materials), it was observed that the Cyd^ -variant 
cells ruptured much more rapidly than théir Wild-type counterpart. 
This difference was quantitated by estimating the % cells ruptured 
after homogenization in a Bounce homogenizer. In order to make the 
data as reliable as possible, the same homogenizer and pestle were 
used, and an identical number of cells were homogenized. The % of 
cells ruptured after 5 to 30 strokes with a dounce homogenizer (in 
increments of 5 strokes) is shown in Table 15. The results confirm that 
Table 16. Measurement of membrane fragility in AK 412 and Cyd^ -variant populations^  
Number strokes Approximate percent of cells broken by homogenization^  
homogenized CHO Cyd^ -8 R.C. 3 Cyd^ -10 R.C. . 1 Cyd^ -20 R.C. 1 Cyd^ -8 S.C.4.;.S.C.5° 
Experiment 1 
5 20 20 36 30 
10 30 45 50 40 
15 45 65 80 70 
20 65 85 95 10,0 
25 85 100 100 100 
30 95 100 100 100 
Ei^ eriment 2 
5 40 60 70 50 
10 55 85 90 75 
15 70 95 100 90 
20 80 100 100 100 
25 95 100 100 100 
30 100 100 100 100 
Experiment 3 
5 45 60 55 
10 60 75 60 
15 75 80 75 
20 90 95 90 
25 95 100 100 
30 100 100 100 
a 8 
Total of 1 X 10 cells scraped from tissue culture dishes with rubber policeman, washed 3 
times in PBS, pH 7.2 and resuspended in TEA buffer, 1 x 10® cells in 5 ml total of TEA. Cells 
homogenized with Dounce homogenizer using tight-fitting pestle, 0.1 ml aliquots removed after 
every 5 strokes and observed under inverted scope.  ^
A^pproximate % of cells broken determined by estimating % of whole cells and subtracting 
from 100% estimate error of + 5%. 
'^ Sensitive revertant of Cyd^ 8 R.C. 1 selected as described in Methods and Materials. 
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the Cyd -variants cells are more "fragile", as measured by the ability 
of a Bounce homogenizer to rupture intact cells. Interestingly, Riordan 
and Ling (1979) reported that the pressure required to rupture 
colchicine-resistant mutant cells with a Sternsted Cell Disrupter 
was less than half the pressure required to rupture wild-type cells 
(150 vs. 350 p.s.i.) or drug-sensitive revertant cells (300 p.s.i.). 
The major phenotypic characteristics of the Cyd^ -variants have 
now been described. Enrichment selection for CD-resistance has re­
sulted in the isolation of CHO variants resistant to 1 yg/ml CD. The 
membrane lesion resulting in CD-resistance also confers on Cyd -variant 
cells the following properties: (1) a longer T^  in nonselective medium; 
(2) a partial defect in cytokinesis, resulting in a greater percentage of 
multinucleate cells; (3) drug cross resistance and increased drug 
sensitivity; (4) significantly altered cell surface morphology; (5) 
altered cell surface adhesive properties; and (6) an increase in mem­
brane fragility. All of these characteristics are consistent with a 
change in membrane structure resulting in a change in membrane function. 
A question still to be addressed is what change(s) at the membrane 
level is responsible for the Cyd -phenotype? It has already been men­
tioned that changes in cell surface glycoproteins accompany reduced drug 
uptake/permeability in other drug resistamt mutants (pp. 25-37). Also, 
R 
altered response to three different lectins by the Cyd -variants is 
indicative of chcuiges in cell surface glycoproteins. Consequently, three 
different methods were used to qualitate and quantitate cell surface 
176 
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glycoproteins of AK 412, Cyd -variants, and drug-sensitive revertants 
isolated by a single step. 
10. Biochemical analysis of Cyd -variants 
a. lodination of surface membrane proteins Procedures for 
125 labeling cell surface proteins with [ I] isolation of cell surface 
membrane and separation of membrane proteins by ID-SDS-PAGE are 
described in Methods and Materials. The following cell lines were 
used: (1) CHO AK 412; (2) Cyd^ -8, -10, and -20; and (3) sensitive 
revertants of Cyd^ -8 and Cyd^ -10 isolated by a single step (see section 
12). Cells were Icibeled in monolayer or suspension culture. 
Con^ arisons of CHO peirental cells and Cyd -variants labeled in mono­
layer show that there are significant and repeatable differences in 
band migration. In all cases, the protein beinds from the wild-type 
R parent migrate slightly faster than con^ arable bands from the Cyd -
variant preparations. A total of six bands migrate differently in the 
parent compared to the Cyd -variants. Two band migration differences 
at approximate MWs of 123-140,000 and 104,000 are readily observable 
in both 10-15% linear gradient and 7% gels (Figures 13-15). The highest 
MW band (123-140,000 daltons) in the CHO parental cells is a large, 
diffuse-staining band, which may actually consist of 2 or more bands. 
p 
The same band migrates at 125-145,000 MW in the Cyd -variants. A 
second band migrates at 104,000 MW in the AK 412 parent and 108,000 in 
R R 
the Cyd -variants. Other differences between CHO AK 412 and the Cyd -
variants occur in beinds of 42,000, 95,000, 190,000 and 210,000 daltons. 
That those differences are repeatable is shown in Figure 13c,d. 
Figure 13. Summary of differences in surface proteins/glycoproteins of 
CHO AK 412 and Cyd^ -variant cells labeled with QJ. 
NaBH^  (Monolayer or suspension cultures labeled with 
lactoperoxidase-catalyzed iodination or with [^ H] NaBH^  by 
galactose oxidase as described in Methods and Materials. 
Each lane was loaded with the same number of counts. (1) 
10-15% linear gradient gel of cell surface proteijis labeled 
with 125i in monolayer (a-d) or suspension (e-g). (a) CHO 
AK 412; (b) Cyd®-20; (c) Cyd^ -lO; (d) Cyd®-8; (e) CHO; (f) 
Cyd^ lO; (g) Cyd®^ 8. Top, left arrow points to band at 
approximate MW of 130,000 that migrates slightly faster 
in the CHO parent (a) compared to the 3 variants (b-d). 
Arrow below 45,000 MW standard points to another band of 
MM 42,000 that migrates slightly faster in the parent. Note 
a doublet of beuids just below the 92,500 MW standard that 
again migrates slightly faster in the parent. Also note 
that in suspension (e-g) there are a number of signifi­
cant differences in labeled bands con^ ared to cells in mono­
layer. The arrow in the top right points to a band at a  ^
MW of approximately 170,000 which is present in the two Cyd -
variants.(f fi g) and not in the parent. (2) 10-15% linear 
gel of [%] NaBH^ -labeled cell surface proteins of CHO 
(Icuies 1 & 5) and two Cyd®^ variants (lanes 2, 3, 6, 7). 
See Figure 17 for details. (3) 7% gel of ^ ^^ I-labelcd 
meinbrane proteins, (a) Cip; (b) Cyd -10, R.C. 1 (a) CD-
resistant subclone of C^ d -IQ);(c) Cyd®-10, R.C. 5; (d) Cyd^ -8, 
R.C. 4; (e) Cyd®-10 S.C. 2 (a CD-sensitive revertant of Cyd^ -
10);(f) Cyd®-10 S.C. 3. Arrows point to bands at approxi­
mately 130,000 MW and 104,000 MW that migrate slightly 
faster in AK 412 (a) conpared to the Cyd^ variants (lanes 
b-d). Note that two sensitive revertants of Cyd^ lO (lanes 
e and f) migrate more like the Cyd^ variants than the CHO 
parent. (4) Another 7% gel of cells labeled 72 hrs after 
plating (lames a-f) and 48 hrs after plating, (a,g) CHO; 
(b,h) Cyd^ -lO, R.C. 1; (c,i) Cyd^ -lO, R.C. 5; (d,j) Cyd*-8 
R.C. 4; (e,f,Jc,l) two sensitive revertants of Cyd^ lO, K.c. 
5; (d,u) Cyd^ 8 R.C. 4; (e,f,k,l) two sensitive revertants 
of Cyd®-10 as in (3). Arrows point to band migration dif­
ferences at MWs of 210,000, 190,000, 125-140,000, 104,000, 
92,000 and 42,000. MW standards (xl0~^ ) in the center lane 
of (2) and (4) «md to the left of lane a in (1)) 
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Figure 14. SDS-PAGE analysis of cell membrane proteins of AK 412, Cyd -varisints and a CD-
sensitive revertant labeled with ((a-f) 72 hrs in nonselective medium; (g-1) 
48 hrs in nonselective medium, (a,g) CHOj (b,h) Cyd®-10, R.C. 1; (c,i) Cyd^ lO, 
R.C. 4; (d,j) Cyd^ -8, R.C. 4} (e,k) Cyd^ lO, S.C. 2 (a sensitive revertant of 
Cyd^ lO; (f,l) Cyd^ lO, S.C. 3. Differences in the migration of bands at approximate 
MWs of 210,000, 190,000, 123-145,000, 104,000, 93,000 and 42,000 (arrows to the left 
of lane a) are seen for CHO AK 412 (lanes a,g) compared to Cyd®-8 and Cyd^ lO (lanes 
b-d and h-j). Two CD-sensitive revertants (lanes e,f and k,l) migrate more like the 
Cyd^ -variants than the AK 412 parent. Molecular weight standards are given in 
t h e  c e n t e r  l a n e  ( x  1 0 " ^ ) )  
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Analysis of surface membrane proteins from 2 CD-sensitive revertants 
reveal that the labeled proteins migrate like the membrane proteins of 
the Cyd^ -variants and not like those of the AK 412 parent (Figures 13, 14). 
This somewhat surprising result may seem to lessen the importance of 
these surface membréme proteins in mediating the Cyd -phenotype. How­
ever, results obtained with metabolic labeling of cell surface glyco­
proteins contradict this conclusion. 
The results obtained from cells labeled in suspension are signifi­
cantly different from those obtained in monolayer (Figure 13a). Some 
bands which were present in monolayer are either absent or in reduced 
Eunounts in suspension, and there are several bemds labeled in suspension 
which are not present in monolayer. In Figure 13a, it can be seen that 
bands with approximate MWs of 125,000 and 92,000 are much more intensely 
labeled in the CydR-variants compared to the AK 412 parent. Also, a band 
with an approximate MW of 170,000 is present in two Cyd -variants (Cyd -
10, Cyd -8), but is either absent or present in greatly reduced amounts in 
AK 412. Other differences in low MW proteins are seen as well. Tlie 
surface proteins of CHO and Cyd -variemt lines were compared at dif­
ferent cell densities (Figure 16). 1 x 10® cells were plated in 100 
125 
mm tissue culture dishes and labeled with [ I] every 24 hrs. The 
results of Figure 16 show that there are a number of changes in cell 
surface proteins as cells go from sparse (Figure 16a,a*) to semi-
confluent (Figure 16b,c,b*,c*) to confluent (d,d*) cell densities. 
The sequence of changes in labeling are nearly identical in AK 412 
and Cyd^ -8, demonstrating that the lesion conferring CD-resistance is 
125 Figure 15. Comparison of I X]-labeled surface membrane proteins of CHO 
and Cyd^ l^O, R.C. 1 on a 7% polyacrylamide gel- ((a,c,e,g,i) 
CydR-10, R.C. 1. (b,d,f,h,j) CHO AK 412. The alternating 
step pattern vividly demonstrates the altered migration of 
bands at approximate HWs of 210,000, 190,000, 123-145,000, 
104,000, 92,500 and 42,000. (a,b) 24 hrs after plating in 
1 ptg/ml CD. (c,d) 96 hrs after plating in nonselective 
medium. (e,f) 72 hrs in nonselective medium; (g,h) 48 hrs 
in nonselective medium. (i,j) 24 hrs in nonselective 
medium) 
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Figure 16. Changes in [ I]-labeled cell surface proteins (glycoproteins) with increasing 
cell density ((a-e) CHO AK 412 24 hrs: (a), 48 hrs, (b) 72 hrs, (c) and 96 hrs 
(d) after plating in nonselective medium There are a number of changes in the 
labeling pattern as cells become more confluent and eventually reach confluency 
(arrows to the left of lane a). In (e), cells at 72 hrs had the nonselective medium 
removed and medium containing 1 yg/ml CD was added. Cells were labeled with I 
24 hrs later. At least two differences in the labeling pattern between cells in 
nonselective and selective medium are observed. First, a band of approximate MW 
of 33,000 appears in cells treated with 1 yg/ml CD (arrow to the right of lane e). 
Secondly, a band of approximate MW of 46,000 is lost in cells treated with 1 
yg/ml CD. (a*-e*) Cyd^ 8 with the same time points as for CHO AK 412 (a-e) . 
The shifts in bands minic those seen in AK 412, although the faint band seen in 
lanes b-d at 46,000 is absent in b*-d*. Molecular weight standards are given in 
the center lane (x 10"3). 7% polyacrylamide gel, 4% stack) 
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not the result of a defect in cell proliferation or cell surface dif­
ferentiation. Secondly, the results demonstrate that, in confluent 
cells cultured in 1 yg/ml CD for 24 hrs, there is at least one or more 
changes in cell surface iodination. In Figure 16e and 16e*, it can 
be seen that a band of approximate MW of 33,000 is labeled only in 
AK 412 cells treated with 1 yg/ml CD. In addition, there may be a 
loss of a band at approximately 46,000 MW. Interestingly, the 46,000 
MW band is present in Cyd -8 only in very sparse cell populations (Figure 
16A*). In addition, the band at 33,000 MW is either not labeled or 
only slightly labeled in Cyd -8. This is the first report of an af­
fect of cytochalasin on the ability to label membrane proteins with 
125 [ I]. The significance of this observation is unknown. 
b. Labeling of cell surface glycoproteins with [^ H] NaBH^  
In order to obtain a significemt amount of labeling, this technique 
requires that cells be treated first with neuraminidase to remove termi­
nal sialic acid residues. When this technique is used on cells in mono­
layer, the cells lyse and/or detach. Consequently, cells were labeled 
3 
with ( H] NaBH^  only in suspension culture. No significant differences 
R 
were seen between the CHO parent and the Cyd -variant by this method 
(Figure 17). 
3 
Figure 17. [H] -NaBH^ -labeled plasma membrane glycoproteins of CHO  ^
and Cyd®-variant cell lines ((a,d) CHO AK 412; (b,e) Cyd -
10; (c,f) Cyd^ -S. 15,000 cpm were loaded on lanes a-c 
and 10,000 cpm loaded on lanes d-f. Molecular weight 
standards are given in the center lane (x 10"^ )) 
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c. Metabolic labeling of membrane glycoproteins 
Several membrane glycoprotein differences are observed when AK 412, 
Cyd -variant and CD-sensitive revertant are labeled with either [ H]-
3 3 
glucosamine or I H]-fucose (Figure 18). .In cells labeled with [ H]-gluco-
samine, a 90,000 MW glycoprotein is present in the variants and a sensitive 
revertant which is absent in the CHO parent (Figure 18). One of two 
Cyd^ -variants along with the sensitive revertant show enhanced labeling 
of a 190,000 MW glycoprotein. The 190,000 MW band migrates slower in the 
Cyd -variants than the sensitive revertant or the AK 412 parent. 
3 When Icibeled with either I H]-glucosamine or -fucose, the Cyd -
variants have significantly enhanced labeling of a glycoprotein of 140,000 
MW. The degree of labeling is significémtly reduced in AK 412 and the 
sensitive revertant (Figure 18). In addition, the glycoprotein at 
140,000 MW as well as ones of 190,000 emd 225,000 MW, migrate slightly 
R 
slower in the Cyd -variemts. The same bands migrate faster in AK 412 
and slightly faster for the CD-sensitive revertant. 
Thus, there are significant differences in cell membrane glyco­
proteins between the AK 412 cells and Cyd^ -variemts. The large number 
of differences observed, depending on the technique used, makes it 
difficult to interpret which change(s) is responsible for the Cyd -
phenotype. The equivocal results observed with the CD-sensitive re-
vertants further complicates the identification of glycoprotein(s) 
involved in CD resistance. Most likely, there is a change in the 
activity of an enzyme that regulates the level of glycosylation of 
membrane glycoproteins, and that is responsible for the Cyd^ -phenotype 
Figure 18. Fluorogreun of polyacrylamide gel (10-15% linear gradient) of cell surface 
glycoproteins labeled metabolically with j3j -fucose or [%]-glucosêunine 
((a,c,e,g) cells labeled with [%]-glucosamine. (b,d,f and h) cells labeled 
with [%]-fucose. (a,b) CHO AK 412; (c,d) Cyd®-8 R.C. 3, S.C. 4, S.C. 5 (a 
twice subcloned CD-sensitive revertemt of Cyd -8, R.C. 3); (e.f.) Cyd^ -10; 
(g,h) Cyd®^ 20. The two upper arrows point to bands of approximate MW's of 
220,000 and 190,000 which migrate slightly faster in CHO (lane b) compared 
to the Cyd^ -10 and -20 (lanes f and h). In the CD-sensitive revertant, these 
two bands migrate slower than CHO but slightly faster than Cyd®-10 and -20. 
At an approximate MW of 140,000 there is a band that migrates slower in the 
CydR-variants (lanes e-h) and is more highly l^ eled compared to AK 412 (a,b) 
and the CD-sensitive revertant (c,d)(large arrows). A band of approximate 
MW of 90,000 is present in the CD-sensitive revertant and Cyd^ lO and -20 
which is absent in CHO (the double-headed arrow). Molecular weight 
standards are given at the left (x 10"3)) 
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(see Discussion). 
11. Chromosomal analysis 
The Cyd -variants share several phenotypic characteristics which are 
commonly found in other exeutples of drug resistance mediated by gene 
amplification (pp. 38-77). These characteristics include: (1) gradual 
loss of the resistant phenotype from the population when the resistant 
population is subcultured in nonselective medium; (2) loss of the 
resistant phenotype occurs in a similar time period (i.e., a few months); 
(3) the longer T^  of the drug resistant cells con^ ared to the parent; 
and (4) the apparent return to a "normal" (like the parental popula­
tion) phenotype upon "reversion" to CD sensitivity. 
It has been demonstrated that drug-resistant mutants containing 
an amplified gene usually contain DMs or an HSR(s) (Schindce, 1981). Those 
structures are usually absent in the wild-type parent and are lost in 
drug-sensitive revertants. Consequently, Cyd -8 and Cyd -10 were care­
fully examined cytologically by aceto orcein and trypsin-Giemsa banding 
techniques. All CD-sensitive and CD-resistant cells had the same modal 
chromosome number of 20. However, all six subclones of the two Cyd -
variants have a novel HSR (Table 17, Figures 19-22). The HSR is located 
at the end of the long arm of chromosome #1 and is unique in that there 
are a variable number of bands (1-6) distal to the HSR. If one cuts a 
photograph of chromosome #1 in the middle of the HSR and then reverses 
the distal portion so that the two HSR halves are side-by-side, there 
is an almost one-to-one correspondence in bands (Figure 20). In some 
Table 17. Summary of HSR and ring chromosome number in seven independent lines of two Cyd -variants, 
the AK 412 parental line, and a CD-sensitive revertant 
Cell lines 
No cells with rings/ 
total examined 
Number cells with HSR® 
total examined 
Parent 
AK 412 2/64 (3%) 0/33 
Original isolates 
Cyd*-8 
Cyd^ -lO 
0/34 
0/39 
30/34 
21/39 
(88%) 
(54%) 
CD-resistcmt subclonal lines 
Cyd^ 8, R.C. 1-1 
Cyd^ -8, R.C. 1-5 
Cyd^ -10, R.C. 3® 
Cyd^ -10, R.C. 3-3 
Cyd^ -10, R.C. 3-5 
9/68 
9/63 
15/71 
11/62 
1/53 
(13%) 
(14%) 
(21%) 
(18%) 
(2%) 
5/7 
ND^  
7/7 
5/6 
6/7 
(71%) 
(100%) 
(83%) 
(86%) 
CD-sensitive revertant line 
Cyd^ -8, R.C. 1, B.C. 5 9/22 (41%) 1/69 (1.4%) 
S^R on the long arm of chromosome 1, detected by Giemsa banding, 
b. Original isolate, twice subcloned in nonselective medium. 
'Subcloned twice in OS-ICD, after growth in nonselective medium. 
N^ot determined. 
'Subcloned once in as-lCD, after growth in nonselective medium. 
I^solation is described in Materials and Methods. 
Figure 19. Karyotypes of AK 412 (D) and Cyd -8 (A-C) (Arrows 
indicate HSR in chromosomes Iq. Note 2 HSR regions on 
chromosone 1 in (C). (A, x 500 : B-D, x675)) 
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Figure 20. Banding patterns distal to the HSR look like inverted 
repetitions of banding patterns between HSR and the 
centromere. Trypsin-Giemsa banded chromosomes from 
preparations of Cyd®-8 (A-D) (Chromosome 1, containing 
«m HSR (arrow) was cut at the arrow and inverted, showing 
a concordance of bemds on both sides of the HSR. In C, 
there are 2 HSRs. HSR was cut at the upper arrow. 
(C,D, X 1000: A,B, xl200)) 
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Figure 21. Trypsin- Giemsa banding of a Cyd -8 metaphase (Metaphase of 
Cyd^ S showing HSR on the long am of chromosome 1 (arrow) 
xllOO) 
199 
Figure 22. HSRs on chromosome #1 (Trypsin-Giemsa banded metaphase of 
Cyd^ S showing 2 HSRs on the long arm of chromosome 8 
(arrows) (Also note the presence of 2-4 constrictions 
(centromeres) on chromosome 1, xl090) 
201 
%5@ 
^ 
;u»>«nS5 .^'.•>«•••'«. 
•*1 
Kg< 
202 
cases, 2 HSRs were observed on the long arm of chromosome 1, with a 
small number of bands separating the HSRs (Figures 19, 20c, 22). The 
bands separating the 2 HSRs may be identical to the bands distal to the 
second HSR. No HSR has been observed in cuiy of the parental control 
metaphases examined (Table 17). 
The number of DMs in the drug-resistant vs. parental lines was also 
examined (Table 18). The Cyd -variant lines, as well as a drug-sensitive 
revertant, have a higher percentage of cells with DMs than the parental 
line, although this varied considerably depending on the resistant clone 
used, the cytological preparation, and the amount of time in non­
selective medium. In AK 412 and all of its derivative lines, few DMS were 
observed. This contrasts with the large numbers of DMs per cell (10 to 
1000) seen in some mouse lines and cancer lines (Barker and Stubblefield, 
1979; George and Powers, 1981; Schimke, 1981); for example neuroblastoma 
(Baskin et al., 1981; KcUio-Janaka et al., 1982) or SEWA (Levan et al., 
1976, 1977, 1981). When DMS were observed in AK 412 and variant sublines, 
they usually occurred in the range of 1 to 4 per cell. The percentage 
of parental CHO cells with DMs reported here is higher than previously 
reported by others (Kaufmcui and Schimke, 1981; Kuo et al., 1981). In 
one unique metaphase of CHO parental cells, there were over 1000 DMs 
as well as numerous chromosomal abnormalities, including acentric frag­
ments and a "meiotic-like" configuration similar to a triradial (Figure 
23). 
A 4- to 13-fold increase in the number of ring chromosomes is found 
in metaphases of five of seven variant lines as well as in the CD-sensitive 
Table 18. Incidence of double minute chromosomes (DMs) in AK 412, Cyd -10, Cyd -8, and a 
CD-sensitive revertant 
Number of cells with DMs/ 
total metaphase cells 
excunined 
Total number 
DMs 
Average DMs 
per cell 
Parent 
AK 412 
CD-resistant lines 
C^ d®-10 
Cyd^ -8 
CD-sensitive line 
1^  
Cyd -8, R.C. 1, 
S.C. 5 
4/25 (16%) 
17/37 (46%) 
14/21 (67%) 
10/22 (45%) 
10 
32 
18 
2.5 
2 
1 
14 
Figure 23. Trypsin-Giensa banded netaphases ((A) large numbers of DM 
chromosomes (arrows) in a very rare cell of AK 412 (x500); 
(B and C) ring chromosomes in a CD-sensitive revertant of 
Cyd^ 8 (R.C. 1, S.C. 5) (x470) ; and (D) a ring chromosome 
in Cyd^ -8 CD-resistant R.C. 3 (x890)) 
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revertant (Table 17). The greater frequency of ring chromosomes may 
indicate a heightened genomic instability. The ring is always quite 
large (Figure 28B-D), and the ratio of length of the ring to the length 
of chromosome 1 ranges between 0.8 to 1.1 
12. Isolation of cytochalasin D-sensitive revertants 
In order to determine which phenotypic characteristics of Cyd^ -
varicuits result from, or are closely associated with, the membrane 
lesion conferring CD resistance, CD-sensitive revertants of newly 
purified CD-resistant subpopulations were isolated. Although the method 
used to isolate CD-sensitive revertants is not a true single-step selec­
tion it nonetheless closely approximates a single-step selection (e.g., 
<20 generations after isolation of fully CD-resistant subline). The 
method used for "single step" selection of CD-sensitive revertants is out­
lined in Figure 25. A fully CD-resistant subline, purified as described 
in Methods and Materials, wcis isolated. The fully resistant line was 
recloned in both selective and nonselective medium. The cloning ef­
ficiency of the CD-resistant subclone line was determined as described 
in Methods and Materials. After 6-10 days, when clones in nonselective 
medium were visible, the nonselective medium was removed. Selective medium 
was added to the flasks and the clones were incubated at 37° for 1-4 
hours. The clones were then examined under the inverted microscope, and 
clones exhibiting CD-sensitive morphology were marked and the picked. 
Sensitive-revertant clones are distinct in morphology from CD-resistant 
clones (Figures 26, 27). CD-sensitive cells, as described previously, 
contract, form retraction fibers, and have protruding nuclei. 
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Start with a CD-resistant population or subline (<20 generations 
in nonselective medium) I 
2 
Plate 100 cells/25-cm 
Tissue culture flask 
5 flasks contain 1 yg/ml CD 
5 flasks contain nonselective medium 
Allow to grow 6-10 days, 37°C, 5% CO 
Remove nonselective medium from control flasks and add medium 
containing 1 Pg/ml CD. Inci^ ate 37®, 1-4 hrs 
Observe under inverted, phase contrast 
microscope 
Pick clones exhibiting CD-sensitive morphology. 
These will be rare segregants 
Grow to confluency for further testing 
Figure 24. Single-step method for isolation of CD-sensitive 
revertants from a CD-resistant cell line 
R 
Figure 25. Example of a CD-resistant clone ((a) Cyd -8 cell clone in 
nonselective medium, (b) same clone after removal of non­
selective medium and addition of 1 V>g/ml CD for 4 hrs. 
Cells are slightly contracted but otherwise retain a normal 
morphology. Phase contrast, X1180) 
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Figt re 26. Example of a CD-sensitive revertant clone ( (a) Cyd -8 
cell clone in nonselective medium, (b) Scune clone 1 hr 
after addition of 1 ]ig/ml CD. Most cells are contracted 
and exhibit CD-sensitive morphology, including retraction 
fiber formation amd protruding nuclei. Phase contrast, 
X1180) 
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The phenotypic characteristics of the CD-sensitive revertants are 
summarized in Table 19. The following phenotypic characteristics are 
lost concordantly in the CD-sensitive revertants; (1) CD resistance; 
(2) cross resistance to other drugs; (3) longer T^  in nonselective medium; 
(4) increcised levels of multinucleate cells; (5) the presence of an HSR 
on the long arm of chromosome 1; and (6) enhanced labeling (by (^ H) 
glucosamine and (^ H) fucose) and/or slower migration of membrane glyco­
proteins of approximate MWs of 140,000, 170,000 and 190,000. This last 
125 
conclusion is tentative in light of the results with I léibeling. 
Table 19. Summary of CD-sensitive revertant phenotype 
CD-sensitive % Multinucleates i to cell surface 
line 
HSR on Cross-resistance Loss of altered 
to cell surface 
other drugs glycoproteins 
Cyd^ -10 
S.C. 1 15 hrs 5.2 N.T. N.T. No 
S.C. 2 15 hrs 5.4 N.T. N.T. No 
Cyd*-8 
S.C. 4, S.C. 5° 14.5 hrs 3.2 No No Yes^  
N^ot tested. 
S^ee Figure 14 and Results for explanation. 
°Twice purified sensitive revertant. 
'^ See Figure 18 and Results for explanation. 
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V. DISCUSSION 
A. %e Mechanism of CD Resistance 
The original goal for selecting CHO cells resistant to cytochalasin 
was to isolate cells with a lesion(s) in the primary cellular target of 
cytochalasin, presumably the F-actin microfilament system. However, re­
sults from three separate experiments show that the CD resistance of the CHO 
variants selected is due to reduced membrane permeability for CD. First, 
a [^ H]CB binding assay demonstrated at least a 4-fold reduction in 
3 R binding sites or uptake of [ H,]CB in whole cells of Cyd -variants com­
pared to those of AK 412. No difference in for I^ HJCB by intact 
Cyd -variant or AK 412 cells was found. In contrast, there was no dif­
ference in either the or the number of binding sites in extracts 
(soluble and membrane-particulate) of CHO AK 412 compared to the Cyd -
varicmts. This binding assay measured CB, êind not CD, binding and up-
take. Inasmuch as the Cyd -variants are at least 2-fold more resistant 
to CB, the 4-fold reduction in CB binding sites is reasonable. It is 
also reasonable to infer that the mechanism underlying CB resistance 
is also responsible for CD resistcince. This can be inferred because, 
with the exception of the glucose transport site, CB cuid CD possess 
the same cellular binding sites. Secondly, CD-sensitive revertants 
are also sensitive to CB. Thus, this experiment suggests that CD 
resistance is due to a reduction in the number of "binding sites" or 
permecibility to CD. 
To prevent confusion, it should be noted that the 4-fold reduction 
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in "binding sites" for CB does not necessarily mean that there is a 
reduction in the number of membrane binding sites for CB; i.e., these 
results do not inply that there is a specific protein receptor for CB 
which is responsible for intracellular transport of CB. This experi­
ment only measures the amount (in pinoles) of CB bound or taken up by 
whole cells per mg of cellular protein. Differences in the amount of 
[^ H]CB bound or taken up by different cell lines do not give any in­
formation on the mechanism of CB entry. 
Since CB (and not CD) binds to cuid inhibits sugar transport sites, 
3 
it might be suggested that the 4-fold reduction in binding of [ H]CB 
is due to a reduction in the number of glucose transport sites. How-
ever, this is clearly not the case. First, the Cyd -variants were 
selected against CD, which does not bind or inhibit glucose transport 
sites. Thus, there is no reason to expect a decrease in the number of 
glucose tramsport sites. Secondly, the differences in whole cell binding 
(or uptake) of [^ H]CB were differences in CD-displaceable binding sites 
(or uptake). Since CD does not bind to glucose transport sites, it 
does not displace CB from this site. Thus, the differences measured 
were in CB-sepcific, nonglucose "binding" sites. 
The Cyd^ -variants are cross-resistant to structurally and func­
tionally distinct drugs. They are 6 to 7-fold more resistant to 
colcemid (a microtubule poison) and 10 to 12-fold more resistant to 
actinomycin D (a DNA intercalator which inhibits DNA and RNA synthesis), 
Drug cross-resistance is a common characteristic of drug uptake and 
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efflux mutants (see pp. 20^25) .  In addition, the CD-resistant variants 
are 2.2-fold more sensitive to the membrane anesthetic procaine. This 
observation is consistent with the conclusion that a change in membrane 
permeability is responsible for CD resistance. 
1^  
Finally, CD sensitivity of the Cyd -variants is increased (po­
tentiated) by 100 yg/ml Tween 80. It was shown that potentiation of CD 
sensitivity was not due to toxicity of Tween 80, since the plating 
efficiency in 100 yg/ml IVeen 80 was unchanged compared to controls. 
IWeen 80 has been previously shown to increase drug sensitivity in drug 
permecibility mutants (see p. 23 and Stavroskaya et al., 1975). 
Taken together, these results demonstrate that CD-resistance (and 
presumably drug cross resistance amd collateral sensitivity) is medi­
ated by a change in the plasma membrane that reduces permeability for 
CD or transport of CD. 
B. Genetic vs. Epigenetic Nature of the Lesion 
Conferring CD Resistance 
The criteria used to define a "true" somatic cell mutant have been 
described previously (see pp. 6-14). Unfortunately, none of these 
criteria have been met and/or tested in the Cyd -variants. Because an 
enrichment selection technique was used, it was not possible to deter­
mine the frequency of CD-resistant variants in the AK 412 population, 
or to test whether mutagens can increase variant frequency. In tests 
for phenotypic stability, it was found that resistance to CD was lost with 
time in nonselective medium (Table 6) . TOiis result can be interpreted 
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as indicating that CD-resistance is due to an epigenetic event, and 
not to a classical mutation. However, three separate experiments demon­
strated that loss of CD-resistance was due to segregation of CD-sensi­
tive cells from the CD-resistant population, combined with selection 
against the CD-resistant cells in nonselective medium (Figures 7 and 8). 
No cells with intermediate levels of CD were observed, unlike examples 
of "enzyme induction" in MTX-resistant cells (Bertino et al., 1981). 
These results are consistent with a genetic basis for CD resistance, 
and demonstrate cellular inheritance of the Cyd -phenotype. 
R 
Although altered cell surface glycoproteins are found in Cyd -
variant cells, it is not clear that these changes are due to the primary 
lesion mediating CD-resistance. Also, it is not clear what gene(s) are 
responsible for these glycoprotein differences. 
As of yet, no change in DMA sequence has been demonstrated in the 
Cyd -variant lines compared to the AK 412 parent. However, a unique 
HSR on the long arm of chromosome 1 (Figures 19-22) is present ex­
clusively on CD-resistant cells, and is absent in AK 412 parental cells 
and in CD-sensitive revertants. The consistent presence of an HSR on 
a chromosome of a drug-resistant cell line and its absence or diminution 
in drug-sensitive revertants is considered very strong (although not con­
clusive) evidence that gene an^ lification is the molecular (genetic) 
event underlying drug resistance (see section: Gene Anplification). Con­
clusive evidence of gene amplification as the mediator of drug resistance 
requires identification of the gene product and demonstration of increased 
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levels of the gene product, mRNA, and gene copy number in the drug-
resistant mutants. In addition, the causal link between increased 
levels of gene product and drug resistance must be demonstrated. 
It is possible to invoke an epigenetic mechanism to explain CD 
resistance. There may exist a gene that either metabolizes (modifies 
and inactivates) cytochalasin, or a gene that controls plasma membrane 
uptake of CD, This gene may be "turned off" in wild-type cells by the 
mechanisms described on pages 7-11 (such as hypermethylation of the 
gene). Enrichment selection in CD may select and enrich for cells that 
have "turned on" the gene by hypomethylation or other epigenetic mech­
anisms. In the absence of selection, cells that have turned off the 
gene by hypermethylation (and are thus CD-sensitive) would have a selec­
tive advantage over CD-resistant cells. The selective advantage(s) 
would be the same one(s) described in the results section (p. 141); a 
shorter T^  in nonselective medium eund significeuitly fewer multinucleate 
cells. This mechanism assumes that the HSR on chromosome 1 is either 
not related or only peripherally related to the Cyd -phenotype. 
C. Analysis of the Cyd^ -phenotype 
The Cyd -variants have many phenotypic characteristics associated 
with CD resistance. These phenotypic characteristics include: (1) a 
longer T^  in nonselective medium; (2) a 5- to 10-fold higher per­
centage of multinucleate cells in the population, presumably due to a 
partial lesion in cytokinesis ; (3) cross-resistance and collateral 
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sensitivity to structurally and functionally distinct drugs; (4) altered 
cell surface morphology; (5) altered adhesive properties, such that 
there is an increêise in cell-cell and cell-substrate adhesiveness; (6) 
reduced membrane pliability (i.e., increased membrane fragility); (7) 
changes in the pattern of cell surface glycoproteins; and (8) the 
presence of a novel HSR on the long arm of chromosome 1. 
As a result of these observations, a question immediately arises. 
Are all of these phenotypic characteristics pleiotropic, that is, are all 
of these characteristics "coded for" by the seune gene? Results shown 
in Figure 7 indicate that the longer and the partial defect in cyto­
kinesis are intimately associated with the lesion conferring CD resistance. 
Data from the isolation of CD-sensitive revertants also suggest that the 
longer T^ , the presence of an HSR on the long arm of chromosome 1, CD 
resistance, and drug cross resistance are under the control of the same 
gene; presumably the gene an^ lified on chromosome 1. Furthermore, the 
results tentatively suggest that altered cell-surface glycoproteins and 
the partial lesion in cytokinesis are also associated with CD resistance 
and the HSR on chromosome 1. However, the results are equivocal on 
these latter two points, and further experimentation is necessary. The 
other phenotypic characteristics were not tested in drug-sensitive re­
vertants (e.g., altered cell surface morphology, cellular adhesiveness, 
membrane fragility). The important point is that a technique has been 
developed which will detect CD-sensitive segregants within a few (less 
than 20) generations after isolation of fully CD-resistant subclones. 
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It is possible that one of the characteristics of the Cyd^ -variants, 
collateral drug sensitivity to procaine (emd perhaps other drugs not 
yet tested), can be utilized to select emd isolate drug sensitive re-
vertants by a single step. CHO AK 412 can clone in procaine concen-
trations of .3 and .4 yg/ml, whereas Cyd -variants do not clone in con­
centrations of procaine eibove .25 yg/ml. Consequently, it should be 
R 
possible to subclone Cyd -variants in 1 yg/ml CD, grow the subclones 
to confluency in 1 yg/ml CD, remove selective medium and add non­
selective medium. At Vcurious time points (e.g., every cell generation), 
the cells could be cloned in concentrations of procaine that only allow 
CD-sensitive revertant cells to form colonies. This would allow a 
quantitative measurement of the frequency of CD-sensitive segregants 
and would essentially result in single step selection of CD-sensitive 
revertants. 
It is difficult to envision the relationship between the other 
Cyd -variant characteristics and CD resistance. In the form of a ques­
tion, why would cells with reduced permeability or uptcdce of a certain 
drug (such as cytochalasin) also have altered adhesive properties, no 
blebs, fewer microvilli, etc.? There are a nunOser of possible answers 
to this question. The simplest explanation is that the other pheno-
typic characteristics are not related to CD resistance, and are the 
result of a secondary mutation(s) totally unrelated to CD resistance. 
One of the disadvantages of enrichment selection is the increased 
likelihood of isolating mutants with more than one mutation. However, 
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drug cross-resistance, altered cell surface morphology, changes in 
cellular adhesive properties, reduced membrane pliability, and changes 
in cell surface glycoproteins are commonly observed in other drug 
uptake/ permeability mutants (see pp. 18-38). 
It may be that the genetic lesion responsible for CD resistance 
R 
also confers altered cell morphology and adhesion, etc., i.e., the Cyd -
phenotypic characteristics are pleiotrophic. The data obtained thus far 
support this conclusion. However, these other phenotypic changes (e.g., 
altered adhesive properties, altered cell surface morphology, etc.) may 
have no role in CD resistance and may be only secondary changes asso­
ciated with the change in mendarane structure necessary for CD-resistance. 
In this case, the advantages of. CD resistance outweigh any disadvantage 
of altered surface morphology, adhesiveness, reduced membrane pliability 
etc., as long as the cells are in em environment containing cytochalasin. 
I would like to suggest an intriguing, alternative exclamation to 
the question about the role of cell morphology, cell adhesion, a partial 
defect in cytokinesis, membrane fragility, etc. Perhaps many or all the 
changes induced by the CD lesion contribute to CD resistance. For 
example, increased cell-cell emd cell-substrate adhesion may reduce the 
cell surface area exposed to the extracellular medium, and thus reduce 
contact with drug. The inability to form blebs and the reduction in 
microvilli would have the same effect, i.e., reduction of cell surface 
area exposed to the extracellular medium. It is harder to rationalize 
the advantage of a partial defect in cytokinesis or a decrease in membrane 
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pliability. Perhaps this is part of the "price" a cell must pay in 
order to deal with a severe environmental stress (the presence of a 
drug). Or maybe there are some hidden advantages to these characteris­
tics as well. 
If this third eiqplanation is correct, it becomes obvious that there 
are other disadvantages to the Cyd -phenotype in nonselective medium 
besides the ones already enumerated. For example, Cyd^ -variant cells 
in nonselective medium will have reduced uptake of necessary meta­
bolites due to the reduction in cell surface area in contact with the 
extracellular medium. 
It may be significant that so many drug uptake and efflux mutants 
have pleiotropic drug cross-resistémce. Host of the drugs that cells 
display cross-resistance to are produced by moulds (fungi) or bacteria. 
Thus, the gene(s) mediating drug resistance may be ancestral eukaryotic 
gene(s) which confers survival in an environment containing many toxic 
metabolites. 
D. Biochemical Changes Associated with CD 
Resistance 
A number of differences in cell surface glycoproteins were found in 
the Cyd^ -veuriants compared to the AK 412 parent. All of the changes were 
of the same type, that is, cell surface glycoproteins of the Cyd -
variants migrated slightly slower in SDS-polyacrylamide gels than the 
same glycoproteins of the CHO parent. This suggests that the glyco-
proteins of the Cyd -variants are higher in MW than the corresponding glyco-
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proteins of the parent.. The glycoproteins of the Cyd -variants may have 
more carbohydrate moieties covalently attached, increased levels of phos­
phorylation and/or other modifications (such as methylation, ADP-
ribosylation, etc.), that would increase the molecular weight of glyco­
proteins . 
Previous reports on drug uptake mutants have correlated reduced 
drug uptake with changes in cell surface glycoproteins and glycolipids 
and/or changes in the degree of phosphorylation of cell surface glyco­
proteins (see pp. 25-38). However, no gene product (enzyme or struc­
tural protein) has been positively associated with reduced drug uptake. 
A model showing how plasma membréuie drug permeeJaility could be modu­
lated by changes in glycosylation cuid phosphorylation levels of cell 
surface glycoproteins has been described previously (pp. 32-35). The 
R 
changes in cell surface glycoproteins observed in the Cyd -variants are 
consistent with changes found in other drug uptcUce mutants isolated in 
hamster and nonhamster cell lines. 
The results from the analysis of cell surface glycoproteins of drug-
sensitive revertants are equivocal. lodinated membfane glycoproteins of 
CD-sensitive revertants migrate (on SDS-polyacrylamide gels) identically 
to those of the Cyd -variamts, whereas glycoproteins labeled metabolically 
with either [^ H]-glucosamine or [^ H]-fucose migrate like AK 412 parental 
cells and not like the Cyd^ -variants. There may be a simple explcmation 
for these results. For example, the CD-sensitive revertants labeled with 
were from Cyd^ -10, and the sensitive revertants labeled metabolically 
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were from Cyd -8. The differences in membrane glycoproteins between the 
two sensitive revertant lines may reflect differences in the genotype 
R R between Cyd -8 and Cyd -10 and/or their sensitive revertants. Only 
further experimentation can resolve this question. 
I would like to suggest an alternative explanation for the dif­
ferences between [^ ^^ I]-labeled glycoproteins of Cyd^ -10 sensitive re-
vertants and metabolically-labeled glycoproteins of Cyd -8 sensitive 
revertants. Perhaps these differences were due to the different lengths 
of time the CD-sensitive revertants were maintained in culture before 
labeling of cell surface glycoproteins. The CD-sensitive revertants 
labeled by iodination were labeled almost immediately after their re­
trieval (i.e., less than 20 generations after isolation of CD-sensitive 
revertants). The CD-sensitive revertemts labeled with [^ H]-fucose and 
[^ H]-glucosamine were labeled more than 30-40 cell generations after 
isolation. 
I would like to propose that increased glycosylation of membrane 
glycoproteins on the Cyd -variants significantly lowers their turnover 
rate. Previous studies of the role of glycoprotein moieties on cell 
surface proteins (such as the acetylcholine receptor) involved blocking 
glycosylation by growing cells in tunicamycin. Tunicamycin blocks the 
first step in glycosylation of asparagine-linked glycoproteins. Conse­
quently, many proteins, including cell surface proteins, are "sugar-
free". It was found that "sugar free" membrane proteins were still 
inserted through the membrane in the correct orientation and still 
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retained normal receptor function. Numerous experiments with tunicamycin-
treated cells have led to the conclusion that the sugar moieties on 
glycoproteins serve two in^ ortant functions: 1) protection of glyco­
proteins from protease degradation; and 2) the carbohydrate moiety of 
many glycoproteins functions as a "tag" which defines the route of 
intracellular transport (Parent et al., 1982; Newton et al., 1982; 
Bernard et al., 1982). The half-lives of some glycoproteins are often in 
days, or even weeks, while the half lives of the same proteins without 
sugar moieties are in minutes. 
If the Cyd^ -variants have amplified a gene that increases the amount 
of glycosylation of specific menû)rcuie glycoproteins, the turnover rate 
of these glycoproteins may be significantly longer. When the amplified 
genes (in the form of an HSR) were lost, newly synthesized glycoproteins 
would eventually contain the "basal" level of sugar moieties and would 
turnover at normal rates. However, the "over-glycosylated" glyco­
proteins may be retained in the drug-sensitive revertants for a pro­
longed period of time. First, there may be a lag period until the levels 
of amplified mRNA and protein (the protein enzyme) responsible for in­
creased glycosylation (such as a glycosyItrans ferase) are returned to 
control levels by cell division (dilution) and turnover. Secondly, some 
cell surface glycoproteins may have a long half life. The "over glyco­
sylated" membrane glycoproteins might turnover at an even lower rate 
than the normal glycoprotein. Thus, at least some of the "abnormal" 
glycoprotein would remain in the cell membrane for extended time periods. 
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Finally, it has been previously observed that actinonycin D-resistant 
L5178Y cells have higher levels of glycoprotein transferases and greatly 
reduced glycosidase activity (Kessel and Bosmainn, 1970). Thus, there 
may be negative control of glycosyltransferases and glycosidases, such 
that when the activity of one increases, the activity of the other is 
decreased. Thus, the combined effects of increased levels of glyco-
sylatrêinsferase, significantly lowered turnover rates of membrane 
glycoproteins, and decreased glycosidases may result in the prolonged 
appearance of highly glycosylated glycoproteins in CD-sensitive re-
vertants. However, there would not be enough of the highly glycosylated 
glycoprotein for CD resistance. Although I have no proof for this 
hypothesis, it can be easily tested by measuring the turnover rates of 
cell surface glycoproteins from AK 412, Cyd -variant, and CD-sensitive 
revertant cells. 
If this hypothesis is correct, it would predict that at least 
some of the Cyd -phenotype would be retained for varying lengths of 
time in CD-sensitive revertants (until the altered glycoproteins were 
completely lost). In this regard, it weis noted that CD-sensitive 
revertants of Cyd^ -10 (the same ones labeled with had 5% multi-
nucleate cells in the population. CD-sensitive revertants of Cyd -8 
had lower numbers of multinucleate cells in the population (2-3%). 
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E. %e Relationship Between the Cyd -phenotype. Changes in 
Cell Surface Glycoproteins, and the Proposed Mechanism 
Underlying CD-Resistance (Gene amplification): A Model 
In the preceding sections, many similarities were noted between the 
Cyd -variant phenotype cuid other drug v^ take and efflux mutants (see pp. 
18-38). These similarities include: (1) the method of selection 
(multiple-step or enrichment selection); (2) a longer in nonselective 
medium; (3) loss of the drug-resistant phenotype during subculture in 
nonselective medium; (4) generalized drug cross-resisteuice; (5) hyper­
sensitivity to certain membrane-specific drugs and hormones; (6) changes 
in cell surface glycoproteins, usually of high MW emd usually involving 
an apparent increase in the MW of cell surface glycoproteins of drug-
resistant cells; (7) increased cell-cell emd cell-substrate adhesion; 
(8) altered cell surface morphology; (9) reduced sensitivity to various 
lectins; (10) decreased membrane pliability; (11) decreased tumori-
p 
genicity (not tested in the Cyd -variemts); (12) the presence of an HSR 
or DMs in drug-resistant cells and their absence in the drug-sensitive 
parent emd drug-sensitive revertants; and (13) loss of all or most of 
these traits in drug-sensitive revertants. 
The literature on drug tgptake and drug efflux mutants has been in 
a state of disarray. The cell lines in which drug uptake and efflux 
mutants have been isolated has varied greatly. In addition, the 
drug(s) used for selection for drug resistance has varied considerably. 
Different aspects of the drug-resistcint phenotype were investigated. 
For example, some investigators have reported on changes in cellular 
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adhesion and/or tvunorigenicity associated with drug resistance. Others 
have looked at changes in cell morphology, membrane glycoproteins, etc. 
Very few investigators have looked at membrane glycolipids, phospho­
lipids or sterols in drug uptake/efflux mutants. No single gene product 
has been definitively associated with the drug-resistant phenotype. 
Only recently has a conçrehensive review been made of drug-uptake 
and efflux mutants (Biedler êind Peterson, 1981). However, no genetic 
or molecular mechanism was proposed to ea^ lain drug resistance except 
for the vincristine-, daunorubicin- and actinonycin D-resistant Chinese 
hamster variamts isolated by the authors. Biedler and Peterson (1981) 
proposed that gene amplification might be the mechanism resulting in 
drug resistance and drug cross-resistance. Recently, Ling and his 
colleagues have suggested that, in retrospect, the colchicine-resistant 
mutants they reported on in 1974 may be an example of reduced drug 
permeability mediated by gene amplification (Debenham et al., 1982). 
I propose the following model for the control of drug uptake by the 
plasma membrane, including a role for the level of membrane protein 
glycosylation in regulating cellular adhesion, cell surface morphology, 
membréine pliability and drug cross-resistance : 
1. Normal drug-sensitive cells have a mechanism for "sensing" the 
presence of a drug(s) in the extracellular environment. Entry of a 
drug into the plasma membreme would result in a localized disruption 
of lipid fluidity or a cheuige in some other property of the plasma 
membrane. The initial membrane change could trigger a secondary cellular 
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response, for example, an Increase in the activity of adenylate cyclase. 
The secondary response results in an increase in the activity of enzymes 
responsible for glycosylation (and perhaps phosphorylation) of cell 
surface glycoproteins (perhaps by a cAMP dependent or independent pro­
tein kinase) such that there is an increase in the amount of one or 
more sugar moieties added to mendsrane glycoproteins. The increased 
glycosylation may be manifested in three ways: (i) an increased frequency 
of addition of sugar moieties to asparagine residues (or perhaps serine 
or threonine residues) that are rarely glycosylated in normal cells; (ii) 
an increase in the amount of one or more types of sugar residues added to 
a particular branch(es) of membrane glycoproteins (e.g., the addition of 
3 or more galactose residues to a particular polysaccharide instead of 
the normal number of 1); (iii) the increased probability that a certain 
sugar species is added to one or more branch points on the carbohydrate 
backbone (e.g., the addition of fucose or sialic acid residues to sites 
that are only rarely conjugated in parental cells). It is possible that 
a combination of these three proposed mechanisms may be used. 
i 
The increased glycosylation of membrane glycoproteins could result 
in reduced drug uptake (permeability or diffusion) in normal cells by 
one or both of the following mechanisms: (a) a change in membrane 
fluidity as proposed by Ling (see section: A Model for Regulation of 
Drug Upteike/Permeability Derived from Studies of Drug-Resistant Somatic 
Cell Mutants, pp. 32-38); or (b) a "sieving" effect, such that the 
increase in cell surface Ccurbohydrate (glycoproteins emd glycolipids) 
induces configurational changes that impede the passage of drug molecules 
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to the plasma membrane (i.e., the cell surface acts as a "net" for the 
passage of drugs into the membrane, the "mesh size" of the net being 
decreased with increased glycosylation). These two proposed mechanisms 
could es^ lain the observations of: (i) a linear relationship between 
the level of resistance to a drug emd the drug's hydrophobicity (mech­
anism (a); also see page 22); and (ii) an increase in drug resistance 
with increasing MW of drug (mechanism (b); see page 22). 
A decrease in mendsrane fludiity (mechanism (a)) could e:qplain the 
degrease in membrane pliability cuid reduction of cell surface micro-
villi and blebs observed in the Cyd -variants. 
Cell surface glycoproteins are important determinants of cellular 
adhesion and cell morphology (Gahmberg, 1981). Consequently, differences 
in cellular adhesion étnd cell morphology cam be induced by modulating 
the activity of enzymes involved in the synthesis of these glycoproteins. 
For exanple, gene amplification mutants of CHO resistant to tunicanycin 
have a 15-fold increase in the activity of UDP-N-acetylglucosamine; 
dolichol phosphate transferase (the first enzyme involved in the syn­
thesis of asparagine-linked glycoproteins). These cells have an 
altered morphology and increéised cellular adhesion (Criscuolo cmd Krag, 
1982). 
2. It is proposed that multiple step or enrichment selection for 
drug permeability mutants favors the isolation of cells that have 
amplified a gene(s) which controls the level of membrane protein (and 
glycolipid) glycosylation and/or phosphorylation. Drug-resistant cells 
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would have reduced permeability to drug(s) by virtue of decreased 
membrane fluidity (mechanism (a)) and/or by a "sieving" effect (mechanism 
(b)). Increased glycosylation of cell surface glycoproteins and glyco-
lipids could explain the pleiotropic phenotype common to mciny drug 
uptake mutants. 
3. Gene amplification is often an "unstable" genetic event. In 
the absence of selective pressure (i.e., in the absence of drug) drug-
sensitive revertants that have lost the amplified gene(s) are at a 
selective advantage compared to drug-resistant cells. Eventually, drug 
sensitive revertants will overgrow and completely supplant drug-
resistant cells. The growth adv«mtage of drug-sensitive revertants in 
nonselective medium has been mentioned previously. 
' Conferral of drug resistance via gene amplification has a "built-in" 
advantage over drug resistêuice miediated by classical mutation. In gene 
amplification mutcuits, as in classical mutcuits, resistance is inherited 
in a Mendelian fashion. However, gene amplification mutcuits have a 
higher frequency of reversion than classical mutants. Also, reversion 
of classical mutants often involves a second mutation at another site 
in the samie gene, or at another gene. Very often, second site re­
vertants are not as "healthy" as the wild-type parent. In contrast, 
loss of drug resistance in gene amplification mutants simply involves 
elimination of extra copies of the amplified gene, with the result that 
no mutations in êuiy gene(s) occur. Thus, drug-sensitive revertants are 
identical in genotype to the wild-type parent. This mechanism of drug 
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resistance involves a rare genetic event (gene amplification) conferring 
drug resistcince and the ability to rapidly lose drug resistance when 
no longer necessary. However, unlike some epigenetic events such as 
enzyme induction, drug resistance mediated by gene amplification results 
in the presence of at least some drug-resistant cells in the population 
for extended lengths of time. Consequently, if a harmful drug is re­
introduced in the environment there is a good chance that one or more 
cells will survive drug challenge. 
4. As previously described, a decrease in overglycosylated glyco­
proteins and glycolipids (after elimination of extra copies of an 
amplified gene) might not be immediate. It may require a period of 
turnover during which the altered glycoproteins (and glycolipids) are 
completely eliminated. 
5. There is probably more than one gene which may increase glyco-
sylation and result in the phenotype typical of drug permeability 
mutcuits. For example, it is possible that modification of proteins (e.g., 
phosphorylation) may promote increased glycosylation of these proteins. 
6. Proteins with increased glycosylation levels may be more sus­
ceptible to other modifications, such as phosphorylation. Such secondary 
modifications may contribute to drug-resistance emd the drug-resistant 
phenotype. 
The model of reduced drug uptake via gene amplification is based 
almost entirely on indirect evidence, and results of limited and pre­
liminary studies. However, no model has been previously presented to 
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account for the pleiotropic phenotype associated with so many reports of 
drug uptake mutants. I believe that the model presents a plausible and 
testable mechanism for this mode of drug resistance. This model can 
be tested directly in the Cyd -variants, and if successful, can be used 
as a basis for analysis of other drug-uptake mutants. 
The major direction of future research should be the isolation of 
the gene conferring reduced drug uptake. When this is acconglished, 
it would be possible to clone the gene cuid to test whether cells trans­
formed with the gene exhibit a pleiotropic phenotype (assuming dominance 
or co-dominance of the Cyd -genotype; gene an^ lification mutants 
characteristically behave codominantly in cell hybrids). 
All of the major points of the model have been discussed in pre­
ceding sections. However, it was not mentioned how the model could 
account for a partial defect in cytokinesis, which is a phenotypic 
characteristic apparently unique to the Cyd -variants. Assuming that 
the partial defect in cytokinesis is directly related to the lesion 
(gene amplification) underlying CD resistance, the cytokinesis defect 
can be readily accounted for with the framework of the model. The Cyd -
variants have increased cell-cell adhesion, presumcibly resulting from 
altered membrane glycoproteins and glycolipids. Cytokinesis is thought 
to result from the force generated by the contractile ring of microfila­
ments intimately associated with the membrane, combined with a pulling apart 
R 
of the two daughter cells (Schroeder, 1978). In the Cyd -variants, the 
change in membrame fluidity and pliability may reduce the fore generated 
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by the contractile ring. Alternatively, the increased cell-cell 
adhesion may sometimes result in the inability of two cells to pull 
apart. It is not clear why an increase in multinucleate cells has not 
been reported in other drug uptake mutants; perhaps the increase in 
multinucleate cells was simply overlooked. Alternatively, the lack 
of this characteristic in other drug uptake mutants may be indicative 
of a different genotype. The HSR observed in actinonycin D-, dauno-
rubicin- and vincristine-resistant Chinese hamster lung cells is on a 
chromosome different them that reported here for the Cyd -variants 
(the HSR in vincristine-resistant cells is part of a structurally 
abnormal chromosome consisting of chromosome 9 and part of the long 
arm of an X chromosome; Biedler and Peterson, 1981). Finally, it is 
still possible that the partial defect in cytokinesis is not associated 
with the lesion mediating CD resistance, although the data I have pre­
sented do not support this. 
F. CD-Resistance cuid Chemotherapy 
It is becoming well-established that gene amplification is a common 
mechanism whereby cells in culture acquire resistance to a drug(s) 
(see section: Gene Amplification). Until recently, it was thought that 
gene amplification only occurred in response to a specific drug, and 
that only the gene coding for the target of the drug was amplified. It 
is now becoming clear that another type of gene ançlification can con­
fer drug resistance; amplification of a gene(s) which controls drug 
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uptake (permeability, diffusion) and/or drug efflux. This type of 
gene amplification endows a cell with a generalized drug resistanceÎ 
cells are resistant to many other drugs with different structures, 
different cellular targets and different modes of action. This type 
of drug resistance is often found in tumors from patients undergoing 
chemotherapy. It also may occur in some cases of drug resistance in 
I 
insects, parasites, protozoans, etc. Consequently, understanding the 
mechanism(s) by which gene amplification c«m mediate generalized drug 
resistance is of primary in^ rtance. 
Present regimens of chemotherapy involve constant administration 
of increasing doses of a particular drug(s). This mode of drug treat­
ment is analogous to enrichment selection methods used to isolate drug-
resistant mutants of cultured cells. It has been suggested that a more 
efficient method of chemotherapy would be to give short pulses of one 
concentration of a chemotherapeutic drug, interspersed with periods 
without drug treatment (Gottlieb, 1975). To the extent that the results 
from CD-resistamt variants can be extrapolated to cancer chemotherapy, 
it would seem that intermittent drug challenge at one drug concentration 
can also result in drug-resistant tumors. 
Like the colchicine-resistant mutants described by Ling (1975), 
the Cyd -variants are hypersensitive to one or more membrane-specific 
drugs. %us, it might be possible to treat highly drug-resistant 
tumors (where drug resistance is due to changes in membrane permeability) 
with other drugs that tumors might be hypersensitive to. This mode of 
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remedial chemotherapy would have the further advantage of allowing the 
use of drug concentrations that are toxic to cancer cells but that are 
relatively nontoxic to normal cells. Finally, it may be possible to 
chemically modify cancer drugs so that they retain cellular toxicity 
and can also enter resistcmt (inqpermeable) cancer cells. 
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